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Summary
In recent years, interest in the cellular structures known as PM.l Oncogenic Domains
(PODs) has been growing, as it has become increasingly clear that these structures
may be implicated in several cellular functions, such as the regulation of the levels of
active proteins in the nucleus, transcriptional regulation, suppression of growth and
transformation, antiviral response, cell-cycle regulation and apoptosis. The PODs
constitute large, multi-protein complexes associated with the nuclear matrix, and are
visualised under immunofluorescence analysis as discrete dots numbering 10 to 20
per nucleus. A major protein component of the PODs, the promyelocytic leukaemia
protein (PML), appears to be central to the function of these nuclear bodies. Notably,
disruption of the PODs is observed in several malignant tissues, at the beginning of
mitosis, and during infection with several viruses. During the course of a wild-type
adenovirus infection, the PML protein is redistributed from the normal punctate,
nuclear bodies. inr.o "track-like" structures, which colocalise with the viral protein,
E40rf3. By ide itifying a mutant adenovirus defective in track formation, it was
possible to ass"gn responsibility for POD reorganisation to this single viral gene
product. Western blotting analysis of PML has demonstrated the existence of a
characteristic pattern of PML isoforms, some apparently modified by the ubiquitin-
like protein, Sl. MO-I. Analysis of the PML species present in adenovirus infected
cells has shown that this characteristic pattern is altered, with the loss of SUMO-I-
modified isofon 11.3, and the appearance of a novel, infection specific band.
This thesis de ..cribes attempts to further investigate the nature and functional
significance of the interaction between the viral E40rf3 protein and the cellular
protein, PML, as occurs during adenovirus infection, by expressing Orf3 and mutants
of Orf3 in eukaryotic cells through the use of plasmid based gene expression systems.
By these methods, Orf3 was confirmed as necessary and sufficient for the
redistribution of PML from the PODs to the "track-like" structures associated with
adenovirus infection, and regions of the Orf3 protein implicated in the nuclear
retention of the protein or protein stability were identified. Further, a potential link
between POD redistribution and the adenovirus infection-specific PML isoform was
investigated using Western blotting analysis on cell lysates derived from eukaryotic
cells expressing Orf3 or mutants of Orf3 in isolation from other viral compnents. To
facilitate these investigations, attempts were made to develop cell lines capable of
permanent exp« ~:;10nof Orf3 protein. These experiments led to the identification of a
potentially cytc pathic effect associated with the long-term expression of Orf3 in
eukaryotic cells. Attempts were also made to construct whole, infectious virus,
expressing mutant Orf3 proteins.
11
Abbreviations
Ad: Adenovirus
Ad2: Adenovirus serotype 2
AdS: Adenovirus serotype S
APL: Acute promyelocytic leukaemia
ASK 1: Apoptos s signal-regulating kinase 1
ATRA: All-trans retinoic acid
BH3: Bcl-2 homologous region 3
BLMs: Bloom's syndrome protein
BRK: Primary baby rat kidney cells
BSA: Bovine serum albumin
CBP: CREB-binding protein
cdk: Cyclin-dependent kinase subunit
ClAP: Calf intestinal alkaline phosphate
CMV: Cytomegalovirus
CTL: Cytotoxic T lymphocyte
CVB: Coxsackievirus group B
DBP: DNA binding protein
DMEM: Dulbecx, I••modified Eagles medium
DMSO: Dimetr l' sulphoxide
DNA: Deoxyril xmcleic acid
DTT: Diothiothreitol
E2F: E2 binding protein
EBV: Epstein-Barr virus
Ecoli: Escher'; ila coli
EDC: Epidermal differentiation complex
EDTA: Ethylenediaminetetra-acetic acid
eIF3-p48: Eukaryotic translation initiation factor-3
eIF-4E: Eukaryotic translation initiation factor 4E
ESI: Electron microscopic imaging
FCS: Foetal calf serum
FITC: Fluorescenc 'sothiocyanate
FU: Fluorine-substituted uridine
12
GAPDH: Glyceraldehyde 3 phosphate deydrogenase
GAS: IFN-g activation site
Hepes: N-2-hydroxyethylpiperazine-N'-2-ethanesulphonic acid
HIP-I: Huntingtin interacting protein I
HMG 1: High mobility group 1 protein sequence
hPML: Human ?ML
hr: Hour
HSV: Herpes Simplex Virus
HTLV: Human T-cell leukaemia virus
IE: Immediate-early protein
Ig: Immunoglobulin
IF: Immunofluorescence
IFN: Interferon
Immuno-FISH: Immunofluorescence in situ hybridisation
ISRE: IFN-stimulated response element
JNK: Jun NH2 -terminal kinase
Kr: Kremer bod :('s
LANDS: Lymphocyte associated nuclear domains
LBamp: LB covaining (lOOmicrogram/ml) ampicillin
MARs: Matrix •.ssociated regions
MHC: Major Pi srocompatibility Complex
MKP: MAP kinase phosphatase
MMTV: Murine mammary tumour virus
mRNA: Messenger RNA
NB: Nuclear Body
NCS: Newborn calf serum
ND: Nuclear dots
NF-I: Nuclear factor-I
NLS: Nuclea, :'Icalisation signal
Nonidet P40: N."'40
ORF: Open reading frame
Orf3: Adenovirus E4orf3 protein
Orf6: Adenovirus E4orf6 protein
PARP: Poly(ADP-ribose )polymerase
13
PBS: Phosphate buffered saline
PBC: Primary biliary cirrhosis
PCD: Programmed Cell Death
PEG: Polyethylene glycol
p.i: Post-infection
PIG3: p53 induced gene 3
PML: Promyelocytic leukaemia protein
POD: Promyelocytic oncogenic domain
Pol: DNA polymerase
p.t: Post-transfection
PT: Virion proteinase
PTP: Terminal protein precursor
RARa.: Retinoic acid receptor alpha gene
Rfp: Ret finger protein
RGD: Arg-gly-asp sequence
RNA: Ribonucleic acid
SDS: Sodium Dodecyl Sulphate
SDS-P AGE: SDS polyacrylamide gel electrophoresis
SMN: Survival of motor neurons protein
TBP: TAT A-binding protein
TNF: Tumour Necrosis Factor
UbH domain: Ubiquitin-like domain
VSV: Vesicular stomatitis virus
55K: Adenovirus Elb-55kDa protein
14
1. Introduction
1.1. The Adenoviridae
The adenoviruses comprise a group of related pathogens, first isolated and
characterised by investigators searching for the etiological agents of acute respiratory
infections. The prototype viral strain was isolated from adenoid tissues and in 1956
the agents were named adenoviruses. Epidemiological studies confirmed that
adenoviruses were the cause of a large number of acute febrile respiratory symptoms
among military recruits (Commission on Acute Respiratory Disease, 1947; Dingle et
al., 1968; Ginsberg et al., 1955). They are not however, the etiological agent of the
common cold, accounting for only a small proportion of acute respiratory morbidity,
and only 5% to 10% of respiratory illness in children. Adenoviruses can also cause
epidemic conjunctivitis (Jawetz, 1959), and have been linked with a variety of clinical
syndromes including infantile gastroenteritis (Morris et al .• 1975; Yolken, 1982).
1.1.1. Classification
The Adenoviruses constitute the Adenoviridae family of viruses, which is divided into
two genera, the Mastadenovirus and the Aviadenovirus (Norrby, 1969). The
Aviadenovirus genus contains viruses of birds, while the Mastadenovirus genus
includes human, simian, porcine, bovine, equine, canine and opossum viruses. There
is antigenic cross-reactivity among members within each genus, but no known antigen
common to all adenoviruses.
To date, 51 hun-a-i serotypes have been identified (De Jong et al., 1999) on the basis
of resistance to "'Jutralisation by antisera to other known adenovirus serotypes. This
type-specific re utralisation is due primarily to antibody binding to epitopes on the
virion hexon J:'(C iein and the terminal knob portion of the fiber, protein (Norrby, 1966;
Toogood et al., 1992). These serotypes are classified into six sub-groups based on
their ability to agglutinate red blood cells (Hierholzer, 1973; Hierholzer et al., 1988;
Rosen, 1960). A variety of additional classification schemes have been fielded, but all
produce similar groupings, suggesting that the scheme based on haemagglutination is
a reasonable standard.
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1.1.2. Virion structure
Adenoviruses are icosahedral particles that are 70-100nrn in diameter (Home et al.,
1959), containing DNA (13% of mass), protein (87% of mass), no membrane or lipid,
and trace amounts of carbohydrate. The virions consist of a protein shell around the
DNA-containin~ core. The protein shell (capsid) is made up of 252 capsomere
subunits of wh.ch 240 are hexons and 12 are pentons (Ginsberg et al., 1966).
Electrophoretic analyses of purified virions disrupted with sodium dodecylsulphate
(Ishibashi and Maizel, 1974; Maizel et al., 1968; van Oostrum and Burnett, 1985) and
comparison of results thus obtained with genomic open reading frames (ORFs),
suggests 11 virion proteins.
The hexon protein is made up of three tightly associated molecules of polypeptide II.
This trimer is often referred to as the hexon capsomere, and is surrounded by six
neighbours on the virion. Five copies of polypeptide III associate to form the penton
base protein (Val' Oostrum and Burnett, 1985) which is found at each vertex of the
virion, surrouc.i.d by five neighbours. Polypeptide IV forms the trimeric fiber protein
(van Oostrum a-'ll Burnett, 1985) which projects from each penton base at each vertex
of the icosahed ron. The combination of penton base and fiber protein is called the
penton capson. re. Polypeptides VI, VIII and IX likely stabilise the hexon capsomere
lattice, and VI ,'tId VIn probably bridge the gap between capsid and core. Polypeptide
IlIa is associate. 1 with hexon units that surround the penton afte ~pyridine dissociation
of virions and :'robably links adjacent facets of the capsid and serves a bridging
function between hexons and polypeptide VII of the core (see fig.l.l).
The core of the virion contains polypeptides V, VII, X and the genome terminal
protein. Polypeptide VII is the major core component and probably serves as a
histone-like centre around which the viral DNA is wrapped (Chatterjee et al., 1986;
Mirza and Weber, 1982). Polypeptide V can bind to a penton base (Everitt et al.,
1975) and might hridge between the core and capsid. The function of the pX protein is
unknown. The ~1.:~:'linalprotein is covalently attached to the 5' ends of viral DNA (see
fig.I.I) and is a~',:eto mediate circularization of the viral DNA through the formation
of a protease-sc-sitive, phosphodiester bond between the ~-hydroxyl group of a serine
residue of the i 'nninal protein, and the 5' hydroxyl of the terminal deoxycytosine
residue (Desicvio and Kelly, 1981; Smart and Stillman, 19~2). It is present in only
two copies per', nion, having served as a primer for DNA re{,.j",ation
16
A.
B.
COflE
Figure 1.1. Diagrammatic representation of the adenovirus particle. A: A three-dimensional
representation of the virion. Indicated are hexons (H), peripentonal hexons (PE), pentons (P) and
fibre (F) (S.Riley, unpublished). B: A stylised cross-section of the virus particle based on current
understanding of polypeptide components. Virion constituents are designated by their polypeptide
number except for the terminal protein (TP). From Stewart et al., 1991.
(Arrand and Roberts, 1979; Challberg et al., 1982; Lichy et al., 1981; Tamanoi and
Stillman, 1982) and as a mediator of attachment of the viral genome to the nuclear
matrix (Bodnar et al., 1989; Fredman and Engler, 1993; Schaack et al., 1990).
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1.1.3. Genome Organisation
All adenoviruse .s examined to date have the same general genome organisation, which
is to say that specific genes are at the same relative positions on the genome, with the
exception of the VA RNA gene which is positioned differently on the avian CELO
virus genome than in its mammalian counterpart (Larsson et 'dl.,1986). The genome
comprises a single, linear double-stranded DNA molecule, with short terminal repeats
(STRs). The inverted structure of the STRs plays a role in DNA replication. Each
terminal repeat contains an origin of replication, each identical to the other.
Conventionally, the viral replication cycle is divided into early and late phases,
separated by the onset of viral DNA replication. Early events begin immediately upon
interaction with the host cell, and include adsorption, penetration, transcription and
translation of an "early" set of genes. The viral chromosome carries five early
transcription units (EtA, EtB, E2, E3, and E4). The products of these genes are
implicated in the mediation of viral gene expression and DNA replication, the
induction of cell cycle progression, and the blocking of apoptosis and other cell-
defence mechanisms (see section l.t.S). In HeLa cells infected at a multiplicity of 10
plaque-forming units per cell, the early phase lasts for 5-6 hours. Two viral proteins
(IX and IVa2) oegin to be expressed at an indeterminate time and so constitute
"delayed early" units. The late phase of the viral replication cycle begins with the
onset of viral DNA replication, and is characterised by the expression of a set of
"late" viral genes from the "major late" unit (MLTU), and the assembly of progeny
virions. Transcripts from the MLTU are processed to generate five families of late
mRNAs (Ll to LS). All are transcribed by RNA polymerase II. Depending on the
serotype, adenoviruses also carry one or two VA genes, transcribed by RNA
polymerase III. The infectious cycle is completed after 20-24 hours in HeLa cells
(reviewed by Shenk, 2001).
Both strands of the DNA are transcribed. The rightward reading strand yields EtA,
EIB, IX, major late, VA RNA and E3. The leftward reading strand encodes the E4,
E2 and IVa2 units.
The genes transcribed by RNA polymerase II give rise to multiple RNAs that are
differentiated by the use of alternative splicing and in some cases, by the use of
different poly(A) sites. The alternative products of the same transcription unit may be
related in their sequence, or have no sequence in common at all. Often, the individual
transcription units encode polypeptides of related function. Among the early genes,
18
for example, the ElA unit encodes two proteins that activate transcription and induce
host cells to enter S phase. El B encodes two proteins that cooperate with El A
products to induce cell growth. E2 encodes three proteins that function in DNA
replication, and E3 encodes products that modulate the response of the host to
infection. However, the E4 unit encodes what appears to be a disparate set of
functions, as will be discussed in detail below.
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1.1.4. RepUcaUve eyele
Studies of the replicative cycle have primarily focused on the closely related human
serotype!, Ad2 and AdS, as these viruses have proven easy to cultivate, and a host of
mutants have been generated. Insights gained using these viruses have shown to be
applicable to the other adenoviruses. The replicative cycle is divided into two broad
stages, the early and late stages of infection. The early phase is characterised by
0rf1 L- -0r12r-0r13:-=
Orf4~,...-
0r15t--
L- _0r1'8I7!- _
IW
r----pTP
~i Pol
IVI2 E2S
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adsorption of the virus to the host cell, penetration, transcription and translation of
early genes. The early viral gene products are responsible for regulation of viral gene
expression and DNA replication, induce cell cycle progression, block apoptosis and
antagonise host antiviral measures. In HeLa cells, the early phase lasts for five to six
hours, after which replication of viral DNA is first detected. At this point, the
infection is entering late phase, characterised by the expression of "late" genes and the
assembly of progeny virus (approximately 104 progeny virus particles per cell, plus
unassembled excess protein and DNA). The infectious cycle is completed after 20 to
24 hours in HeLa cells.
Adsorption is mediated by the fiber protein at the distal, carboxy-terminal portion of
the protein. Specificity of attachment may be due to sequence heterogeneity between
serotypes at this. "knob" region. Ad infection is initiated by the formation of a high
affinity complex between the fibre protein and a host cell protein that for most Ad
serotypes is the 46kDa coxsackievirus group B (eVB) and ac :.;~ovirus(Ad) receptor
(He VADR, formerly HeAR), a cell surface protein with two immunoglobulin-like
regions (IGI and IG2) (Bergelson et al., 1997; Tomko et al., 1997; Tomko et al.,
2000). A second molecule, the MHe class I, may also be involved in Ad type 2 and
Ad type 5 uptake (Hong et al., 1997).
Entry of the particle into the host cell requires penton base binding to cellular
integrins, primarily av~3 and av~s vitronectin-binding integrins, through an arg-gly-
asp (RGD) sequence present in the polypeptide III molecules of the penton base
(reviewed by Shenk, 2001; Wickham et al., 1993). This interaction results in diffusion
of the particle into clathrin-coated pits, followed by internalisation by receptor-
mediated endocytosis.
Upon internalisation, the early endosome is disrupted, probably after a drop in pH
(reviewed by Shenk, 2001) which the virus may harness somehow to escape to the
cytosol, from where it moves to the nucleus by a process probably involving
microtubules (Suomalainen et al., 1999). The virion is disassembled in an ordered
manner following internalisation, culminating in the release of the DNA at the nuclear
pore (Dales and Chardonnet, 1973;Greber et al., 1997).
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1.1.5. The early viral genes
Early adenovirus gene expression has three main effects. These are to induce the host
cell to enter into the S phase of the cell cycle thus creating the optimal environment
for viral replication, to protect the cell from the various antiviral defences of the host
organism including the cell's own responses to viral attack, and to synthesise viral
gene products needed for viral DNA replication.
1.1.5.1. The EIA transcription unit
The viral EIA region unit (Jones and Shenk, 1979) is the first transcription unit to be
activated after entry into the nucleus, producing two disti~ct early mRNAs with
sedimentation coefficients of 13S and 12S, in turn generating t':yo polypeptides of280
and 243 amino acids respectively. The EIA proteins are able to activate expression of
adenovirus transcription units by binding to a number of different cellular
transcription factors and regulatory proteins. The l3S E1A protein is believed to bind
directly to the TATA-binding protein (TBP), possibly relieving pS3 suppression and
ultimately resulting in upregulation of the basal transcription machinery. In addition
to this interaction, the E1A proteins also act to activate transcription of viral genes
through the E2F transcription factor. This protein is found to bind to the adenovirus
E2 promoter ar.. : v ithin the enhancer domain of the El A gene. In complex with the
cellular retinoblastoma tumour suppressor protein, pRB, E2F is inactive, but both
El A proteins are believed to bind to pRB, dissociating the E2F -pRB complex and
liberating the. transcriptional activation ability of the transcription factor. This
activation of E2F by ElA influences the expression of viral genes, and in addition,
affects the cell-cycle progression of the host cell.
Free E2F can activate transcription, and ectopic expression of E2F induces cells to
enter S phase. E2F likely activates a series of genes that are important for cell growth
and S phase that contain E2F binding sites in their promoters, including dihydrofolate
reductase, thymidine kinase, thymidylate synthetase, cdc2, c-myc and others. It is
likely that pRB is one of several proteins that regulate cell cycle progression through
interactions with E2F. Indeed, two cellular pRB family members p107 and pI30, have
also been found: to complex with E2F. Interestingly, these proteins can also be bound
by E1A, dissociating E2F. The EIA proteins also complex with CBP, the cellular
transcriptional. activator p300 (Rikitake and Moran, 1992; Barbeau et al., 1994;
Shenk, 1996), and the p400 protein (likely a chromatin-modulating factor) (McMahon
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et al., 1998; Fuchs et al., 2001) resulting in deregulation of the cell cycle and entry
into S-phase.
Other roles of [he EIA unit include a role in inhibition of the antiviral effect of
interferon by blocking the activation of interferon response genes. The transcription
factor ISGF3 transduces interferon (IFN)-alpha signals and.activates the transcription
of cellular antiviral defence genes. EtA blocks ISGF3 DNA-binding in response to
interferon activation (Kalvakolanu et al., 1991). Bhattacharya et al. (1996) showed
that p300 and/or CBP (CREB-binding protein), interact specifically with Stat2, one of
the components of ISGF3, and that by inhibiting p300/CBP function, EIA represses
ISGF3 function.
1.1.5.2. The E1B Transcription unit
The EIB transcription unit encodes two main proteins of 55kDa and 19kDa. When
transiently expressed in cells, EIB-55kDa is detected throughout the cell in a diffuse,
speckled pattern. During wild-type infection, the protein shows diffuse nuclear
staining overlai ! vith a variable number of discrete foci (Leppard and Everett, 1999).
It was thought t) form a specific and predominantly nuclear complex with the E4orf6
(Sarnow et al., 1984) that shuttles between the nucleus, and cytoplasm mediated
predominantly by the Orf6 protein (Dobbelstein et al., 1997; Goodrum et al., 1996).
However, recei.t work has shown that EIB-55kDa is capable of independent
nucleocytoplasmic shuttling, and that the 55kDa protein may in fact be the "driving
force" for adenovirallate mRNA transport (Kratzer et al., 2000; Dosch et al., 2001).
Orf6 is necessary for localisation of 55K to the periphery of the viral replication
centres (Omelles et al., 1991), and the 55K10rf6 complex has been shown to perform
at least two functions in infection.
The deregulation of cell cycle control by EIA results in the accumulation of high
levels of p53 in the nucleus, which can then induce apoptosis. The EIB-55kDa
protein allows adenovirus to replicate successfully by blocking EIA-induced
apoptosis (reviewed by White, 1995; Chinnadurai, 1998). This is achieved by
targeting the cellular p53 tumour suppressor protein. This tumour suppressor is a
sequence-specific DNA-binding protein that can activate ~ription when it binds
to pS3 respqnse elements. and in addition, can repress a variety of genes that lack a
binding site for pS3. It normally functions as a component of the G) checkpoint that is
induced by DNA damage, acting as a sequence-specific transcriptional activator, and
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can transactivate target genes such as that encoding the pro-apoptotic factor Bax,
which is involved in the mitochondrial checkpoint of apoptosis. It also neutralises the
anti-apoptotic functions of BCL-XL and BCL-2 (Ko and Prives, 1996; Chao et al.,
1998). Under various stress conditions p53 undergoes post-translational modification
that affects its conformation and binding to several proteins, resulting in its
stabilisation and increased DNA-binding potential (Giaccia and Kastan, 1998; Levine,
1997), and high level expression can result in apoptosis. The p53 gene is mutated in
the majority of human cancers, indicating that loss of p53 function may have an
important role in tumourigenesis (Jomvall et al., 1982; Hollstein et al., 1994). p53-/-
mice are develcpmentally normal but are highly prone to developing spontaneous
tumours (Donehower et al., 1992), and p53-/- cells such as primary thymocytes are
protected from DNA-induced apoptosis (Clarke et al., 1993; Lowe et al., 1993). The
Elb-55kDa protein binds to, and blocks transcriptional activation by p53. The 55kDa
protein colocalizes with p53 in cytoplasmic clusters in the absence of E4 proteins
(Blair et al., 1988; Zantema et al., 1985), but upon E4orf-.:; coexpression, p53 is
strongly destabilised and steady-state amounts of the protein are greatly reduced
(Querido et al., 1997; Steegenga et al., 1998). Consequently, it appears that EIB-
55kDa and E40rf6 work in complex to reduce p53 abundance.
The second major function of the complex is as a modulator of mRNA transport.
When both proteins are expressed during infection, viral mRNAs are efficiently
carried to the cytoplasm while most cellular mRNAs are retained in the nucleus
(Babiss et al., }985; Beltz et al., 1979; Pilder et 01., 1986). 55K-deficient mutants
show failure of late mRNA export correlating with impaired release of RNA from its
tight association with the nuclear matrix.
The smaller, 19kDa EIB protein is more effective at blocking apoptosis, acting on
Bax in a similar manner to the cellular Bcl-Z protein (Han et al., 1998; Ohi et al.,
1999). The cellular protein Bax, was found to act pro-apoptotically, disrupting the
mitochondrial membrane potential. This could be rescued by El B 19K, which was
found to interact specifically with the protein through its Bcl-2 homologous region 3
(BH3) (Han et 01.• 1998). BH3 regions are sufficient for the interaction of pro-
apoptotic and anti-apoptotic BcI-2 family members, and binding specificity at these
regions was found to regulate mitochondrial membrane potential and apoptosis. El B
19K may act to antagonise pro-apoptotic proteins rather than as an effector of
survival. Current studies suggest that amongst other activities, certain of the
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adenovirus E4 proteins may also be directed against apoptosis by a different
mechanism, as will be discussed in detail below. The EIB-19kDa protein also protects
against the effects of TNF-a, a cytokine secreted by activated macrophages and
lymphocytes that can induce apoptosis resulting in cytolysis (Gooding et al., 1991;
Wold,1993).
1.1.5.3. The E2 transcription unit
The E2 region encodes three proteins essential for viral DNA replication. These are
the 80-kDa precursor terminal protein (Challberg et al., 1980; Stillman et al., 1981),
the 72kDa ss DNA binding protein (DBP) (van der Vliet and Levine, 1973) and a
140-kDa polymerase, with both 5' to 3' polymerase activity and 3' to 5' exonuclease
activity that probably serves a proofreading function (Field et al., 1984). The E2
promoter can be activated by EIA directly, the E2 binding protein (E2F), or the
17kDa E4orf617 protein via interaction with E2F (Neill et al., 1990; Raychaudhuri et
al., 1990).
1.1.5.4. The E3 transcription unit
The E3 encoded proteins appear to be important antagonists of the cytotoxic T
lymphocyte (CTL) response, and TNF-a. The E3-gp19 kDa protein is a
transmembrane protein that is held in the membrane of the endoplasmic reticulum,
where it binds to the peptide-binding domain of MHC class I antigens, preventing
these from leaving the ER and marking out infected cells to CTLs. In addition, either
the E3-14.7kDa protein or an E3-14.SkDaJE3-10.4 kDa protein complex protects
against some of the effects ofTNF-a (reviewed by Burgert and Blusch, 2000).
1.1.5.5. The E~ transeription unit
To date, all sequenced human adenovirus genomes contain a gene that is closely
related to the E4 gene, first identified in human Ad2. This locus of the viral genome
has a primary transcript approximately 3kb in length, which contains at least seven
ORFs (Open Reading Frames - see fig 1.3.). The transcript can produce more than
eighteen distinct mRNAs through alternate splicing, giving rise to six different known
peptides (0rfl,2,3,4,6,617), which have been demonstrated to exist in infected cells.
Adenovirus mutants lacking the E4 region display a complex mix of aberrant
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phenotypes including defects in viral gene expression, viral DNA replication,
accumulation of late mRNAs, synthesis of viral proteins and virus-induced host cell
shutoff (reviewed by Leppard, 1997). Most of these phenotypes can be assigned to
lack of the E4orf6 and/or E40rf3 proteins.
The E4orf6 and E40rf3 proteins can both independently improve the stability of late
RNA in the nucleus and play an as yet unidentified role in regulation of Ad DNA
replication. In the absence of both proteins, DNA replication is seriously impaired and
heterogeneous populations of large, concatemeric viral DNAs produced (Bridge et al.,
1989; Halbert et al., 1985; Huang and Hearing, 1989a; Weiden and Ginsberg, 1994).
Either one of these two proteins is sufficient for efficient virus production, their
activities apparently being largely redundant, although Orffi deficient virus does have
some residual phenotypic similarities to the double mutant.
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sequences unless they share the same number.
Adapted from Lcppard (1997).
In accordance with their partially redundant roles in infection, both 0rf3 and Orf6
have been reported to have transforming potential. E4orf6 has been demonstrated to
cooperate with EtA and EtA plus EtB-55kDa, to transform primary baby rat kidney
(BRK) cells in tissue culture (Moore et al., 1996; Nevels et al., 1997). It is likely that
this is effected through modulation of p53 function. The E40rf6 protein works in
complex with the EIB-55K protein to facilitate the export of viral mRNAs from the
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nucleus, and to inhibit the export of most cellular mRNAs (see 1.1.5.2.). It also binds
to pS3, abrogating p53-induced apoptosis, independently of 55K. Nevels et al. (1999)
reported that E4orf3 could also cooperate with the El A and El B proteins to transform
BRK cells, acting synergistically with E40rf6 in the presence of EIB-55kDa. Using
0418 selection, transformed cell lines were generated expressing El A and El B,
EIAIB plus E40rf6 or E4orf3, and EIAIB plus E40rf6 and E40rf3. Those lines
expressing E4mfo had considerably lower pS3 levels than other cell lines. Those
expressing E4orf3 did not affect pS3 levels, thus unlike E40rf6, the E40rf3 protein did
not modulate the function or stability of p53. Using the same- cell lines in combined
immunoprecipitation-immunoblotting assays, it was demonstrated that E40rf3 could
not be detected in interaction with p53 or the cellular protein, PML (see 1.2.3.), but
did bind to EIB-SSkDa. It has now been shown that the E40rf3-11kDa protein does
interact with EIB-55kDa to relieve p53 inhibition indirectly (Konig et al., 1999).
EIB-55kDa transiently expressed in cells has a diffuse, cytoplasmic stain with
characteristic clusters (Samow et al., 1984 and this thesis). In a wild-type infection,
this diffuse stain is overlaid with punctate nuclear 55K staining regions. When cells
are infected ,·,h:. a virus mutant lacking a functional E4orf6 coding region, these
punctate region': are increased in number and prominence. These nuclear foci have
been found to colocalize both 55K and the virus E40rf3 protein, 0rf3 being necessary
for association :' f 55K with the nuclear matrix (Leppard and Everett, 1999).
Konig et al. (l ('Q9) showed that when transiently expressed in HeLa cells, E40rf3
redirects EIB-55kDa from the cytoplasm to nuclear tracks and went on to argue that
the E40rf3 protein has a role in liberating pS3 from SSK-induced inhibition of
transcriptional activity. E40rf3, EIB-55kDa and pS3 were transfected into HeLa cells
in different combinations, and detected by immunofluorescence. In the absence of
viral proteins, pS3 was found in a nuclear distribution. In the presence ofEIB-5SkDa,
it was relocated to cytoplasmic clusters. The addition of E40rf3 to the system
relocated EIB-S5kDa to nuclear tracks, while pS3 was distributed over the nucleus in
a similar pattern to that found in the absence of viral proteins. E40rf3 alone did not
appear to have aoy effect on pS3 distribution.
These same authors used a reporter plasmid with a p53-dependent promoter driving a
luciferase reporter gene to measure pS3 activity in human osteosarcoma-derived cell-
lines (8aos-2 cells) either singly or doubly transfected with EIB-SSkDa and/or
E40rf3. A pS3 expression plasmid was added as Saos-2 is a· pS3-null cell-line. The
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results showed that EIB-55kDa alone reduced activity from the pS3-dependent
promoter while E40rf3 alone slightly increased pS3 activity. More striking, was the
result that coexpression of the two proteins led to an abolishment of EIB-SSkDa
inhibition of pS3 activity. Cotransfection of 55K and E40rf6 had the effect of down-
regulating pS3 activity to an even greater extent than 55K alone. This effect was not
reversed by the addition of E40rf3. The same group concluded that E40rf3 does not
influence p53 stability.
To test whether the above observations were relevant to infection, KOniget al. (1999)
used a variety of adenovirus mutants to infect AS49 cells. During wild-type infection,
EIB-SSkDa moves from cytoplasmic clusters early in infection, to concentrate at
replication centres within the nucleus. This localisation has been shown to depend on
E40rf6. During infection with a mutant virus lacking the entire E4 region, the El B-
55kDa protein did not leave the cytoplasmic clusters. When cells were infected with
mutant 366*+0rf3, which lacks the E4 region but expresses E40rf3, EIB-SSkDa
moved from cytoplasmic clusters to the nuclear tracks typical of E4orf3 localisation.
Later in infection. EIB-5SkDa did move to the replication centres suggesting E40rf3
is another mediator of the nuclear localisation of the protein in infected cells. In
contrast with the gradual pS3 degradation seen during wild type infection, this process
was accompani \l Jy a nuclear accumulation of pS3. Under these circumstances, a
large proportior. ofthe pS3 moved to within the virus replication centres, colocalising
with viral DNA. while EIB-SSkDa accumulated in the peripheries of these centres.
These results support the suggestion that E40rf3 can dissociate pS3 from association
with EIB-55kDa not only when transiently expressed, but.also during infection.
E40rf3 expression precedes that of E40rf6 during infectio t. but ultimately SSK
preferentially complexes with E40rf6 away from the tracks, and in concert these two
proteins eliminate pS3 activity. However, it is thought that certain viruses (CMV,
HSV) might make use of upregulated pS3 in their infectious process, and it may be
the case that prior to EIB-SSkDaIE4orf6 inactivation and degradation ofpS3, E40rf3
facilitates temporary pS3 activity in adenovirus infected cells.
As well as these functions, the E40rfJ product is necessary and sufficient for the
reorganisation of cellular, nuclear structures known as promyelocytic oncogenic
domains (PODs). This phenomenon forms the major focus of the work discussed in
this thesis, and the PODs and their viral interactions will be shortly be discussed in
detail.
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Of the remaining proteins, Orf617 regulates the Ad E2 promoter through its ability to
bind to and stabilise E2F dimers (Huang and Hearing, 1989b). The Orf4 protein can
induce caspase-independent cell death, and is important in down-regulating the
expression of EtA and E4 genes which is effected through interaction with protein
phosphatase 2A (Bondesson et al., 1996). Orfl has been shown to have oncogenic and
transforming potential, promoting focus formation of CREF cells in vitro (Weiss et
al., 1996), and driving the formation of mammary tumours in female rats (Javier,
1994; Javier et al., 1992). Ort2 is a soluble cytoplasmic protein with no known
function (Dix and Leppard, 1995).
1.2. Nuclear Substructure
The deeper OUI understanding of the nucleus becomes, the less it appears to resemble
the loosely organised "bag" of proteins and DNA originally envisaged by some.
, "
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Indeed, it is becoming evident that the nucleus contains a var...:ty of domains that are
morphologically and functionally distinct as part of a defined, if dynamic,
substructure. Stresses of various types including viral infection, oncogene expression
and inherited human disorders. can cause profound and specific changes in nuclear
organisation.
1.2.1. The Matrix
The nuclear substructure known as the matrix is a highly organised 3D framework
consisting of proteins and ribonucleoproteins, as revealed by electron microscopy
(Fey et al., 1986). This structure remains after removal of the soluble proteins and
chromatin. It consists of a nuclear lamina, completely enclosing the nucleus and lining
the inside of the double membrane (Gerace and Burke, 1988), and an internal fibro-
granular framework (Capco et al., 1982; Verheijen et al., 1988; He et al., 1990).
Many nucleus-specific processes such as RNA synthesis (Jackson and Cook, 1985),
transport (Schroder et al., 1987; Xing and Lawrence, 1991) and processing (Smith et
al., 1989; Zeitlin et al., 1989) and DNA replication (Jackson and Cook, 1986;
Nakayasu and Beremey, 1989) are matrix associated and linked to specific nuclear
domains. Indeed, chromatin has specific sequences known as matrix associated
regions or MARs (Mirkovitch et al., 1984; Gasser et al., 1989) via which it interacts
with the nuclear matrix, resulting in the organisation of the chromatin into loops with
an average size of 80-90 kbp (Jackson et al., 1990). It is thought that the matrix may
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function to order and regulate active regions within the nucleus by controlling spatial
distribution. Individual chromosomes occupy discrete patches called chromosome
territories, which are separated by interchromasomal domains resembling channels
(Schardin et al., 1985). Active genes are preferentially localised to the peripheries of
the chromosome territories, where RNA transcripts are formed and shed into the
interchromasomal domains for further processing and transport (Kurz et al., 1996;
Wansink et al., 1996). Relative to less active chromosomes, transcriptionally active
chromosomes have more surface area in contact with the channels. The arms of
chromosomes have been shown to move within the nucleus during interphase and in a
cell-cycle dependent manner (Li et al., 1998; Robinett et al., 1996). These
observations would support the idea that to be replicated, DNA must be brought to the
.,
postulated "replication factories", presumably at the out 'kirts of chromosome
territories. These sites would be large, multienzyme complexes, fixed within the
nucleus, where movement of the chromosomes to the factories would be necessary for
initiation of replication, and provide a point of regulation.
1.2.2. Nuclear Bodies
Several nuclear substructures have been observed by indirect immunofluorescence,
that seem to comprise distinct "bodies" or regions, apart from the nucleolus (the
factory in which 28S, 18S and 5.8S rRNAs are transcribed, processed and assembled.
Among these are the snRNPs, coiled bodies and gems, and the PODs.
The VI, V2, U41U6 and VS small nuclear ribonucleoproteins (snRNPs) are
nucleoplasmic RNA-protein complexes that function as subunits of the spliceosome.
These structures yield speckled staining under immunofluorescence, upon a diffuse
staining background, probably representing collections of splicing components.
Coiled bodies r~··;pearas bundles of tangled threads, under microscopic analysis. They
contain high concentrations of coilin (Chan et al., 1994), fibrillarin (Raska et al.,
1990; JimenezGarcia et al., 1994) and certain splicing components (Huang and
Spector, 1991; Carmo-Fonseca et al., 1992). They are highly dynamic structures that
disassemble during mitosis and reform during GI phase, and may have a role in
snRNP transport, maturation or both. These structures are modified during AdS and
HSV-l infection (Bridge et al., 1993; Phelan et al.,1993), and proteins associated with
them may have: a role in AdS late splicing. Gems are often found paired to coiled
bodies, and contain the SMN (survival of motor neurons) protein, encoded by the
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gene responsible for a severe inherited form of human spinal muscular atrophy (Liu
and Dreyfuss, 1996; Lefebvre et 01., 1995). Of growing interest is the role of the
PODs also known as NDs (nuclear dots), Kremer bodies (Kr) and NDI0s. These
structures appear to be important to many cellular functions as will be discussed
below.
1.2.3. PML Oncogenic Domains (PODs) .
PODs were originally described as the autoantigenic target in patients with primary
biliary cirrhosis (PBC) (Bernstein et 01., 1984; Powell et 01., 1984), but are
components of most cell types, where they are visualised under immunofluorescence
analysis as discrete dots numbering 10 to 20 per nucleus. The POD constitutes a large,
multi-protein complex associated with the nuclear matrix. Under high magnification
light microscopy and electron microscopy, larger PODs have been shown to have a
"doughnut-like" shape, consisting of a dense fibrillar ring around a less-dense central
core, with many pores and channels throughout (Boisvert et 01., 2000). The exact
protein composiu.n and number of PODs varies between cell-types and with the cell
cycle, containmg a heterogeneous mix of functionally important proteins such as
ISG20 (Gongor. et 01., 1997). PICIISUMO-l (Boddy et 01., 1996), LYSPI00 (Dent et
01., 1996), Pl'?F (Ruthardt et 01., 1998), INT6 (Desbois et 01., 1996), CBPIP300
(LaMorte et al., 1998), RFP (Cao et 01., 1998), Daxx (Li et 01., 2000), BLM (Ishov et
al., 1999) and ribosomal protein P (Borden et 01., 1998). The promyelocytic
leukaemia protein (PML) and Spl00 are generally considered consistent and therefore
diagnostic components of PODs. Both these proteins were found to be autoantigens in
PBC, antibodies against Sp 100 and PML often co-occurring in the sera of patients.
While normally found attached to the insoluble nuclear matrix, PODs are dynamic
structures sensitive to numerous external and internal stimuli such as heat shock,
heavy metals, PML-RARa expression (a fusion protein associated with acute
promyelocytic leukaemia, see below), interferon, transformation and amino acid
starvation. The PODs are also strongly modified by infection with many viruses,
including herpes simplex virus (Maul et 01., 1993), cytomegalovirus (Kelly et 01.,
1995), Epstein-Barr virus (Szekely et 01., 1996), influenza (Guldner et 01., 1992),
human T-cell leukaemia virus (Desbois et 01., 1996). and adenovirus (Carvalho et 01.,
1995), through the action of viral regulatory proteins (reviewed by Sternsdorf et 01.,
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1997). In addition, a number of cellular POD proteins, including PML and Sp100, are
highly interferon-inducible, suggesting a possible role for these structures in the early
or late antiviral response.
Disruption of the PODs is also observed in patients with acute promyelocytic
leukaemia (APL). This malignancy manifests as a block in the differentiation of
promyelocytes, precursors of the granulocyte/neutrophil pathway. This leads to an
accumulation or' promyelocytes that infiltrate the bone marrow. This event is the..
result of a reciprocal translocation event, t(15; 17) between PML on chromosome 15
and the retinoic receptor alpha gene (RARa) on chromosome 17 (de The et al., 1990;
Goddard et al., 1991). The resultant PML-RARa fusion protein does not localise to
the PODs and, what is more, interferes with wild-type PML, disrupting the PODs and
resulting in a "microspeckled" appearance of PML under immunofluorescence (Dyck
et al., 1994; Koken et al., 1994). Evidence suggests that the PML domain of PMLRAR
plays a specific and critical role in the pathogenesis of APL (Kogan et al., 2000).
Disruption of the PODs is also observed in malignant tissues other than those of APL.
In the case oft:';;M,ocarcinoma, both the PML and Spl00 proteins are altered (Terris
et al., 1995). Interestingly, both retinoic acid and arsenic trioxide, that have been
shown to indueI I.linical remission through differentiation and apoptosis, respectively,
induce the rest ).'ation of normal PODs (Dyck et al., 1994; Koken et al., 1994; Zhu et
al., 1997; MU~I~ret al., 1998). These results suggest that disruption of the PODs is,
required for malignant cell proliferation at least in these insta.ces and further, imply,
that these structures may have a role during cell cycle regulation.
The heterogeneity of proteins that accumulate at these nuclear domains makes it
difficult to identify a single function for the PODs. It seems likely that at least
partially they act as nuclear storage sites for active proteins, accumulating or releasing
them as is appropriate to the correct functioning of the cell. For example, certain
proteins, such as the tumour suppressor BRCA1, only localise to PODs when
overexpressed (Maul et al., 1998), and the pRB tumour suppressor protein
accumulates at these sites, but only when in its inactive, phosphorylated form
(Alcalay et al., 1998). In this scenario, the PML protein would play a central role in
accumulating the components of PODs, as proteins such as CREB binding protein
(CBP), Daxx, Bloom's syndrome protein (BLMs) and Spl00 do not localise to PODs
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in the absence of PML. Indeed, PML overexpression has been shown to recruit CBP
to the PODs (La Morte et 01., 1998).
1.2.4. The Pro myelocytic leukaemia (PML) protein
The PML protein has been implicated in numerous cellular processes, including
transcriptional regulation (Boisvert et 01., 2000), suppression of growth and
transformation (Ahn et a/., 1995; Le et 01., 1996), antiviral response (see 1.2.4.7),
cell-cycle reguietion (see 1.2.4.2. and 1.2.4.5) and apoptosis (see 1.2.4.3).
The N-terminus of the protein contains 3 cysteine-rich metal binding domains which
probably complex zinc. These regions have been shown to be essential for localisation
of the protein ll: PODs, and are thought to mediate protein:protein interactions. The
first cysteine-rich region makes up a RING motif. This motif is shared by a family of
proteins found in a wide range of organisms from plants h viruses, and includes
proteins with many different functions, including many proto-oncogenes and
components of signal transduction pathways (Lovering et 01., 1993; Freemont et 01.,
1991). The other two cysteine-rich regions are known as the Bland B2 boxes. These
are followed by an a-helical coiled-coil domain, involved in dimerisation. This
RING-B-Box-coiled-coil pattern is common to a subgroup of RING finger proteins.
Like PML, two other members of this subgroup (TIF1 and Rfp) also become
oncogenic as a result of chromosomal translocations (Le Douarin et 01., 1995;
Hasegawa et ~L. 1996). The coiled-coil region is followed by a serine-rich domain,
which is absent from the PML-RARa fusion protein, and is speculated to have a
regulatory role.
Western blotting of PML in interphase cells reveals a complex family of isoforms
derived from alternatively spliced transcripts and post-translational modifications,
with a major band at 140 kDa (reviewed by Sternsdorf et 01., 1997).
1.2.4.1. Control and modulation of PML gene expression
Analysis of the PML promoter has identified several potential transcription factor
binding sites. There is no associated TATA or CCAAT-box, and transcription is
initiated at multiple sites (Stadler et 01., 1995). The PML promoter contains a
potential binding site for the huntingtin interacting protein I (HIP-I), a protein
implicated in caspase-8 activation and the initiation of apoptosis during the
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pathogenesis of Huntington's disease, which could indicate constitutive promoter
activity (Wanker et al., 1997; Wanker, 2002). In addition, the transcription factor Ets
probably plays a role in PML gene transcription. Transcription factors of this family
are thought to regulate gene expression in many diverse processes such as
transformation, differentiation and growth control (reviewed by Wasylyk et al., 1993),
which may bear a functional relationship to the role of PODs within the cell.
In addition, treatment with type I (a,l3) or type II (y) interferons (IFNs) strongly
enhances PML gene expression at the RNA and protein levels (Chelbi-Alix et al.,
1995; Grotzinger et al., 1996; Lavau et al., 1995). The PML promoter contains an
IFN-stimulated response element (ISRE) and an IFN-y activation site (GAS). The
ISRE alone is sufficient to mediate type 1111IFN-enhanced gene expression (Stadler et
al., 1995). What is more, IFN treated cells have been reported to express PML
isoforms not detected in untreated cells (Grotzinger et al., 1996) which may suggest
that IFN modulates alternative splicing of the mRNAs, generating PML proteins of
different functionality in response to invasion by virus.
1.2.4.2. PML, PICI/SUMO-l and Cell-Cycle regulation
As previously mentioned, the average size and number of PODs varies during the cell
cycle (Koken et al., 1995; Terris et al., 1995). During S phase. PML and SpiOO are
colocalized to 1.}": PODs (though no direct interaction between the two proteins has
been demonstrated), although both proteins also have a diffuse nuclear component.
Later, in G2; many cells have an increased number of POD. At the beginning of
mitosis, the PODs (stained with anti-PML antibody) become disrupted and as cells
enter prophase, the diffuse portion of PML is excluded from condensing
chromosomes. ID fact, both PML and Sp 100 become separated' from the PODs during
mitosis and at the breakdown of the nuclear envelope, PML forms irregular
accumulations where no SplOO is present (Everett et al., 1999). Once mitosis is
complete, cells enter G 1 when the process is reversed and the PODs reform (reviewed
by Stemsdorf et al., 1997). A proportion of the PML remains in the cytoplasm in
punctate bodies. This pattern is characteristic of cells in G1.
The mechanism by which localisation of PML is controlled is of interest as it has
implications not only in cell cycle regulation, but also for those investigating the
disruption of PODs during virus infection and tumourigenesis. The POD-associated
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protein SUMO-1 (also known as PIC1) is now known to modify a number of proteins
in a reversible manner, correlating with an alteration of the target protein's sub-
cellular localisation (reviewed by Johnson and Hochstrasser, 1997; Hodges et al.,
1998; Rodriguez et al., 2001). Amongst these proteins is PML, which SUMO-I has
been observed to modify in a cell cycle related manner (Everett et al., 1999). For
these reasons, SUMO-1 is an important candidate for regulating the activity of the
PML protein.
SUMO-1 is a member of a ubiquitin homology protein family, a heterogeneous group
that is characterised by an ubiquitin-like domain (UbH domain) (Boddy et al., 1996;
Mahajan et al., 1997). UbH domains often show amino acid changes in residues as
compared with ubiquitin required for the normal ubiquitination/degradation pathway,
\'
suggesting a different role for these proteins (Watkins et al., 993). In SUMO-I, the
lysine residues necessary for polyubiquitination are not present, suggesting it
functions as a monomer. It has a calculated mass of I1.5kDa, and has been shown to
have a strong and specific covalent linkage with the PML protein (Boddy et al., 1996;
MUller et al., 1998). SUMO-I has also been implicated in nuclear pore complex
function in protein transport, apoptosis, DNA recombination and repair where no
direct link to PODs has been observed (reviewed by Sternsdorf et al., 1997).
Studies transiently expressing SUMO-l in NIH3T3 cells showed a nuclear staining
pattern coincic> o: with that of the endogenous mouse PML. Cotransfection of
SUMO-I and human PML (hPML) generated completely overlapping patterns of
distribution (Boddy et al., 1996). Of interest is the observation that there was no
significant coloealisation between SUMO-I and the PML-RARA fusion in the APL-
derived cell line NB4, unless the cells had previously been treated with trans-retinoic
\'
acid, known to result in the formation of normal PODs in APL-derived cell lines
(Boddy et al., 1996). In a related observation, PML and SUMO·1 colocalised at the
PODs during interphase, but as the PODs broke down during mitosis, separation
occurred. Any remaining PML foci during mitosis have been shown by
immunofluorescence not to colocalize with SUMO-I (Everett et al., 1999). These
results imply a link between SUMO·IIPML colocalisation and POD
formationlbreakdown.
Further investigation revealed that SUMO-l is in fact, covalently linked to a subset of
PML in a reversible and phosphorylation-dependent manner. The SUMO-I·
polymodified forms of PML are compartmentalised into the PODs, in contrast with
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unmodified PML which is found in the soluble nucleoplasmic fraction. Zhong et al.
(2000) showed that SUMO-I conjugation of PML was necessary for NB recruitment
ofPML.
Endogenous PML in interphase cells can be detected by Western Blot analysis (using
mAb 5E 10. Stuurman et al.. 1992). revealing a complex family of isoforms derived
from both alternatively spliced transcripts and the effects of secondary modifications.
Above the major isoform at about 140kDa, are a three further species that are
generally held to represent conjugation by 1, 2 and 3 molecules of SUMO-l at
separate lysine residues.
At mitosis, these three SUMO-l modified isoforms of PML are. absent, and instead a
novel modified form of PML appears, migrating just slower than the major I40kDa
band. The lower molecular mass isoforms of PML do not appear to be affected. In
synchronised cells, the novel mitotic form of PML was observed along with a
corresponding decrease in the levels of the SUMO-I-modified isoforms, at 11 hours
after release from an aphidicolin block. By 13 hours, the interphase pattern had re-
established itself, but a little of the mitosis-specific isoform remained (Everett et al.,
1999). The quantitative deconjugation of SUMO-I from PML and the novel PML
modification appear to be rapid events confined to mitosis itself.
Conjugation of ~l'r.10-1to over-expressed PML in an engineered cell line was shown
to be inhibiteo cv the phosphatase inhibitor calyculin A (MUller et al., 1998), and
treatment of cu. cure cells with the phosphatase inhibitor generated an electrophoretic
profile of PML with considerable similarity to that for mitotic cells (Everett et al.,
1999). The drug rapidly induced the loss of the endogenous SUMO-I-conjugated
forms of PML, and in addition caused the production of a PML band that migrated
just slower than the major isoform, suggesting that it represented the same species as
was seen in mitotic cells. This mitosis specific isoform is highly labile, but was
stabilised by phosphatase inhibitors, supporting the hypothesis that a major factor in
the gel mobility of this form of PML is the presence of phosphate groups, and that it is
in fact, the same species as that derived by hyperphosphorylatioD of PML by calyculin
treatment. Treatment of interphase cells with okadiac acid, another phosphatase
inhibitor, gave similar results. Taken together, these results suggest that SUMO-I-
conjugation is dependent on PML phosphorylation state.
The predicted model during the cell cycle has deconjugation of SUMO-I from the
PML protein, probably by the SUMO-I de-conjugation enzyme HsUlp 1 (Li and
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Hochstrasser., 1999), with the appearance of a novel, hyper-phosphorylated PML
isoform. This results in POD disruption (observed in cells treated with calyculin A).
This process is reversed at OJ, with the reformation of PODs. A MAP kinase
phosphatase (MKP-4) has been detected in the PODs of about 20% of interphase cells
(Muda et al., 1997), and the cdk inhibitor p27KIPl (Quignon et 01., 1998) has been
reported to localise to these structures, connecting PODs and cell cycle regulated
phosphorylation.
1.2.4.3. PML and Programmed Cell Death (PCD)
Programmed cell death, also known as cell suicide, is a normal physiological process
:;...
important in development, maintenance of tissue homeostasis, and in the elimination
of cells that would otherwise constitute a danger to the organism, such as virus-
infected or genetically altered cells. Disruption of this process is involved in several
diseases. Programmed cell death is distinct from necrosis. The latter is characteristic
of cells that die of physical damage or poisoning, and typically the cells swell and
burst, spilling their contents over their neighbours. PCD is in fact a tidy process,
creating no mess. The most common form of PCD is apoptosis, in which the cell
nucleus becomes condensed and the DNA is fragmented, generating characteristic
"ladders" upon ~d'analysis, the cell shrivels, and the shrunken corpse is generally
engulfed and 1.!1.~estedby neighbouring cells. This process is mediated by a class of
cysteine proteases called caspases, which cleave key cellular proteins, inducing the
typical morphological features described above. Specific caspase inhibitors can
sometimes block or delay peD, but not in all cases. This will be discussed later (see
1.2.4.3.3).
PML expression or POD localisation is altered in a number of situations involving
abnormal cell survival, including virus infections, senescence or other human cancers.
What is more, Pml-I- mice are protected from the lethal effects of radiation and anti-
Fas antibody (Wang et al., 1998). A possible explanation for these findings is that
PML is involved. in the control of cell survival or death, and that disruption of PML
results in inappropriate cell survival. Recent evidence indicates that PML may in fact
be implicated in several different cell-death pathways. PML has been shown to act as
a transcriptional co-activator with pS3, colocalising with the protein in the PODs,
defining a PML·dependent, pS3-regulatory pathway for apoptosis (Guo et 01., 2000).
PML has also been shown to be essential for the induction of apoptosis by multiple
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stimuli such a DNA damage, Fas, TNF, ceramide and IFNs, by a pS3-independent
pathway (Wang et al., 1998). Further research suggests that PML overexpression
induces rapid cell death in a caspase-independent death process, independently of de
novo transcription and cell cycling (Quignon et al., 1998). Taken together, these
results suggest that PML is essential for multiple PCD pathways.
1.2.4.3.1. PML in p53-dependent apoptosis
As has previously been discussed, pS3 is a tumour-suppressor protein that has
functions in regulation of cell growth and cell death in response to cellular stress (see
1.1.5.2.). In thymocytes, DNA-damage-induced apoptosis in ~sponse to y-irradiation
is dependent on normal pS3 function (Lowe et al., 1993; Cla.....c- et al., 1993). Wild-
type and Pml-r- thymocytes were compared, and a marked reduction in the level of
apoptosis in Pml-deficient cells observed (Guo et al., 2000; Wang et al., 1998). PML
was found to markedly increase the level of transcriptional activity at pS3 response
elements, but was unable to act directly upon them. In this case, PML was found to
co-activate the Bax and GADD45 promoters. GST-pulldown experiments
demonstrated that PML and pS3 physically interact through the pS3 DNA-binding
domain, and the C-terminal domain of PML. Interestingly, in about 10% of U20S
cells, pS3 was found to colocalize with PML to the POD. Using PML mutants for
POD localisation. but still capable of pS3 interaction, it was shown that localisation of
PML in the POD., was necessary for the enhancement of transcriptional activation by
pS3 (Guo et al.. 2000).
These results demonstrated that PML was involved in regulation of pS3-dependent
apoptosis in cells such as thymocytes, and bone marrow haemopoietic cells. The
protein acts in this pathway as a pS3 transcriptional co-activator, that is necessary for
correct p53-DNA binding and induction of p53 target genes following y-irradiation. It
is likely that this effect is mediated through the post-translational modification of p53
by acetylation, by which it is made transcriptionally active. While PML has no
intrinsic acetyltransferase activity, it nevertheless is found in close association with
CBP (La Morte et al., 1998), a known acetyltransferase ofp53. This is another POD-
associated protein, and the observation that PML, CBP and p53 all co-localise to
PODs supports the hypothesis that the reciprocal interactions between these three
proteins are important for stabilising the pS3-CBP acetylation complex.
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Recently. Fogal et al. (2000). demonstrated that pS3 is recruited into the PODs
specifically by sumolated PML isoform IV (previously termed' PML3 in Fogal et al.,
2000). resulting in a marked increase in transcription from certain pS3 responsive
promoters. Interestingly. SUMO-l, required for PML localisation to PODs, was found
to modify pS3 directly (Gostissa et al.• 1999; Rodriguez et al.• 1999; MUller et al.,
2000), and when coexpressed with hUbc9 (the sumolation enzyme) localised pS3 to
POD-like nuclear structures. However. Fogal et al. showed that this effect did not
depend on the direct sumolation of the protein. since a conjugation-deficient mutant
was efficiently targeted to the PODs. They went on to demonstrate that pS3
recruitment to PODs was specifically mediated by the PML IV splice variant. in
comparison with an alternate splice variant. PML III (previously termed PML-L in
Fogal et al., 2000). This specificity was shown to be due to a region of the PML
variant outside the central domain and therefore the known sumolation sites of the
protein. As overexpression of hUbc9 and SUMO-l had the same effect. it is likely
that this was achieved via enhanced sumolation of endogenous PML, augmenting the
PODs. Overexoression of PML IV resulted in significantly .educed cell survival,
dependent upoi, the presence of pS3. PML III did not have 'any effect upon cell-
survival in this assay. These results demonstrate that not only do PML and the PODs
affect cell survival in a pS3-dependent manner, but that this is specific to a subset of
PML types. perhaps only one type. Co-expression of pS3 and PML III confirmed that
this isoform strongly increased the transcriptional activity of pS3 at the well-
established pS3 responsive promoter PIG3. (pS3 induced gene 3) involved in
apoptosis (Polyak et al., 1997; Venot et al., 1998). Interestingly. activity of pS3 at
another well-known pS3 responsive promoter, p21 (El-Deiry et al., 1993) was not
greatly enhanced. demonstrating that PML IV is able to enhance pS3-dependent
transactivation in a promoter-specific manner. Worth noting is that PIG3 is involved
in the inductic r of apoptosis in response to oxidative stress (Polyak et al., 1997),
consistent with" role for the PODs in pS3-dependent apoptosis. Where PML IV
mutants deficie.a in sumolation and consequently POD localisation were used, pS3
transcriptional activity was not significantly increased. Thus, interaction of pS3 with
PML IV is not alone enough to enhance transcriptional activity, it must also be
relocated to the PODs.
Further evidence for the importance of PML in pS3 activity comes from the
observation that the pS3-PML binding site is the location of the majority of pS3
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inactivating mutations observed in naturally occurring tumours. It is possible that
functional inactivation of PML through a failure to properly colocalise p53, results in
tumour formation.
1.2.4.3.2. PML in pS3-independent (Bell-inhibitable) apoptotie pathway
In mice and celis in which Pml was ablated by homologous recombination, Wang et
al. (1998) demonstrated that PML antagonised the initiation, promotion and
progression of tumours of various histological origins, acting as a cell-growth and
tumour suppressor, They went on to demonstrate that haemoglobin concentrations and
red blood cell counts following y-irradiation were reduced to a lesser extent in Pm!-I-
mice as compared with their Pm!+I+ littermates. DNA-damage-induced apoptosis
was reduced in splenocytes, and reduced lethality was observed in the irradiated Pml-
1- group, where death following irradiation is generally due to anaemia following
acute bone marrow aplasia. Their studies also demonstrated that PML is active in Fas-
and caspase-dependent apoptosis. This is a p53-independent (BcI2-inhibitable)
pathway, involving the induction of Fas and its ligand (Fasl). This results in the
activation of a cascade of caspase cysteine proteases, ultimately causing apoptosis. T-
lymphocyte activation causes the upregulation of the Fas receptor and caspases, while
DNA damage tl'~bers the production of Fasl, again resulting in caspase activation and
programmed ce. t death.
In situ TUNEL. cell viability and 3H-thymidine incorporation assays have shown that
in vitro, Pml-r- splenocytes and thymocytes were protected from Fas-induced
apoptosis (Wang et 01., 1998). In addition, Pml-I- mice were protected from lethality
that otherwise results from massive apoptosis in the liver, consequent to
administration of an anti-Pas antibody that is known to engage with and activate the
Fas receptor. This protection from lethality was shown not to be the result of impaired
Fas and Fasl induction. Finally, caspase 1 and caspase 3 activation was reduced in
Pml-I- splenocytes upon y-irradiation; inhibition of these caspases is sufficient to
block Pas-induced apoptosis and DNA-damage-induced apoptosis of mitogen treated
splenocytes (Nagata, 1997; Enari et 01., 1995; Enari et 01., 1996).
Taken together, 'these results demonstrate that PML is essential for Pas-induced cell
death, acting downstream of Fas, and suggest that PML is required for caspase 1 and
3 activation.
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1.2.4.3.3. PMl induction of a caspase-independent death process
While the most common form of PCD is apoptosis, mediated by caspases, certain cell
death processes exist that are not blocked by the broad caspase inhibitors such as
zVAD-fmk (zVAD) or BD-fmk (BD) (Xiang et al., 1996; de Maria et al., 1997; Miller
et al., 1997; McCarthy et al., 1997). In particular, the continued induction of cell
death in the presence of these inhibitors by the proapoptotic protein, Bax, which is
known to trigger caspase activation, suggests that cell-death executioners other than
the caspases exist.
Transfection of a PML expression vector into an SV40-transformed rat embryonic
fibroblast (RET1cell line, resulted in morphological changes suggestive of apoptosis,
yielding a positive TUNEL assay result and some DNA cleavage. However this cell
death was not associated with the typical nuclear morphological features of apoptosis
such as internucleosomal DNA laddering, chromatin condensation and nuclear
fragmentation In addition, poly(ADP-ribose)polymerase (PARP) and lamin B
remained uncleaved unlike during normal apoptosis wher, they are cleaved by
activated caspv e 3 (Quignon et al., 1998). Together with the observation that basal
levels of caspase substrates were not increased following PML transfection (in
contrast to IFN treatment), this result suggests that caspases are not activated during
PML-triggered cell death in this system. Moreover, using zVAD to eliminate caspase
activation in IFNa-treated cells not only failed to inhibit cell death, but was found to
increase PML expression and enhance IFN-triggered cell death (Quignon et al.,
1998).
BAX is a nuclear protein that has been shown to induce caspase-independent cell
death, and which; upon induction of apoptosis, is targeted to the mitochondria (Miller
et al., 1997; Wolter et al., 1997).Double labelling ofBAX and PML has shown that a
nucleoplasmic portion of BAX colocalizes with PML to the PODs. Interestingly, not
only does ove-e (pression of PML induce the recruitment of BAX to PODs in HeLa
to ;'
cells, but in AP.. cells, BAX shows a similar diffuse, speckled pattern of distribution
to PML, shifting to a normal pattern after retinoic acid or arsenic treatment. Similar
observations have been made for the cdk inhibitor p27KIPl, which is partially POD-
associated (Quignon et al., 1998).
PML may be implicated in known instances of caspase-independent cell death,
induced by BAX or MYC expression, adenovirus E40rf4, ceramides and inhibition of
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the ubiquitin degradation pathway. Recruitment of BAX or other proteins may
constitute the death signal. SUMO-l binding to PML may be involved, as
overexpression has been linked to modulation of apoptosis (Okura et al., 1996).
1.2.4.4. The PODs in transcriptional regulation
The PML protein has variously been described as both an inhibitor and an enhancer of
transcription. Other RING finger family members are also implicated in
transcriptional control. Two further RING finger proteins, XNF7 and pWA33, both
amphibian maternal factors, associate with lampbrush chromosome loops suggesting
an involvement in transcription. The localisation of CBP to the PODs also implicates
these structures in transcriptional regulation, as CBP acts as coactivator to several
regulatory transcriptional events (Chrivia et al., 1993; Kamei et al., 1996; Chakravati
et al., 1996) and possesses acetyl-transferase activity, implicating it in the remodelling
of chromosomes/histones for active transcription (Bannister ~d Kouzarides., 1997;
Ogryzko et al., 1996). Indeed, cotransfection of PML increar !..i transactivation by a
GaI4-CBP fusicn protein in vivo in a dose-dependent manner (Doucas et al., 1999).
Deletions in PML affecting its binding with CBP not only abolished transactivation of
the GaI4-CBP construct, but slightly reduced basal levels of activity. These results
suggest that PML binds to CBP, acting as a cofactor to increase transcriptional
activity. Further, PML was found to be a potent cofactor in the hormone stimulated
interaction of CBP with steroid hormone nuclear receptors (NRs), driving hormone-
dependent transcription. While PML does not interact directly with NRs,
cotransfection of PML and the glucocorticoid receptor (OR) into cells undergoing
hormone stimulation, showed that at the lowest doses, PML increased GR activity
more than tenfold (Doucas et al., 1999). These data show that PML can act in
transcriptional regulation as a potent cofactor for CBP. The interaction of PML and
CBP with other proteins at the PODs might represent, in part, a large coactivation
complex, directly participating in transcriptional regulation.
If the PODs and/or PML were involved in transcription, one might expect to find
them in proximity to nascent or newly transcribed RNA. However, work utilising Br-
UTP labelling of newly transcribed RNA failed to identify any colocalisation with
PML or PODs (Jackson et al., 1993; Wansink et al., 1993). To eliminate the
possibility that RNA localising to PODs is inaccessible to antibodies to Br-UTP or
that the membrane permeabilisation required for Br-UTP labelling disrupts proper
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RNA synthesis, LaMorte et al. (1998) employed a new approach involving the direct
microinjection of a fluorescenated nucleotide (FITC-UTP) into HEp-2 cells. The
localisation of newly synthesised RNA incorporating the stain was then visualised by
immunofluorescence microscopy. By co-staining using an anti-PML antibody, it was
shown that the vast majority of FITC-UTP foci localised to the PODs but that a small
number also coocalized with the coiled-bodies. This group. went on to argue using
immunoelectron .nicroscopy data, that nascent RNA exists within PODs, suggesting
their direct involvement in the regulation of gene expression. The findings of LaMorte
et al. (1998) were challenged, however, when electron microscopic imaging (ESI)
revealed that PODs did not contain nascent RNA or chromatin-nor did they stain with
antibodies recognising highly acetylated histones, a diagnostic feature of actively
transcribed genes (Boisvert et al., 2000). By ESI, the presence of RNA or DNA is
observed as small fibres or granules rich in phosphorus. In contrast, the core of the
nuclear body appeared to be protein based, being a phosphorus-depleted structure.
However, phosphorus-rich fibres were observed at the periphery of the core of the
POD, and, using fluorine-substituted uridine (FU) as a marker, these were shown to
consist of nascent RNA. Using an antibody to the highly acetylated, transcription-
associated species of histone H3 (Boggs et al., 1996), it was demonstrated that highly
acetylated chrct.iar.n surrounded the PODs, even if it was-not found within them.
Some PODs wert: found in association with multiple blocks of acetylated chromatin.
Taken together, these results suggest that, while the core of the POD may not in fact
have a direct association with transcriptionally active DNA, they may nevertheless be
involved in some aspect of transcriptional regulation, perhaps creating a transcription
permissible microenvironment within the nucleus. The high concentrations of CBP at
the PODs might provide a suitable environment for chromatin remodelling and
transcriptional activity. Additional support for POD involvement in transcription was
provided by the finding that PODs are often embedded in the SC35-enriched nuclear
domains where transcriptionally active genes are often localised (lshov et al., 1997;
Smith et al., 1999). This role for the POD would explain the observation that certain
viral genomes and transcripts localise next to this structure (Ishov and Maul, 1996;
Ishov et al., 1997).
Immunofluorescence in situ hybridisation (immuno-FISH) was used to determine the
three-dimensional organisation of gene-rich and gene-poor regions of DNA in the
nucleus in relanon to the PODs. The major histocompatibility complex (MHC) on
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chromosome 6, and the epidermal differentiation complex (EDC) on chromosome 1,
were examined for association with the POD in comparison with each other and a
third region, 6p24 of chromosome 6, containing no known genes and flanked by two
genes (Olavesen et al., 1997), neither of which is expressed in human fibroblasts
(Ebisawa et al.. 1999; Huang and Domann, 1999). Probes hybridising to the
LMPff AP genes of the MHC region, the SPRR genes of the EDC, and a 500bp sub-
region of 6p24, allowed visualisation of the genomic regions, and a rabbit polyclonal
anti-PML antibody was used to relate their locations to that of PML under confocal
microscopy analysis.
Using this technique, Shiels et al. (2001) demonstrated that PODs were found
localising with MHC-probes in -42% of nuclei. In comparison, PODs colocalised
with EDC probes in -24%, and with 6p24 probes in .....20% of nuclei respectively.
Statistical analysis confirmed that these observations represented a significant
difference in POD association between the MHC and other regions. These results
indicate that the PODs can form specific associations with chromosomal regions. To
test whether this MHC-POD association reflected transcriptional activity of the locus,
cells were treated with known regulators of MHC transcription. Treatment with IFNy
stimulates activity at the MHC (Boehm et al., 1997), and also induces PML
expression. IN:~,l ..e this upregulation, no statistically significant alteration to the
MHC-PML association was observed.
While not completely clarifying the role of PODs in transcription, the above-outlined
results do suggest that in at least some cases, the PODs or surrounding regions are
involved in nascent RNA synthesis. It has been suggested thal\:PODs might associate
with specific gene-rich regions such as the MHC to form a functional compartment
involved in the regulation of transcription oftbat region. While a direct role for PODs
in transcription of genes other than those involved in growth suppression and/or
apoptosis would appear to be at variance with these processes, it may be that the
functional state of the structure is delicately balanced between inhibition or
enhancement of specific gene expression, dependent upon external or internal stimuli.
1.2.4.5. PML interaetions with eyelin Dl and eIF-4E
Cyclins were onginally discovered as a result of their intense synthesis following the
fertilisation of marine invertebrate eggs (Rosenthal et al., 1980). DNA replication and
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mitosis are dependent on the activity of heterodimers comprising a catalytic cyclin-
dependent kinase (cdk) subunit, with a cyclin subunit. There are several different
types of cyclin and cdk that are involved at different stages in the cell cycle. Cell
cycle progression is driven by the coordinated regulation of the activities of cdks in
response to external signals, achieved by the post-translational modification of cdks
by phosphorylation-dephosphorylation cascades, and by changing rates of
transcription or proteolysis of individual cyclins, with consequent changes in the
substrates of CCK through the cell cycle (reviewed by John et al.• 2001; Obaya and
Sedivy,2002). Ihe process is regulated by protein kinases and phosphatases such as
Weel and Cdc25 (reviewed by Niwa and Walter, 2000; John et al..• 2001).
'!'.
The cyclin D 1 protein functions at the G liS transition of the cell cycle (Hunter and
Pines, 1994) and is found in complex with Cdc28 to initiate the expression of other
cyclins and genes involved in DNA replication. Because expression of cyclin Dl is
strongly influenced by conditions affecting cell growth, it has been suggested to play
a central role in coupling growth rate to cell cycle progression (Neufeld and Edgar,
1998). Overexpression of eukaryotic translation initiation factor 4E (elF -4E) was
demonstrated to increase cyclin D 1 levels (Rousseau et al., 1996). This translation
factor has been shown to promote growth and oncogenic potential, playing well
defined biochco.cal roles as the limiting component in translation initiation
(Sonenberg and Gingras, 1998). eIF4E binds the 5'm7G cap ofmRNA, and this cap-
binding is essential for the initiation of cap-dependent translation and the regulation of
mRNA stability (Marcotrigiano et al..• 1997; Keiper and Rhoads, 1997; Dehlin et al..•
2000) Overexpression of eIF4E has been linked to increased nucleocytoplasmic..
transport and increased cytoplasmic levels of cyclin D 1 (Rousseau et al., 1996; Lai
and Borden, 20(0). The resultant increase in cyclin D 1 protein levels has been linked
to the transformation activity of elF4E (Rousseau et al. 1996).
Interestingly, immuno-staining experiments demonstrated that a large proportion of
eIF4E colocalised with PML to a subset of PODs (Lai and Borden, 2000; Cohen et
al., 2001). Immunopurification assays were used to demonstrate a direct and specific
interaction between the two proteins, and it was later shown that this interaction
occurred at the RING finger ofPML (Cohen et al., 2001). These observations, and the
known roles of the PODs in apoptosis and cell-cycle regulation, suggested a potential
connection between these structures and cyclin D I regulation. Lai and Borden (2000)
went on to determine the significance of the observed interaction between PML and
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eIF4E by transfecting NIH3T3 cells with PML and monitoring the production of the
cyclin Dl and glyceraldehyde 3 phosphate deydrogenase (GAPDH) proteins. GAPDH
was chosen as a control as the level of the protein product had previously been shown
to be unaffected by overexpression of eIF4E (Rousseau et al., 1996). They
demonstrated that PML overexpression specifically reduced the production of cyclin
Dl, via increased retention of mRNA in the nucleus, mediated by the PML-eIF4E
interaction. This effect could be abrogated by the coexpression of eIF4E with PML,
which caused an increase in the nuclear-cytoplasmic transport of cyclin D1 mRNA.
PML was found to modulate the mRNA transport function of elF4E by reducing its
affinity for the m'G cap substrate (Cohen et al., 2001). These results provide a
mechanism for the previous observation that cyclin D1 protein levels were reduced by
PML overexpression in breast cancer cells (Le et al., 1998).
Further studies have shown that elF4E forms nuclear bodies independently of PML.
In an APL-derived cell line where the PODs were disrupted, elF4E formed nuclear
bodies, which became the sites for POD formation upon ATRA treatment of the cells
(Cohen et 01.,2001). Dispersal ofelF4E from the nuclear structures by treatment with
an analogue of its substrate, m7GpppG resulted in the disruption of the PODs via the
dissociation of PML (Cohen et al., 2001). These results suggest that eIF4E may be
ancestral to P1v;I and have important implications for the role of the PODs. These
structures may t:ave evolved as an elaboration of elF4E regulation. This idea is
supported by the conservation of elF4E among eukaryotes from unicellular yeast to
mammals (Sonenberg and Gingras, 1998) whereas PML is present only in mammals,
and the observations that PML-I- mice are morphologicallyjnormal (Wang et al.,
1998) whereas deletion of the elF4E gene appears impossible due to its essential
function in cellular metabolism.
1.2.4.6. Other POD associated proteins
SUMO-l and CBP have already been discussed in relation to PML, but several other
proteins are commonly found in association with PODs and may have a bearing on
their function. Of major importance is Sp100 and its variants, and others include
IS020, Int-6 and LYSP1OO/Sp 140.
SplOO is an acidic protein that is known to transactivate a number of promoters,
although the mechanism by which this is achieved is presently unclear (reviewed by
Stemsdorf et al.. 1997; Dent et al., 1996). Like PML, Sp100 is highly interferon-
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inducible. Several different isoforms are generated by alternative splicing at the C-
terminus and are designated SpAlt or SplOOB (Dent et 01., 1996; Guldner et 01.,
1999). The Sp 100 variants of the SpAlt family, contain a high mobility group 1
(HMG 1) protein sequence, called an HMG-box, as a C-terminal domain (Ouldner et
01., 1999). Indeed, SpAlt-HMG has the highest homology to HMG I thus far observed
in any HMO-box protein. Proteins of this superfamily have been shown to bind
directly to DNA, some with high sequence specificity (reviewed by Grosschedl et 01.•
1994), and have been shown to be involved in processes as diverse as activation of
rRNA transcription, sex determination in mammals or determination of fungal mating
type (Laudet et al.. 1993).
Lyspl00-A, Band Spl40 are splice variants from the same gene, taken by some to
represent a leukocyte-specific class of POD component (Bloch et al., 1996). Others
debate the exact localization of these proteins, one group reporting only partial
overlap with PODs in novel domains termed LANDS (Lymphocyte Associated
Nuclear Domains) (Dent et al., 1996). The proteins have several structural similarities
to SpIOO and SpAltlSPlOO-B, but the LYSPIOOB/Sp140 proteins contain two
additional motifs not present in any known Sp I00 splice variant. These constitute a
RING-finger like, cysteine/histidine rich PHD domain, and a bromodomain. The
pairing of these domains is common to several cellular co-activators including CBP
(Arany et 01., ~~95). Thus it is possible that LYSPIOOB/Sp140 act as transcriptional
co-activators, and it is thought that they may playa role in lymphocyte differentiation
(Bloch, 1996). While limited to lymphocytes, the postulated role of these proteins is,
given their similarity to standard POD components, consistent with a role for PODs as
"
centres for the .accumulation and regulation of factors important in cell growth,
differentiation and transcriptional regulation. .,
ISG20 (interferon-stimulated gene product of 20kDa) was identified by differential
screening ofa cDNA library from an IFN treated-human lymphoblastoid cell line, in a
search for unknown IFN-inducible proteins. It was observed by confocal
immunofluorescence analysis to localise to the PODs although yeast two-hybrid study
showed no direct interaction between ISG20 and PML or Spl00 (Gongora et al.,
1997). Sequence analysis of the IS020 cDNA suggests a very basic protein with a
relative molecular mass of 20.4kDa. Interestingly, it is predicted to form a coiled-coil
domain and, as these structures are known to mediate protein:protein interactions, it is
likely that ISG20 acts as part of a multiprotein complex.
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The function of ISG20 is not yet known, but certain pieces of evidence support the
idea that it may act as a negative regulator of cell division. The subcellular
localisation of ISG20 is predominantly nuclear and punctate, but varies from one cell
to another. This presumably reflects the cell-cycle dependent state of the PODs.
ISG20 may have a direct role in the cell cycle, or simply be shuffled about as the
PODs undergo alterations, In addition, ISG20 has significant homologies to the
Xenopus laevis '.{~MC2gene product, which has been shown to rescue a fission yeast
mitotic catastrophe mutant defective in both Weel and Mikl kinases (Su and Maller,
1995). While ISG20 did not achieve similar complementation, the protein appears
truncated in the N-terminal half in comparison with XPMC2, and it is possible that
;,
the protein requires additional interactions via the coiled-coil domain to mimic the
function of the amphibian gene product in humans.
The Int-6 gene was originally identified as one of the integration sites of the murine
mammary tumour virus (MMTV) (Marchetti et al., 1995), and has been shown to
colocalise to the PODs, probably through interaction with the Ret finger protein (Rfp)
(Desbois et al., 1996). It has been shown to encode the p48 component of the
eukaryotic translation initiation factor-3 (eIF3-p48) and to playa role in the control of
cell growth (Asano et al., 1997; Akiyoshi et 01.,2001). Disruption of the Int-6 locus
by integration {If ("',~MMTV virus results in expression of a truncated protein, and has
been speculate,' to be the crucial event in the virus-induced transformation process
(Marchetti et 0/. 1995). More recently, a reduction in Int-6/eIF3-p48 expression has
been observed in certain malignancies (Marchetti et al., 2001). In summary, the role
of Int-6 is curreuly poorly understood, but it is possibly another negative regulator of
1,
cell growth and division.
Daxx is a Fas-bi-iding protein that has been shown to promote Fas-mediated apoptosis
through activation of the Jun NH2-terminal kinase (JNK) and JNK kinase ASKI
(apoptosis signal-regulating kinase 1) (Yang et al., 1997; Chang et al., 1998) and is a
strong repressor of basal transcription, appearing to interact directly with histone
deacetylases. It was demonstrated that Daxx resided primarily in colocalisation with
PML in the nucleus at the PODs (Li et al., 2000). Interestingly, recruitment of Daxx
to the PODs was shown correlate with enhanced Fas-mediated cell death (Torii et al.,
1999) and with the inhibition Daxx-mediated transcriptional repression (Li et al.,
2000). SUMO-~modification of PML was shown to be required for this effect (Ishov
et al., 1999; Li Cl al., 2000). That PML interacts with Daxx in this manner, suggests a
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role for the PODs in suppression of transcriptional repression, and again implicates
these structures in the regulation of Fas-mediated apoptosis.
1.2.4.7. PODs and virus infection
As previously mentioned, the PODs are dynamic sub-nuclear structures that can be
altered by any of several factors. Among these, infection by certain viruses can bring
about changes in the appearance, distribution or composition of these bodies, notably
human influenza A, human T-cell leukaemia virus (HTLV), herpes simplex virus
(HSV), human cytomegalovirus (CMV), Epstein-Barr virus (EBV), and adenovirus
(reviewed by Sternsdorf et al., 1997). Taken with the highly interferon-inducible
nature of PML .and other POD proteins, the propensity of ~iruses to disrupt these
I
structures make it likely they have a role in the early or late antiviral response, which
the viruses are seeking to evade.
1.2.4.7.1. POD. and RNA virus infections
Infection with the RNA virus, influenza A, causes an increase in the number and
staining intensity of PODs in HeLa cells when using Sp100 antibodies (Guldner et al.,
1992) similar to that observed upon interferon treatment of cells. Interestingly, it has
been reported t~ilt overexpression of PML confers resistance to infection by both
influenza A a.:~;vesicular stomatitis virus (VSV), both RNA viruses whose infections
are sensitive to interferon (Chelbi-Alix et al., 1998). PML expression was found to
interfere with VSV mRNA and protein synthesis. The inhibition of viral
multiplication by PML was found not to be common to all RNA viruses, and was not
as strong as that conferred by the IFN mediator protein, MxA 'However, these results
suggest that elevated PML expression can contribute to the antiviral state induced in
IFN-treated cells.
HTLV is the human retrovirus responsible for adult T cell leukaemia. The viral
oncoprotein Tax, interacts with the cellular protein Int-6, which has been reported to
localise to the PODs. Expression of the Tax oncoprotein of HTLV I from a
Herpesvirus saimiri vector, was shown to induce a diffuse, cytoplasmic redistribution
of Int-6 from the PODs. Tax binds to Int-6, causing it to be retained in the cytoplasm
and preventing I..., localisation to PODs (Desbois et al., 1996). Expression of Tax is
necessary and sufficient for transformation of primary human T cells (Grassman et
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al., 1992) and since no other POD proteins are affected by Tax, this suggests that Int-
6 redistribution is significant to this process.
1.2.4.7.2. PODs and herpes virus interactions
During infection with the various herpes viruses, the parental viral genomes migrate
to the periphery of the PODs, components of which are then dispersed or relocated
I':
(Kelly et al., 1995; Korioth et al., 1996; Maul and Everett, 1994; Ishov and Maul,
1996).
The HSV-l viral immediate-early (IE) protein, Vmwll0 (also known as ICPO) is a
positive regulator of gene expression that is required for the disruption of the PODs
during HSV infection (Maul et al., 1993; Maul and Everett, 1994). This disruption
was found to correlate with the loss of several PML isoforms, dependent upon
Vmwll0 and active proteasomes (Everett et al., 1998). HSV-l infection of HEp-2
cells caused the rapid loss of those higher molecular-weight isoforms of PML thought
to be SUMO-! modified, Indeed, transfection of a SUMO-l expressing plasmid
(pCIPIC1) and • ubsequent SOS-Page and Western blot analysis, produced a multitude
of high molecu 1:weight polypeptides corresponding to SUMO-l conjugates. These
included a maier band at 90kDa corresponding to a form of RanGAPl known to be
covalently attac led to SUMO-l (Mahajan et al., 1997; Matunis et al., 1997). Upon
superinfection v.ith wild-type virus, many of these higher molecular weight SUMO-l
conjugate bands disappeared. However, superinfection with Vmwl l O-deficient
mutant viruses did not result in the loss of any SUMO-I conjugates, demonstrating
that this process is dependent upon Vrnwll 0 and the integrity of its RING finger. As
certain of the conjugate bands were not reduced (including that for RanGAP1), this
would appear to be a specific process.
An HSV -1 mutant deficient in POD modification was used to determine the location
of viral DNA replication compartments relative to the PODs in HEp-2 cells. Using the
Vmwl10 RING finger deletion mutant FXE, Ishovand Maul (1996) demonstrated
that while the replication compartments developed away from the PODs, later in
infection (8 hr p.i.) the two were adjacent. The use of wild-type virus demonstrated
that this was not mutant-specific behaviour, and that even at 3 hours after infection,
HSV -I input DNA and transcripts could be observed preferentially localising to the
periphery of the PODs. These results paralleled findings obtained from the study of
the relationship between adenovirus 5 DNA and the PODs by the same group.
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In addition, human cytomegalovirus (HCMV) and Epstein-Barr virus have also been
demonstrated to disperse POD-associated proteins.
Upon infection with HCMV, PML and Sp 100 were rapidly dispersed from the PODs,
as occured during HSV -I infection (Kelly et al., 1995; Korioth et al., 1996). This was
induced by expression of the immediate-early gene IE-l (Korioth et al., 1996).
In the case of Epstein-Barr virus, the redistribution of POD proteins occurred in a
markedly different manner. Bell et al. (2000) found that in latently infected Burkitt's
lymphoma and iymphoblastoid cells, the PODs remained intact, with no association
between these structures and the viral genomes. Interestingly, upon lytic activation,
the POD-associJted proteins were sequentially dispersed at different stages of the
lytic cycle, with SplOO and Daxx being dispersed before the onset of viral replication,
and PML dispersed after. The EBV genome associated with the remnants of the POD,
which were retained until the early stages of lytic replication (Bell et al., 2000).
Although EBV has developed an alternative method of replication by remaining latent
in cells, it would appear from the results shown above, that dispersal of POD proteins
is important for the more "aggressive" process of lytic replication.
1.2.4.7.3. PML, PODs and adenovirus infection
The replication r.nmains of adenovirus 5 are visible as round or goblet shaped, viral
DNA-binding protein (DBP)-positive sites, within the nucleus of infected cells
(Pombo et al., 1.994). Early in infection, replication domains are found in association
with sites of high nuclear factor-l (NF-l) accumulation (Ishov and Maul, 1996). NF-l
is a cellular, smgle-stranded DNA-binding protein that is present throughout the
nucleus but is highly concentrated in a few domains numbering one to six in HEp-2
cells. Later in AdS infection, when the replication sites have expanded, the protein is
targeted to the viral replication domains where it is used to aid assembly of the
nucleoprotein complex at the viral origin of replication (Bosher et al., 1992).
Replication sites are also often found in close proximity to coiled bodies. However,
not all sites of viral replication are associated with an NF-l site or coiled body (Ishov
and Maul, 1996), indicating that these cellular structures are not of primary
importance in AdS DNA replication.
During adenovirus type 5 infection, the POD-associated proteins PML and Spl00
were shown to be redistributed into track-like structures. These ''tracks'' had no
obvious spatial relationship with the viral replication domains early in infection
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(Ishov and Maul, 1996). More detailed analysis revealed that while Spl00, PML and
other POD-associated proteins were distributed to the tracks prior to viral DNA
replication, most of these proteins (notably Spl00) eventually segregated from the
tracks and joined the replication domains upon DNA replication. Interestingly, of the
antigens tested, only PML did not at any point join the replication domains as
determined by immunofluorescence microscopy, remaining at all times in tracks. In
contrast, while adenovirus relocates the majority of POD proteins to viral replication
domains, HSV-l does not (Maul et al., 1993; Maul and Everett, 1994). The
significance of these relocations to the progress of adenovirus infection is as yet not
known. The distribution of POD-associated proteins to viral replication domains
might indicate a positive role for these proteins in viral replication, or might be an
element of the' host antiviral response. Ishov and Maul (199q went on to use an in
situ nuclear run-on procedure incorporating BrUTP, to demonstrate by confocal
microscopy that the distribution of the POD-associated proteins within the viral
replication domains did not correlate with viral transcription.
By identifying a mutant adenovirus defective in track formation, it was possible to
assign responsibility for POD reorganisation to a single viral gene product. Distinct
deletion mutants of the E4 region were infected into HeLa cells, representing
deletions of ORFs 1 and 2 (H5dl 1005), ORFs I, 2 and 3 or just ORF3. The results
showed that tl« viruses lacking E40rf3 did not form PML tracks (Carvalho et al.,
1995). These observations were mirrored by the work of Doucas et al. (1996), who
demonstrated. the requirement for E40rf3 in track formation by using an insertion
I
mutant of E4orf3 (inorf3), where the number of infected cells scoring positive for
track formation was drastically reduced. Nevertheless, Spl00 W~ still found to locate
to the viral replication domains, albeit after a delay. In a reciprocal experiment, an E4
mutant expressi-ig only E40rf3 was shown to induce POD reorganisation at a similar
efficiency to wild-type AdS. It was shown by immunofluorescence microscopy that
the E40rf3 protein colocalized to these filamentous tracks with PML. Transient
transfection of both Hel.a and Hep-2 cells with a pCMV E40rf3 expression vector
also resulted in the formation of PMUE40rf3 co-staining tracks (Carvalho et al.,
1995; Ishov and Maul, 1996; this thesis), demonstrating that E40rf3 was necessary
and sufficient for track formation. Overexpression of PML by cotransfection
antagonised track formation, generating unusually large PODs. Co-expression of
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E4orf3 and PML~lz, deleted in the 60 amino acids constituting the main dimerization
domain, resulted in a diffuse nuclear and cytoplasmic PML stain, where E4orf3 did
not associate with the mutant PM protein, but was found at the PODs with
endogenous PML
Mutants for the EIA, EIB and E3 regions had wild-type phenotypes in respect to
POD reorganisation, other than that onset of track formation was delayed from -Bhr
to -24 hrs p.i. where cells were infected with the EIA deleted mutant (Ishov and
Maul, 1996). This is an interesting observation, as the EtA protein can be found in
association with the PODs following infection or transfection of the protein, though it
does not appear to affect the integrity of the structures. It may more simply reflect
delayed expressron ofE40rf3 in the absence ofEIA transactivation.
Use of the deletion mutant HS 1004 which expresses only ORFI from the E4 gene
region, enabled retention of the PODs during infection, and here it was possible to
demonstrate that viral replication domains located adjacent to or closely associated
with PODs. Further, using wtAdS, it was shown that while at early stages in infection
(1.5hr p.i), adenoviral DNA had no obvious correlation wit. ;PODs, at later times
(4hrs p.i.) -50% of the input viral DNA was found close to the PODs. As the PODs
only occupy <0.05% of the total nuclear volume, this is undoubtedly significant and
represents a preferential association of viral DNA with PODs. This association was
found to be independent of new transcription and protein synthesis.
POD disruption is common to several different viruses suggesting that it plays a
crucial role in the success of infection. However, the fact that E40rf3 is absolutely
required for track formation while E40rf3 deficient mutants grow in a similar manner
to wild-type viruses, at least in standard cell cultures, argues that track formation is
not a necessity for viral replication. However, while not essential, the reorganisation
of the PODs may be linked to more efficient viral replication. It has been
demonstrated, in an otherwise completely E4-deficient background, that E4orf3
stimulates the .efficiency of viral propagation >2000-fold .,(Huang and Hearing,
1989a). Cell lines engineered to stably overexpress PML showed an inhibition of
track formation by E40rf3 (using dI366*+ORF3), concomitant with a decrease in
replication of the virus (Doucas et al., 1996). This result argues that the function of
E40rf3 in POD reorganisation is responsible at least in part, for the ability of the
protein to enhance viral propagation.
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The biochemical status of PML following Ad5 infection was analysed by Leppard and
Everett (1999), using Western blotting with the PML specific monoclonal antibody,
5E10 (Sturman et al., 1992). Uninfected cells had the typical array of PML isoforms
with SUMO-l modified and unmodified forms present (see fig lA.). By 16 hours p.i.,
two new bands had formed, and a third intensified, at the apparent expense of
intensity in the major PML bands at about 120 and l40kDa. At a later stage in
infection, the isoforrns generally held to represent SUMO-l modified PML were
reduced or absent, as were the two slower migrating infection-specific bands.
However, the third band generated by Ad5 infection (indicated in lane 10 of fig 4.1.
by the filled arrow), became more intense.
le hr p.i.
2 3 4
24 hr p.i.
6 7 8 9 101 5
........
Fig 1.4. PML isoforms in infected HEp-2 cells, HEp-2 cells were infected with adenovirus dl309
(lanes 1,6), dl338 (2, 7), dl355 (3,8), dll-3 (4, 9) or mock infected (5, 10) at 37°C. Extracts were
separated on a 6% SDS-Page gel, blotted and probed for PML with mAb 5ElO. The filled arrows show
virus specific PML isoforms when infected with E4orf3 wI virus. Open arrows point out SUMO-J-
conjugated isoforms lost during infection with E4orf3 w: virus (from Leppard and Everett, 1999).
In comparison, extracts of cells infected with various deletion mutants demonstrated
that the same changes to the PML species occurred in the absence of either E40rf6 or
E1B-55kDa. However, cells infected with a deletion mutant lacking E4 Orfs l-J
showed the same PML staining pattern as uninfected cells (Leppard and Everett,
1999). These results demonstrated that either E4orfl, 2 or 3 proteins or a combination
of all three, was required for the PML biochemical alteration underlying this change
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in banding pattern. As E40rf3 has been shown to be necessary and sufficient for POD
reorganisation as determined by immunofluorescence, it seems likely that these
phenomena are two aspects of the same, Orf3-dependent process.
Interestingly, the major novel PML species observed subsequent to wild-type
adenovirus infection has marked similarity to the new species observed during the
normal cell-cycle at mitosis when the PODs temporarily disperse (see 1.2.4.2.). Also,
the slower migrating SUMO-l modified PML isoforms are reduced or lost as occurs
during mitosis. It would appear that adenovirus might make use of a similar
mechanism, potentially hijacking the cell's own components to deregulate cell cycle
progression and prevent cell-suicide upon infection.
1.2.4.7.4. POD redistributlen after Don-virological stress
In attempting to gain an insight into the role of the PODs, it is worth noting other
stress factors that result in abnormal POD appearance. Heat shock or cadmium
treatment results in redistribution of the PODs into a microspeckled appearance
consisting of hundreds of small dots amongst the chromatin (Maul et al., 1995). This
change is rapid and independent of protein synthesis. During recovery, the POD
components regroup into discrete structures, passing through an intermediate track-
like stage. These observations might result from a process of active transport with
POD compone. ,. travelling along nuclear filaments. Amino acid starvation also
affects the POI)~"in this case reducing their number but increasing their size (the
resulting struct..res are called "large bodies") (Kamel, 1996).
1.3. CODclusiot,:i
The importance cf the cellular structures known as PODs and lieir associated proteins
has become ineeasingly clear as research in diverse biological fields has converged
on these subnuclear domains and their functions. Currently, they appear to be
involved in several distinct cellular and viral processes, leading to a certain degree of
confusion as to their prime function in the cellular environment. However, perhaps it
will be possible to relate these seemingly disparate functions to a coherent whole, by
gaining a greater insight into each separate process. It already seems apparent that,
through negative regulation, the defining POD component, PML, plays important
roles in cell-cycle regulation and PCD. While these are separate processes, it is not
difficult to see how these two functions are related, in that both involve altered
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patterns of transcription; indeed they are linked processes, failure of one resulting in
the other. The model of the POD as the centre of a cell cycle "braking" and apoptosis
mechanism, fits comfortably with the observed disruption of the structures in several
malignancies and by virus infections, where unregulated cell proliferation is necessary
or advantageous to the progression of the disease.
Although, simplistically, this hypothesis might imply that PODs negatively regulate
gene expression work focusing on the transcriptional significance of the PODs
suggests a more positive role. CBP is a coactivator of several regulatory
transcriptional events, SplOO is a known transcriptional transactivator, and even PML
has been reported to act as a transcriptional co-activator. In addition, certain viral
transcripts localise next to these structures (lshov and Maul, 1996; Ishov et al., 1997),
and PODs seem to associate preferentially with transcriptionally active chromatin.
These observations, taken with the apparent identification of nascent RNA at the
peripheries of the PODs, seem to strongly indicate a role for these structures in
transcriptional activation where the POD may enhance transcription of target genes
through recruitment of activators, and also the inhibition of transcriptional repressors
such as Daxx. Until the exact function of each POD-associated protein is known, it is
entirely possible that the role of the POD in transcription is still an inhibitory one.
PML after all is required for localization of CBP to the POD, and suppresses
production of the cyclin 01 protein by interaction with eIF4E at the POD. Perhaps the
PODs exist to concentrate antagonistic factors in one location, where they can be
released as is appropriate. This may be a complex interaction of multiple sub-units,
not requiring direct association of all components with PML. Instead, each may be
sensitive to the state of others, thus providing a framework for the establishment of
feedback loops and potentially quite complex responses to numerous stimuli. This
would also explain why, during adenovirus infection, the PODs are dispersed, but the
majority of the associated proteins ultimately localise to the nearby viral replication
domains, while PML is excluded.
1.4. Aims of this Thesis
The main aim of this thesis was to further investigate the role of the PODs, using a
virological approach to study several aspects of virus-host interaction between Ad5
E40rf3 and PML and the PODs. Specifically, the objectives were:
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• To identify regions of the OrO gene necessary for POD component reorganisation
and PML modification by expressing the gene in eukaryotic cells, using
eukaryotic expression vectors
• To determine the relevance of those functions to the infection process
• To mutate single amino acids within OrO using peR techniques and examine any
resultant modification of function in POD organisationIPML modification
• To determine whether POD reorganisation and PML modification functions of
OrO could be separated in our system
• To relate structural information to observed interactions between El B-55K., orO
and POD components in both mutant and wild-type virus/viral elements, making
"
use of immunofluorescence analysis and western blotting techniques
• To determine a phenotype for orO mutants using whole virus
,.
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2. Materials and Methods
2.1. Materials
2.1.1. Common buffers and solutions
Chloroform/iso-amyl alcohol: 96% (v/v) chloroform, 4% (v/v) iso-amyl alcohol.
LH: 1% (w/v) bactotryptone, 1% (w/v) NaCI, 0.5% (w/v) yeast extract.
LH agar: LB containing 1.5% (w/v) bacto-agar.
Miniprep solution I: 25mM Tris.HCI adjusted to pH 8.0 with HCI, 10mM EDTA,
50mM glucose (5mglmllysozyme added just prior to use).
Miniprep solution II: 200mM NaOH, 1.0% (w/v) SDS.
Miniprep solution III: 600mM potassium acetate, 11.5% (v/v) glacial acetic acid, pH
4.8 with acetic acid if required.
Phenol/chloroform: 50% (v/v) Tris-buffered phenol, 48% (v/v) chloroform, 2% (v/v)
iso-amyl alcohol.
Phosphate buffered saline (PBS): 137 mM NaCI, 2.7 mM Na2HP04, 1.4 mM
KH2P04.
1 X SDS-PAGE loading buffer: 10% (v/v) glycerol, 50mM Tris.HCI pH 6.8, 4%
(w/v) Sodium Dodecyl Sulphate (SDS), 0.01% (v/v) bromophenol blue, then add
200mM Diothiothreitol (DTT) just prior to use.
THE: 89 mM Tris base, 89 mM boric acid, 1 mM ethylenediaminetetra-acetic acid
(EDTA) pH 8.0,
TD: 25 mM Tris.HCI pH 7.5, 137 mM NaCI, 5 mM KCI, 0.7 mM Na2HP04.
TE: 10 mM Tris.HCI pH 8.0, 1mM EDTA.
TFB I: 1OOmM,RbCl, 50 mM MnCh, 10 mM CaCh, 30 mM potassium acetate, 10%
(w/v) glycerol, adjusted to pH 5.8 with 1M HAc.
TFB II: 10 mM 3-[N-Morpholino ]propanesulphonic acid (MOPS). 10 mM RbCI. 75
mM CaCh, 19% (w/v) glycerol, adjusted to pH 7.0 with 4M NaOH.
TNE: 10mM Tris.HCI pH 8.0, 100 mM NaCI, 1mM EDTA.
TS: 25 mM Tris.HCI pH 7.5, 137 mM NaCI, 5 mM KCI, 0.7 mM Na2HP04, 0.9 mM
CaCh, 1 mM MgCh.
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2.1.2. Bacterialstrams
tt '
Escherichia coli strain Phenotype
XL-I Blue RecAl endAl gyrA96 thi-I hsdRi7 supE44 relAi lac
[F 'proAB lacflZ.1Mi5 TniO (Ten]. (Used for all
cloning steps)
2.1.3. Adenovirus strains
Virus strain Phenotype
.---_"
Wt300 Wild type (Jones and Shenk, 1979)
dl355 Inactivation ofE4-0rf6 product (Halbert et 01., 1985)
__ ,
inorj3 Inactivation of E4orf3 product (Huang and Hearing,
1989)
2.1.4. Celllinc~
Cell line Origin
293 Adenovirus-transformed human embryonic kidney (Graham et al.,
1977)
HeLa Human cervical epitheloid carcinoma (Scherer et al., 1953)
rHuman epidermoid carcinoma (Moore et 01., 1955)HEp-2
-
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2.1.5. Antlbodres and conjugates
Protein Dilution used
recognised Western I.F
PML Mouse monoclonal 5E1O 1:20 1:10
(Stuunnan et al.• 1992)
PML Mouse monoclonal PG-M3 (Santa 1:500 1:500
r: Cruz Biotechnology Inc.)._ --
1 E2a Dt-;A-binding Mouse monoclonal B6-8 (Reich et N/A 1:10-..: protein (DBP) al., 1983)1:::1•to Elb 55K Mouse monoclonal 2A6 (Samow et N/A 1:100•a al., 1982)'C
~
Elb 55K Rat monoclonal 9C 10 (Zantema «t N/A 1:10
al.• 1985)
E4orf3 Mouse monoclonal A4-7 (Carvalho 1:5000 1:1000
et al.• 1995)
E4orf3 Rat monoclonal 6A 11 (Nevels et 1:20 1:10
al.• 1999)
Mouse Ig Biotinylated goat 1:400 N/A
(Amersham Pharmacia Biotech)
Mouse Ig Horseradish-peroxidase linked goat 1:500- N/A
r: A4416 (Sigma) 1000._
j Mouse Ig Horseradish-peroxidase linked goat 1:500 N/A-..:
1:::1
(Chemicon International)•to• Mouse IS Fluorescene isothiocyanate (FITC)- N/A 1:100."
1:::1
j conjugated goat (Calbiochem).-
Rat Ig Biotinylated goat - 1:400 N/A
(Amersham Pharmacia Biotech)
RatIg Horseradish-peroxidase-linked goat 1:500- N/A
(Chemicon International) 1000
Rat Ig Rhodamine-conjugated goat N/A 1:100
(Calbiochem)
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2.1.6. Oligonucleotides
All oligonucleotides were obtained from Life Technologies (now Invitrogen) and are
shown 5' to 3'.
2.1.6.1. peR Primers
Primer JD 1: GGCCAGAT ATACGCGTTGACATTG
Primer JD2: CGCCACTGTGCTGGAT ATCTGC
Primer JD3: TATTTGGCTATGGTTGAAGGTGCTGGAATG
Primer JD4: CAGCACCTTCAACCATAGCCAAA TAATTCTC
Primer JD5: GGGAGGCCGTTCACTTAATAGATCTTC
Primer JD6: TA TTAAGTGAACGGCCTCCCCTCC
Primer JD7: ACGTGGCCGCCGTTTGCCTTTTG
Primer JD8: AAAAGGCAAACGGCCGCCACGTCCAAGT
Primer JD 11: GACCACGCCGTTCACTT AATAGATCTTC
Primer JDI2: AGTGAACGGCGTGGTCAAACTCTACAGC
Primer JDI3: GCGAGATATGGTTGAAGGTGCTGGAA TG
Primer JD 14: CCTTCAACCA TATCTCGCCACCTTC
Primer JDI5: GAGGCTGAAGGAGCAGATTTTTACAA TGGCCGGACT
Primer JD 16: CTGCTCCTTCAGCCTCAAGCAGCGAA TC
Primer JD 17: TTTGACCACGCCGCCGGAG
Primer JD 18: TCCGGCGGCGTGGTCAAA
Primer JO 19: CCACCGCCGGGGAGCGCGTTCACTT AATA
Primer J020: TCCCCGGCGGTGGCGTGGTCAAA
Primer JD21: ACCGGAGCCGAGCGCGTTCACTT AAT
Primer J022: TATTAAGTGAACGCGCTCGGCTCCGGTG
Primer JD23: ~TTAAGTGAACGCGGGCCCCTCC
Primer J024: GGAGGGGCCCGCGTTCACTTAATAG
Primer JD25: 'r(~GAGTAATACGACTCACTATAGGGCGAG
Primer J026: TCGACTCGCCCTATAGTGAGTCGTA TTAC
Primer JC027: CTGGAACAA TGACAGTGGAGAG
Primer JC028: CATTATGACTCCGGACATGACC
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2.1.6.2. Sequencing primers
Primer JD9: GCACAGTCGAGGCTGAT
Primer JDlO: C.\CTGCTTACTGGCTTATCG
Primer JCD29: CCACCACCGCAGAA TAAGCC
Primer JCD30: GCAGACCTGCACGA TTATGT
2.2. Supplien
All chemicals of analytical or molecular biology grade were supplied by Sigma
(Poole, Dorset, UK) or BDH Laboratory supplies (Merck Ltd, Poole, Dorset, UK)
unless otherwise stated below.
Amersham Pharmaeia Biotech (Bucks., UK).
Biotinylated goat a-mouse IgG, Streptavidin-biotinylated horseradish peroxidase
complex, Hybond C membrane, SOS-PAGE molecular weight markers.
Beetcn-Dtcklasen (Cockeysville, USA).
Yeast extract.
BioRad (Hem,-! Hempsted, Herts., UK).
Acrylamide, N,N'-methylene-bis-acrylamide, ammonium persulphate, electrophoresis
grade SOS.
BOC (Surrey, L {~)
C02, dry ice.
Calbiochem (Nottingham, UK).
Goat a-mouse IgG fluorescein isothiocyanate (FITC)-conjugate, goat a-rat IgG
rhodamine conjugate.
Chemicon International (Harrow, UK).
Goat a-mouse IgG horseradish-peroxidase conjugate, goat a-rat IgG horseradish-
peroxidase conjugate.
Difeo Laborat( ,"ies(Hants., UK).
Bacto-agar, bactotryptone, Noble agar.
Fisher Scientiilc (Loughborough, UK).
Caesium chloride. SOS. .,
Fuji Photo Film Co.Ltd. (Dusseldorf, Germany).
Super RX X-ray film.
Gibco BRL Life Technologies Ltd. (Renfrewshire, Scotland).
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Restriction enzymes, lkb DNA ladder, calf intestinal alkaline phosphate (ClAP), Taq
DNA polymerase, T4 DNA ligase, Dulbecco's modified Eagles medium (DMEM),
newborn calf serum (NCS). foetal calf serum (FCS), trypsin, versene.
Kodak (London, UK).
X-ray developing fluid, X-ray fixative.
New England Biolabs (Hearts., UK).
Restriction enzymes.
Premiere Beverages (Stafford, UK).
Dried milk pow l!·I. (Marvel).
Promega UK (:. <. uthampton, UK).
Wizard®PureFc ':'ion plasmid purification kit.
Qiagen (Hilde.i Germany).
Qiaprep minipreo reagents, Qiaprep midiprep reagents.
Univenity of v,.' arwick media preparation service.
Sterile PBS, dis. iIled H20.
Vector Laboratories (Burlingame, CA).
Vectashield® mounting medium.
1.3. Methods
1.3.1. DNA manipulations
2.3.1.1. Restri;:tion enzyme digestion
All DNA Waf digested in the buffers supplied by the manufacturer at the
recommended t -mperature, typically in a volume of 20-100 f,11. Digestion of DNA
with multiple enzymes was performed in the buffer which ga~e the optimum activity
of all enzymes. t{eactions were stopped by the addition of EDTA to 2S mM or heat
inactivation Wilt. re appropriate.
1.3.1.1. Dephosphorylation of DNA
Dephosphorylation reactions were performed in SOmM Tris.HCI pH 8.0, 10mM
MgCh, lOOmM NaCI, using calf intestinal alkaline phosphatase (ClAP). DNA
fragments with protruding 5' termini were incubated at 37°C for 30 min with 1 unit of
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ClAP, followed by a repeat incubation with a further aliquot of ClAP. Reactions were
stopped by heat inactivation (65°C, IS min). Electrophoresis and electroelution were
used to purify the. dephosphorylated DNA prior to its use in cloning steps.
2.3.1.3. Ligation of DNA molecules
DNA fragments with cohesive ends were ligated for 16 hr. at 16°C, using 2 units of
T4 DNA ligase in the supplied buffer (SOmM Tris.HCI pH 7.6, 10mM MgCh, ImM
ATP, ImM dithiothreitol (DTT), 5% (w/v) polyethylene glycol (PEG) 8000).
Typically a 3-fold molar excess of insert over vector DNA fragments was used.
2.3.1.4. Gel electrophoresis of DNA molecules
DNA fragments were separated on type I agarose (0.6-1.4% w/v), TBE gels,
containing O.Smg/ml ethidium bromide. Samples were loaded in 30% glycerol, 0.04%
bromophenol blue. Electrophoresis was performed in TBE at 7.0mA until the required
degree of separation was achieved. Bands were then visualis,» by transillumination
with UV light, d.ld photographed using computerised gel imaging equipment (Prior
Laboratory supplies, UK). DNA fragment sizes were estimated by comparison to a
DNA ladder of known fragment size (lkb ladder, GibcoBRL).
2.3.1.5. Electroelution of DNA molecules from agarole gels
The DNA to be purified was excised from the gel and eluted into 500J,11TBE in sealed
dialysis tubing (molecular weight cut-off, 16,000) by electrophoresis in O.S X TBE at
1SOV for 30min. The eluate was then extracted twice with phenol/chloroform,
followed by ethanol precipitation.
Alternatively, DNA was purified from agarose gel slices using the Qiagen DNA
purification kit. This DNA did not require phenol-chloroform extraction or ethanol
precipitation. ;., .
2.3.1.6. PbenolJdlloroform extraction
An equal volume of phenol/chloroform prewarmed to 37°C was added to the DNA
solution and mixed by repeated inversion. Phase separation was achieved by
centrifugation in a microcentrifuge at 2300 x g for 2 min; the less dense aqueous
phase was removed to a clean tube.
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2.3.1.7. Ethanol precipitation
DNA was precipitated from aqueous solution by the addition of sodium acetate to
300mM, plus 2 volumes of ethanol. This was placed at -70°C for lhr (or -20°C
overnight), after which the DNA was pelleted by centrifugation in a microcentrifuge
at 16,000 x g for IS min, washed with 70% (v/v) ethanol and re-centrifuged for 5 min.
The pellet was dried briefly in a vacuum dessicator and resuspended in IOmM
Tris.HCl pH 7.5.
2.3.1.8. Spectrophotometric quantification of DNA
The concentration and purity of DNA in aqueous solution was determined by
absorbancies at 260nm and 280nm. An absorbance of 1.0 at 260nm indicates a
concentration equal to 50J.1g1mlfor double stranded DNA. Purity was assessed by the
ratio of absorbance at 260nm to that at 280nm, a ratio of 1.7-1.8 indicating purity.
2.3.1.9. Automated DNA sequencing
Automated D~ £\ sequencing was performed by Mrs L.Ward, Department of
Biological Sciences, University of Warwick, using an Applied Biosystems sequencer
(model 373a).
2.3.1.10. Polymerase chain reaction (peR) (after Mullis et al., 1986)
Target DNA was amplified by PCR; all reactions were optimised but a typical S0J.11
reaction mix consisted of 100ng target DNA, 200ng each of forward and reverse
primers, 1mM each of dATP, dCTP, dGTP, dTTP, optimum concentration of MgCh,
1 unit Taq polymerase (non-proof reading) in the buffer supplied by the manufacturer.
Reaction conditions were:
94°C, 1 min; «-c, 1 min; 74°C, 3 min x 19 cycles, then 94°C, 1 min; 60°C, 1 min;
74°C, 7 min x I cycle, followed by a 4°C soak until the sample could be removed for
processing.
A typical S0J.11mutational PCR mix for the primary reaction, would consist of 200ng
target DNA, ImM each ofdATP, dCTP, dGTP, dITP, the optimum concentration of
MgCh, 1 unit Taq polymerase in the buffer supplied by the manufacturer and 200ng
of each primer. Reaction conditions used were:
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94°C, I min; 5:'~C, 1 min; 74°C, 3 min x 19 cycles, then 94°C, 1 min; 55°C, 1min;
74°C, 7 min x 1 cycle, followed by a 4°C soak.
In a typical 50Jl. mutational PCR second stage amplification reaction, approximately
SOOngof each product of two complementary primary PCR reactions would be
mixed, in a total volume of 10....1. To this was added ImM each of dATP, dCTP,
dGTP, dTTP, the optimum concentration of MgCh and 1 unit Taq polymerase in the
buffer supplied by the manufacturer. This mixture underwent one cycle at 94°C, 1
min; 60°C, 1 min; 74°C, 7 min, then 200ng of each outside primer was added, and
DNA amplified by the usual PCR method.
2.3.2. BacteriolOgical techniques
2.3.2.1. Culture and stonge of bacteria
Escherichia coli (E.coli) XLI-Blue were cultured in La containing 15....g/ml
tetracycline at 'j7°C with shaking. Transformed bacteria were grown on LB agar
plates or as liquid cultures, both containing 100....g/ml ampicillin (LBamp) and
incubated at 37°C with shaking.
Cultures were maintained in long-term storage as a 50% (v/v) mix of glycerol and
exponential phase liquid culture, at -70°C.
2.3.2.2. Tran.formlng bacteria, and rendering competent for tranlformation
Sml of LB was inoculated with a single colony of E.coli strain XLI-Blue, and
cultured to stationary phase at 37°C. 50....1 of this was used to inoculate 2Sml of LB
which was cultured to ODs so 0.3-0.4. This was split equally between two flasks, each
containing 2S0ml of LB, and cultured to ODsso 0.4-0.5. The cultures were cooled on
ice for 15 min. 'hen the cells were harvested by centrifugation (1,300 x g, 10 min, at
4°C). Pellets were resuspended gently in 100ml of ice-cold n1B I and re-centrifuged.
The supernatant was discarded and the pellet resuspended in IOmIof ice-cold TFB II.
O.Smlaliquots were rapidly frozen in a dry ice/ethanol bath and stored at -70°C.
To transform competent bacteria, DNA (lOng control plasmid or 15....1 ligation
reaction) was diluted in 100....1of sterile distilled water and placed on ice. Competent
bacteria were thawed rapidly and 150....1added to the DNA solution, which was left on
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ice for lhr, subjected to heat-shock (42°C, 2 min) then placed on ice for 5 min. 300J,1l
of LB was then added and the cells incubated at 37°C for 30 min prior to plating on
, .
LB agar plates containing 100J.1g1mlampicillin, which were then incubated for 16 hrs
at 37°C.
2.3.2.3. Small scale preparation of plasmid DNA
Sml of LBamp was inoculated with a single bacterial colony and grown overnight at
37°C with shaking. Plasmid DNA was isolated from 1.5ml of bacterial culture using a
Qiagen Miniprep plasmid purification kit, following the manufacturer's instructions.
This DNA was suitable for restriction enzyme analysis and cloning.
Alternatively, the alkaline lysis method was used. I.Sml of bacterial culture was
centrifuged in a microcentrifuge for 1 min at 2300 x g. The medium was aspirated,
and the pellet resuspended in I00J.11of ice cold miniprep solution I. This was
vortexed, and left for 5 min at room temperature with an onen lid. Then 200J.11of
freshly made. if';_! cold miniprep solution II was added ar,« Lhe mixture inverted
rapidly 2-3 times before being placed on ice. After 5 min, 150J.11of ice cold solution
III was added and the mixture vortexed gently in an inverted position for 10 sec. This
was then placed onto ice for a further S min, before centrifuging at 13,400 x g for 5
min at 4°C. The supernatant was transferred to a fresh tube, to which was added an
equal volume of phenol/chloroform. These were mixed by vortexing, and centrifuged
at 2300 x g for 2 min. The aqueous phase was removed and 2 volumes of ethanol
added. This was vortexed, and left to stand at room temperature for 2 min. The DNA
was pelleted by micro-centrifugation (16,000 x g, 5 min, room temperature), the
supernatant removed, and the pellet washed by addition of 1ml of 70% ethanol
followed by brief vortexing, and recentrifugation for 5 min at 16,000 x g. The
supernatant was then removed, and the pellet briefly dried in a vacuum. The DNA
pellet was rescspended in 50J.11TE (PH 8.0) containing DNase-free pancreatic
RNaseA (20J.1~ml). The DNA in solution was stored at -20°C.
2.3.2.4. Large scale prepantion of plasmid DNA
A single bacterial colony containing the plasmid of interest was used to inoculate
1.Sml of LBamp and cultured to stationary phase. S0J,11of this was used to inoculate
25ml of LBamp, which was cultured to OD600 of 0.6. This culture was then used to
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inoculate 500ml of LBamp and cultured to OD600of 0.4. Chloramphenicol was then
added at 100flg/ml to amplify the plasmid, and the culture was incubated for a further
16 hrs. All incubations were carried out at 37°C unless stated otherwise in the relevant
results chapter.
Cells were collected by centrifugation (1,600 x g, 30 min, 4°C) and resuspended in
10mi of cold 25% sucrose, 50mM Tris.HCI pH 8.0. 4ml of cold 0.25 M EDT A was
added, mixed gently and placed on ice for 5 min. 20mg of lysozyme dissolved in 2ml
of TNE was then added, mixed gently and placed on ice for 15 min. Following this,
16ml of cold Tnton lysis mixture (0.1% (v/v) Triton X-lOO, 62.5mM EDTA, 50mM
Tris.HCI pH 8.0) was added, mixed gently and placed on.ice for a further 5 min.
Cellular debris was then removed by centrifugation (35,000 x g, 40 min, 4°C). The
supernatant was then extracted by mixing vigorously with 7ml Tris-buffered phenol
and 1ml chloroform/iso-amyl alcohol, allowed to stand for 10 min and then
centrifuged (18,000 x g, 10 min, 4°C). The aqueous phase was removed and further
extracted by the addition of 20ml chloroform/iso-amyl alcohol, vigorous mixing and
centrifugation as before. The aqueous phase was removed and the DNA precipitated
by the addition of 2 volumes of 95% (v/v) ethanol at -70°C for Ihr. The DNA was
pelleted by cen+,tf~'gation (18,000 x g, 20 min, 4°C) and dried in a vacuum dessicator
for 15 min. Th pellet was resuspended in 4.5 ml TNE to which was added 4.72g
CsCI and 320fll ethidium bromide solution (10mglml). Plasmid DNA was purified by
equilibrium density gradient centrifugation in a Beckman Vti6S rotor (200,000 x g,
16hrs, 20°C). t~.hidium bromide was removed from the DNA by repeated extraction
with an equal \ olume of NaCI-saturated isopropanol. 3 volumes of TNE were then
added and the DNA precipitated at -70°C using 9S% (v/v) ethanol. Plasmid DNA was
recovered by centrifugation (15,900 x g, 30 min, 4°C), washed in 70% (v/v) ethanol,
then dried and resuspended in O.Sml 10mM Tris.HCl pH 8.5, containing 10flg
RNaseA.
1.3.3. Tissue culture techniques
1.3.3.1. MaintePkbce of cell lines
All cell lines were cultured in 90mm y-irradiated tissue culture dishes at 37°C in a 5%
C02 atmosphere and passaged when confluent. HEp-2, HeLa and 293 cells (and
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derivatives) were maintained in DMEMllO% newborn calf serum (NCS) (v/v). Cells
were passaged as follows: mono layers were washed with O.Q~% v/v versene, then
cells detached by adding 2.Sml ofO.02% (v/v) versene containing 1.2Smg trypsin, for
3-S min. Cells were removed into O.Sml NCS and centrifuged at 600 x g for 4 min.
The pellet was resuspended in medium and cells seeded at the required density.
2.3.3.2. Long term storage of mammalian cells in liquid nitrogen
Sub-confluent 90 mm dishes of cells were trypsinised for passage and the cell pellet
resuspended in Iml of 92% (v/v) NCS, 8% (v/v) dimethyl sulphoxide (DMSO). The
cell suspension was frozen in O.Sm! aliquots by cooling slowly to -70°C overnight.
Frozen vials were subsequently transferred to liquid nitrogen.
2.3.3.3. Recovery of frozen cell stocks from liquid nitrogen storage
Cells were thawed rapidly at 37°C then transferred to 10m! of pre-warmed medium in
a 90mm dish. The medium was replaced the following day to r 1::10Veresidual DMSO.
2.3.3.4. Tranlfeetion of mammalian cells with dsDNA
2.3.3.4.1. Calcium phosphate tranlfedion
Cells to be transfected were grown to the required density (usually 70% confluency)
in tissue culture dishes (size of dish depended upon assay). The volumes used were
scaled up or down for larger or smaller dishes. The total volume of mix was always
10% of that of the medium in the dish. The calcium phosphatelDNA precipitate was
prepared as follows, for a 60mm dish containing Sml DMEM: O.Sml of mix A
(2S0mM CaCh) 'containing the DNA to be precipitated was added dropwise to O.Sml
of mix B (0 CSmM Na2HP04, lOmM KCI, 270 mM NaCl, 0.2% (w/v) N-2-
hydroxyethyl}:il,erazine-N'-2-ethanesulphonic acid (Hepes), :pH 7.08-7.12) whilst
bubbling air thrc ugh mix B. This was left at room temperature for 30 min then added
dropwise to tl.e cell cultures, O.Sml per 60mm dish containing Sml growth medium.
Cells were incubated at 37°C for 4hrs and the medium replaced. Cells were
subsequently incubated at 37°C/S% C02 for the desired period.
68
2.3.3.4.2. Liposome mediated transfedion
Cells were transfected with LIPOFECTAMINETM (Gibco BRL, Renfrewshire,
Scotland) accorcing to the manufacturer's instructions.
2.3.4. Virological techniques
2.3.4.1. Virus infection of mammalian cells
Infections were initiated by removing the growth medium and adding an amount of
virus calculated to give the desired multiplicity of infection, diluted in DMEM
without serum. Cells were incubated at 37°C and rocked every 15 min. After lhr, full
growth medium containing serum was added and the cells incubated at 37°C for the
time appropriate to the experiment.
2.3.4.2. Large scale preparation of virus stocks and DNA
90% confluent dishes of cells were infected with virus (m ) i, of 2 pfu/cell) and
harvested at full cytopathic effect. Cells were collected by centrifugation (500 x g, 5
min) and resuspended in cold 0.1 M Tris.HCI pH 8.0, to a final volume of 5ml for up
to 4 dishes. This suspension was sonicated on ice using a Jencons sonicator with a
3mm tip, using two sets of ten, one second, pulses separated by 30 seconds. Cell
debris was removed by centrifugation (5,600 x g, 10 min, 4°C) and the supernatant
layered over a two-step CsCI gradient (2ml 1.4 g/ml CsCI, 3ml 1.25 g/ml CsCI, both
final density in. TO). Gradients were centrifuged (1SO,OOO x g, 1 hr, 1SOC) in a
Beckman SW 41 rotor and the virus band collected by puncturing the tube and
collecting the relevant part of the flow-through. This was then diluted with 1.3Sglml
CsClffD and centrifuged to equiibrium (150,000 x g, 16hrs, 15°C) in a Beckman SW
50.1 rotor. TIle virus band was collected as before and either used to prepare a
purified virus stock or viral DNA.
(i). Purified vir'Jlstock
A small sample of the collected virus was diluted 1 in SOO with TElO.1% (w/v) SOS
and the optical density measured. Virus particle concentration was determined using
the formula, A260of 1.0 = 1 X 1012 particles/ml. The remaining virus stock was then
diluted five-fold with stabilising buffer (0.1% (w/v) bovine serum albumin (BSA),
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50% (v/v) glycerol, 10 mM Tris.HCI pH 8.0. 100 mM NaCl, 2mM MgCh) and stored
at -20°C.
(ii). Viral DNA
Collected virus was diluted with two volumes of H20 and precipitated with 2 volumes
of ethanol at -70°C for 30 min. Virions were pelleted by centrifugation (7,600 x g. 20
min. 4°C), dried briefly and resuspended in 2ml TNE with the addition of 120f.L110%
(w/v) SOS, 40f.Ll250mM EOTA and 200f.Lgproteinase K. This was incubated at 37°C
for lhr, then extracted twice with an equal volume of phenolic hioro form. The aqueous
phase was collected and NaCI added to a final concentration ofO.IM. Viral DNA was
precipitated by addition of 2 volumes of ethanol at -70°C for 30 min. DNA was
pelleted by cenrifugation (15,900 x g, 30 min. 4°C). washed in 70% ethanol, dried
and resuspend> in O.5ml TE pH 8.0 at + 4°C.
2.3.4.3. Aden", ':rus reconstruction by In vivo recombination
293 cells were plated at 50% confluence one day before use. The medium was
replaced with DMEM/IO% FCS 3 hrs prior to use. The DNNCa3 (P04)2 precipitate
was prepared 30 min prior to use as follows (volumes correct for one 60mm dish): (a)
A mix of 50f.LI2 x Hepes buffer. approximately 1f.LI100 x P04, and the DNA solutions
made up to 90f.L1total with H20 was prepared. (b) 10J.LIof I.25M CaCh was added to
(a), while bubbles were blown gently through the suspension. This was then left for
30 min at rOOD!temperature. The DNA solutions were in TB and comprised 1J.LIof
Img/ml salmon sperm DNA (unsheared), 1-3 J.Lgplasmid DNA with the viral
sequences liberated by digestion at least at the 0 map unit end, and 0.5-1.0J.Lgviral
genomic DNA .oermitting overlap with plasmid sequences, to regenerate full length
genome). The n.edium was removed from the cells, 0.9ml of DMEMl5% FCS was
added to the DNA precipitate. and this was then layered over the cells. The inoculum
was left on the cells for 3hrs. with rocking at frequent intervals. After this incubation.
1.Oml TS + 20% glycerol was gently added to the monolayer for 1 min only. The
TS/glycerol was then removed. and the monolayer washed twice gently with TS.
Following the wash, liquid or solid media was added as required.
70
2.3.4.4. Standard amplification of viral plaques
The infected· cell monolayer was overlayed with solid medium. Each plaque was
picked with a sterile pasteur and transferred to O.Sml TS/2% NCS, and then
freeze/thawed 3 times. The lysate was subsequently used to infect a 60mm dish of
cells. After 1 week, or at full cytopathic effect (whichever was sooner), the cells were
harvested from the 60mm dish in the medium and freeze/thawed 3 times. Of this
lysate, O.Sml was used to infect a 90mm dish of cells. The remainder of the lysate was
reserved as a stock. The infected 90mm culture was processed for viral DNA by the
rapid preparation procedure (see below) to verify the identity of the starting plaque
before proceeding further. After selecting an appropriate plaque from which to grow a
final stock, about 0.2m) of the reserved 4.Sml of lysate was used to infect 10 dishes of
cells (HeLa or 293 as appropriate). At or prior to full c.p.e, these cultures could be
processed for virions.
2.3.4.5. Adem'. 1rusDNA rapid preparation
The cells from a 90mm dish were harvested at full c.p.e and pelleted at 160 x g for
Smin. The supernatant was removed completely and the pellet was resuspended in
O.4ml TE pH 9.0, IOmM spermine, then O.4ml DOC lysis buffer (20% EtOH,
100mM Tris pH 9.0, 0.4% sodium deoxycholate) was added. This was gently mixed
without vortexing and then centrifuged (12,000 x g, lSmin, 4°C) in a Beckman JA21
rotor. The supernatant was then supplemented with 60JlI 10% SOS, 40JlI 0.2SM
EDTA and 20~1 of 20mglml proteinase K in a I.Sml microfuge tube. This was
incubated for 1hr at 37°C then extracted once in an equal volume of
phenol/chloroform. The aqueous phase was collected and 30Jll of SM NaCI added.
The tube was filled with isopropanol at room temperature, mixed, and the DNA
pelleted by v: .trifugation (15,900 x g, 15 min). Following centrifugation, the
supernatant was discarded and the DNA dried and resuspended in SOJlI TE. RNAse
was added if required.
2.3.4.6. Viral miniprep
Cells from each well of a 12 well dish were harvested at full c.p.e. and transferred to a
1.Sml microfuge tube. These were centrifuged at 1000 rpm for 5 min, the supernatant
removed, and the pellets stored at -20°C. The cell pellet was resuspended in IOOJlITE
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pH 9.0, 10mM spermine. This was mixed, then 100,.11DOC lysis buffer added. The
mixture was centrifuged in a benchtop microfuge. The supernatant was transferred to
a clean microfuge tube, to which was added 15",1 10% SOS, 10",10.25M EOTA and
5",1of 20mg/ml proteinase K. This was incubated for lhr at 37°C then extracted once
in a equal volume of phenol/chloroform. The aqueous phase was collected and 7.5J.11
of 5M NaCI added. 200J.11of room temperature isopropanol was added to the tube,
and the contents mixed before the DNA was pelleted by centrifugation. Following
centrifugation, the supernatant was discarded and the DNA resuspended in 12J.11
dH20. RNAse was added to a final concentration of20",glml.
2.3.5. Analysis of protein expression
2.3.5.1. Extraction of total cellular protein from mammalian cells
The medium was aspirated from tissue culture dishes and the '!p,Hsharvested directly
into a small ., -lume of 1 X SDS-PAGE loading buffer. The volume of buffer
depended upon the size of the assay. A typical volume would be 1OO",lloading buffer
for 106 cells. Samples were stored at -20°C.
2.3.5.2. SDS polyacrylamide gel electrophoresis (SDS-P AGE)
Protein samples were denatured and reduced by boiling in SOS-PAGE loading buffer
for 5 min. Proteins were separated by electrophoresis in discontinuous SOS-
polyacrylamide gels according to the method of Laemmli (1970). Gels consisted of a
5% stacking gel, and resolving gels of various percentages (as noted in the relevant
results chapters). Electrophoresis was performed using the Bio-Rad mini-PROTEAN
IIelectrophoresis system according to the manufacturer's instructions.
2.3.5.3. Westeru blotting
Proteins were separated by SOS-PAGE and transferred to nitrocellulose membrane
according to the method of Towbin et al. (1979). The gel and membrane were
equilibrated in transfer buffer (25 mM Tris base, 192 mM glycine, 20% methanol) for
30 min. Electroblotting was performed in the Bio-Rad Mini Trans-Blor"
Electrophoretic Transfer Cell, at 3SOmA for 1 hr, or at 90mA overnight. The
membrane was blocked in PBS/O.l % (v/v) Tween 20 (PBST)/S% (w/v) milk powder
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overnight at 4°(, before being probed with antibodies (see 2.1.5. for dilutions used).
The membrane was incubated with primary antibody for 2 hr. followed by a 1 hr
incubation with secondary antibody and a 1 hr incubation with enzyme conjugate (if
required). All antibodies were diluted in PBST/5% milk and incubations performed at
room temperature with vigorous shaking. Between each incubation membranes were
washed four times (>5 min per wash) in PBST. Membranes were developed using
Chemiluminescence Reagent Plus Western Blotting detection reagents (NENTMLife
Sciences Products) according to the manufacturer's instructions.
2.3.5.4. Immunofluorescence microscopy
Cells grown on coverslips were washed twice in PBS, fixed for 15 min with a solution
of 3.7% (v/v) formaldehyde in PBS and then washed again with PBS. They were then
permeabilised by incubation for 10 min in 0.5% NP40 in PBS, washed again in PBS
and then stored immersed in PBS at 4°C. Before analysis, coyerslips were incubated
in PBSI1% bovine serum albumin (BSA) for lhr and all rear::.~l·~i.su ed subsequently
were diluted in 'his solution. To detect specific antigens, coverslips were incubated
with the relevant primary antibody for 1 hr, followed by three washes in PBS. Bound
primary antibody was then detected by incubating coverslips for 1 hr with species-
specific secondary antibody conjugates (see section 2.1.5. for details and dilutions
used) for 1 hr and washed as before. If staining of nuclei was required, 4,6-diamidino-
2-phenylindole (OAPI) was added to the final PBS wash at 1J.1g1ml.Coverslips were
mounted in Vectashield'" mounting medium, then viewed and photographed using a
Nikon optiphot microscope and single lens reflex (SLR) 35mm camera loaded with
slide film (typically ASA 1600).
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3. Construction of recombinant plasmids to express wild-type E40rt3
in eukaryotic cells
In order to investigate any effects of Orf3 alone upon the eukaryotic cell, it was
decided to generate an eukaryotic expression vector capable of expressing orO in
isolation from other viral products. A suitable vector would amplify the DNA of
interest in prokaryotic cells, and upon transfection into eukaryotic cells, would drive
expression of E40rf3. Expression of orO would be visualised using Western-blotting
and immunofluorescence microscopy techniques on samples taken from transfected
cells.
3.1. Construction of pEXP4.0rfJ
The plasmid pEXP4 (from Keith Leppard) (fig.3.l) fitted the criteria for the vector,
having an ampR region for selection of recombinants, and the promoter/enhancer
region from the SV40 genome, capable of driving expres;' In in the eukaryotic
environment.
The plasmid contains a pUC18 polylinker region, or multiple cloning site, which
contains several restriction target sites, facilitating insertion of the gene in the correct
orientation between the promoter and a poly-A region.
To simplify the cloning procedure, an existant plasmid, pGEM.OrO was used as a
source of E4orf3 (fig.3.2). In this plasmid, the gene of interest was flanked by
restriction sites; which allowed one step excision of the region using a double digest.
3.1.1. Double digest of pGEM.OrfJ by EcoRI and BamBI
The restriction enzymes BamHI and EcoRI were used in double digest to excise
E4orO from the pGEMOrf3. The total plasmid is 2.8 kbp, and orO is encoded by a
430bp section.' Consequently a successful digest would generate fragments of
approximately 7..lkbp and O.4kbp. If the reaction had not gone-re completion, a band
of 2.8kbp representing undigested parental DNA would also be present. The double
digest generates a linear fragment with two differently cut ends (see figJJ). This
prevents self-annealing of the fragments. as the two ends are incompatible.
Samples of the digest products were loaded onto a 1.4% agarose gel, along with DNA
lkbp marker ladder, allowing sizing of the DNA fragments generated (see fig.3.4)
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Fig.3.1. Plasmid pEXP4.
Map shows unique restriction sites. Abbreviations: amp, ampicillin resistance gene;
tet, tetracycline resistance gene; Psv40, SV40 promoter region; AdpA, adenovirus
polyadenylation site; ori, plasmid origin of replication.
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Fig.3.2. Donor plasmid pGEM.OrfJ.
Plasmid bearing the Ad5 E40rD gene sequence. Map shows unique restriction sites.
Abbreviations: amp, ampicillin resistance gene; SP6, SP6 RNA polymerase
transcription initiation site; T7, T7 RNA polymerase transcription initiation site.
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Fig.3.3. Diagramatie representation of the generation. of sticky-ended fragments.
by EcoRIlBamHI double digest
pGEM 8iunB1
EcoRl +BamHI
BaJIiHI OrD F.coRI
3.1. 2. Restriction digest of Vector pEXP4
In order to linearise the plasmid and allow insertion of E40rf3 in the correct
orientation, the same pair of restriction enzymes was used as above and a sample of
the fragment produced was run on agarose gel (fig.3.4).
Size
(kbp)
1 32
3.0
2.0
1.6
1.0
f).52
0.40
Fig.3.4: BamHIJEcoRI double digest products of pGEMOrf3 and pEXP4. DNA samples
were analysed on a 1.4% TBE/agarose gel. Lane I is loaded with IKb ladder. Lane 2 shows
the products of EcoRIlBamHI digest of pGEMOrf3, where arrow B indicates pOEM, and
arrow A indicates excised E4orf3. Lane 3 show the double digest products ofpEXP4, where
arrow C indicates linearised plasmid, and the cut-out fragment is not visible.
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3.1.3. Ligation ofE4orf3 and Iinearised pEXP4
The digest products of pGEMOrf3 and pEXP4 were separated on individual gels and
slices containing the desired fragments cut away from the rest of the gel. The DNA
was purified from the gel by electroelution. The purified E40rf3 and linearised pEXP4
fragments were then ligated together. Cut pEXP4 alone was ligated to provide a
negative control for transformation. After overnight incubation, the ligation mixes
were used to transform E.coli XLlBlue. A positive control for transformation of uncut
vector DNA was included.
Colonies obtained were used to prepare small scale DNA preparations (minipreps),
samples of which were subjected to analytical restriction digest, to confirm the
presence of an Orf3-sized fragment in the correct orientation, in the pEXP4 vector.
An EcoRI and BamHI digest was performed on DNA prepared in this manner from
twelve picked clones, and the products separated on a 1.4% agarose gel (fig.3.5).
1 2 3 4 5 6 7 8 9 10 11 12 13 14
3.0
2.0
Size (kbp)
0.52
0.40
Fig.3.5: EcoRIlBamHI digest products of miniprep DNA of candidate clones of pEXP4.0rfl.DNA
samples were loaded on a 1.4% agaroseffBE gel. Lanes 1 and 14 were loaded with 1Kb ladder. Lanes
2 to 13 show the digest products of 12 candidate clones of E40rfl in pEXP4. The arrow indicates the
approximately OAKb band, indicating the presence ofE4orf3 in these clones.
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These digests confirmed the presence of a cloned fragment of the correct size in the
vector. However despite the use of two different restriction enzymes, it was still
possible that OrD might have inserted in the wrong orientation or in multiple copies.
To ensure this was not the case, two of the above samples were digested using
different enzymes, chosen to generate a junction fragment characteristic of a correctly
oriented insert. A BamHVBglII digest would be expected to yield a 3.5kbp and a
317bp fragment in a correctly aligned pEXP4.0rfJ plasmid. If 0rf3 had inserted
"backwards", the same digest would yield 3.7kbp and 99bp fragments. If the insert
joined end to er.d 1.> form tandem repeats before insertion into the vector, we would
expect the 3.5ktp vector DNA band, and smaller bands of 226bp, and 317bp.
Accordingly, this digest was performed on samples 2 and 7. A band of the correct size
was seen in the digest of miniprep 2, indicating an insert in the correct orientation.
Clone 2 was used to prepare a large scale plasmid DNA preparation. This plasmid
was named pEXP4.0rD (fig.3.6).
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Fig.3.6. Plasmid pEXP4.0rf3
PEXP4-based plasmid bearing the AdS E40rB gene sequence. Map shows unique
restriction sites. Abbreviations: amp, ampicillin resistance gene; Psv40, SV40
promoter region; AdpA, adenovirus polyadenylation site; tet, tetracycline resistance
gene; ori, plasmid origin of replication.
3.1.4. Transient transfection and Immunofluorescence using pEXP4.0rf3
To assess the suitability of pEXP4.0rf3 as a eukaryotic expression vector for E40rf3,
it was decided to perform transient transfection assays in mammalian cells. The Hep-2
cell line is a readily available laboratory cell line derived from human epithelial tissue
in which AdS-dependent rearrangement of the ND10s and the altered PML isoform
pattern had previously been described. (Leppard and Everett, 1999). Transfection was
performed by the calcium phosphate method upon cells grown on glass coverslips.
The cells were fixed 24 hrs post-transfection and then probed for Orf3 expression. It
was not possible to detect any OrB expression in the transfected cells under
immunofluorescence microscopy as compared with cells infected with wt AdS, In
which OrB tracks are clearly visible (compare panels A and B, fig.3.7).
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Fig.3.7: E40rB expression in transfected or infected HEp-2 cells. Fluorescence microscope
images taken using a xl 00 viewing objective. All panels show HEp-2 cells probed with
antibody A4-7 against E4 OrB, showing green fluorescence where OrB is expressed.
Panel A shows Ad5 wt300 infected cells (at m.o.i. 10), panel B shows pEXP4.0rB transfected
cells and panel C shows mock-infected cells.
3.2. Construction of pcDNA3.1I0rOwt
Vector pEXP4 had been used previously to express heterologous proteins in COSI
cells. However, the vector replicates in these cells in contrast to the situation in HEp-2
celts. In the absence of this replication, expression appears to be too weak to detect. It
was therefore decided to construct a second eukaryotic expression system, placing
E40rt3 under the transcriptional regulation of a stronger promoter. To this end,
pcDNA3.1/HisBIlacZ (fig.3.8.) was chosen. While this plasmid is actually a positive
control for the parent vector, pcDNA3.lIHisB, rather than a vector per se, it was
possible to adapt it for use here. Like pEXP4, the plasmid contains an ampR region,
as well as a polylinker region. Unlike pEXP4 however, pcDNA3.llHisBI/acZ has
been designed to place inserts under the control of the human cytomegalovirus
immediate early promoter region. This confers strong, constitutive expression in many
mammalian cells. The plasmid, pGEM0rt3 was again used as the donor ofE40rf3.
3.2.1. Double digest of pGEMOrf3 with EcoRI and HindUI
The desired vector in this case did not contain the restriction site BamHI.
Consequently, a different cloning approach had to be devised. Fortunately, it was still
possible to generate compatible sticky ended fragments, as both the donor and vector
had EcoRI and HindIII restriction sites in suitable positions (see fig.3.2. and fig.3.8.).
A double digest using these two enzymes was carried out in standard conditions.
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Fig.3.8. Plasmid pcDNA3.1IHisBI/acZ (Invitrogen).
Plasmid containing lacZ reporter gene. Map shows unique restncnon sites.
Abbreviations: amp; ampicillin resistance gene; neo, neomycin resistance gene; CMV
promoter, cytomegalovirus immediate early promoter; Psv40, SV40 promoter region;
SV40 pA, SV40 polyadenylation region.
3.2.2. Double digest of pcDNA3.lIHisBI/acZ
It was possible to digest the vector to generate a linear fragment with ends compatible
with the insert fragment, but at the loss of certain elements of the plasmid.
pcDNA3.lIHisB is designed to enable the formation of a fusion protein between an
inserted fragment of DNA of interest and a six histidine tag sequence, allowing
affinity purification on immobilised nickel ion columns. It also contained a lacZ gene.
Cells expressing the product of this gene tum blue in the presence of Xgal (a
chromogenic substitute for ~ galactosidase). Cleavage with HindlII and EcoRI
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restriction enzymes flanked the region containing both of these elements. Use of these
enzymes to linearise would remove all these elements. This was useful as lacZ
effectively constituted a previous and unwanted insert into the vector. The
HindIII/EcoRI digest was expected to produce two bands. The desired, vector
fragment, was expected to be approximately 5.4Kbp, while the fragment containing
the histidine "tag" and lacZ gene was expected to be around 3.IKbp (fig.3.9.).
Size 1 2
(kbp)
5.0 <==:J A
3.0 <==:J B
Fig.3.9: 0.8% agarose gel of EcoRI + HindllIdigest of pcDNA3.1IHisB/lacZ. Lane 1 shows
1Kb marker. Wide lane 2 shows the fragments generated by EcoRI + HindIII double digest of
pcDNA3.1IHisBllacZ, where arrow A indicates the approximately 5.4Kbp pcDNA3.l fragment.
Arrow B indicates the approximately 3.1Kbp fragment containing the (His)6tag region and lacZ
gene.
3.2.3. Ligation of pcDNA3.1 and E40rt3
The digest products of pGEMOrf3 and pcDNA3.lIHisB/lacZ were separated on
individual gels and the desired fragments purified by electroelution. These were then
ligated together and were used to transform bacteria. Small scale DNA preparations
were performed on 8 clones, and these were then subjected to analytical restriction
digest, to confirm the presence of an Orf3-sized fragment in the pcDNA3.1 vector
(fig.3.10.). Here the arrow indicates E40rf3 coding region as a drop out fragment of
approximately O.4Kbpin each of the clones tested. Again, it was necessary to confirm
that, where present, the insert was in the correct orientation. Two samples were
chosen and BglIVHindIII double digests performed. This digest was expected to yield
fragments of approximately 4.6Kbp, 0.9Kbp and 0.35 Kbp from the desired
recombinant (see fig.3.11.). These fragments are identified by arrows A, Band C
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respectively in figure 3.11, and were present in both samples, thus both bacterial
clones contain the insert in the correct orientation. Therefore, these analytical digests
demonstrated the insertion of E40rf3 into the pcDNA3. I vector in the correct
orientation, to generate pcDNA3. I/Orf3wt (fig.3.l2.).
Size
(kbp)
1 23456789
1.6
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Fig.3.10: EcoRIlHindIII digest products of miniprep DNA of candidate pcDNA3.1 /OrB clones.
DNA samples were analysed on a 1.4% agarose/Tflli gel. Lane 1 shows 1Kb ladder. Lanes 2 to
9 are loaded with EcoRl + HindITI double digested samples of plasmid DNA from eight
different bacterial clones.
A
B
c
Fig.3.11: HindIII/BglII digest products of miniprep DNA of candidate pcDNA3.1I0rf3 clones.
Lane 1 shows lKb marker. Lanes 2 and 3 are loaded with HindITI+ BglII double digests of
samples I and 5 from fig.3.11 respectively. Arrow A indicates a band of approximately 4.6Kbp,
arrow B indicates a band of approximately O.9Kbp, and arrow C indicates a band of
approximately 0.35 Kbp.
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Fig.3.12. Plasmid pcDNA3.1/0rf3wt.
PcDNA3.1-based plasmid bearing the AdS E40rD gene sequence. Constitutive
expression of OrD is driven by the CMV promoter. Map shows unique restriction
sites. Abbreviations: amp, ampicillin resistance gene; neo, neomycin resistance gene;
CMV promoter, cytomegalovirus immediate early promoter; Psv40, SV40 promoter
region; SV40 pA, SV40 polyadenylation region.
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3.3. Expression of pcDNA3.1/0rf3wt in HEp-2 cells detected by
Immunofluorescence
As before, transfection was performed by the calcium/phosphate method upon the
HEp-2 cells grown on glass coverslips. In contrast to the results obtained using
pEXP4.0rf3 (fig.3.8 panel B), OrO was clearly visible in cells transfected with
pcDNA3.1I0rf3wt, and formed nuclear "tracks" in a subset of cells, similar to those
observed during Ad5 infection (compare fig.3.l3. panels A and B). Indeed, using
similar exposure times, E40rO appears to be overexpressed in many cells transfected
with pcDNA3.1/0rOwt relative to infected cells. This could be due to the high
activity of the CMV promoter, and/or multiple transfections into single cells.
Fig.3.l3: E4orO expression in transfected or infected HEp-2 cells. Fluorescence microscope
images taken using a xl 00 viewing objective. All panels show HEp-2 cells probed with
antibody A4-7 against E4 orO, showing green fluorescence where OrB is expressed.
Panel A shows Ad5 wt300 infected cells (at m.o.i. 10), panel B shows pcDNA3.1/0rf3
transfected cells and panel C shows mock-infected cells.
To determine whether these structures stained for 0rf3 colocalised with PML, cells
transfected with pcDNA3.1I0rDwt were co-stained for both OrO, and endogenous
PML. The specificity of secondary antibodies used was tested to prove species
specificity (data not shown). These cells were also DAPI stained, (fig.3.14.). Panel A
shows cells probed with antibody 5E I0 against PML generating green fluorescence
where PML is localised. Panel B shows the same cells probed with antibody 6All
against E40rO, generating red fluorescence where E40rf3 is present. Panel C shows
both stains overlaid to generate yellow fluorescence where the two proteins co-
localrse, plus DAPI-staining, to help determine the outline of the nucleus and the
relation of OrO expression to this structure. As can be seen, these results confirmed
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that E40rD expressed from pcDNA3.1I0rf3wt was detectable in the nucleus ofHEp-2
cells (panel B), and that it appeared to form nuclear structures that colocalised with
and reorganised endogenous PML into track-like structures, similar to those observed
during wild-type AdS infection (panels A and C). Often, in transfected cells, the green
fluorescence equated with the presence of PML, was apparently stronger than that of
surrounding, non-transfected cells. As it is unlikely that expression of Oro causes a
corresponding overexpression of PML in transfected cells, it seems probable that the
apparent increase in green fluorescence represents a "bleed-through" of fluorescence
from the red spectrum. This was not usually problematic to our assay, as the
formation of PML tracks and the loss of the discrete PODs can be unambiguously
visualised in infected cells and those expressing E40rDwt with or without co-staining
for E40rf3. However, when interpreting immunofluorescence data, it was necessary to
be aware that some of the apparent PML staining, might in fact correspond to a very
bright E40rf3 signal and not PML at all.
Fig.3.14: E4orf3 and PML costaining in transfected HEp-2 cells. Fluorescence microscope
images taken using a xl 00 viewing objective. All panels show the same field of HEp-2 cells
transfected with pcDNA3.1/0rf3wt. Panel A shows cells probed with mAb SElO against PML.
Panel B shows the same cells probed with 6AII against E4orf3. In panel C both stains are
overlaid. Additionally, the cells in panel C are DAPI stained.
3.4. Discussion
By cloning the wild-type E40rO gene from the donor plasmid, pGEMOrf3, into
pcDNA3.1/HisBILacZ, it was possible to drive expression of this viral protein in
eukaryotic HEp-2 cells. Earlier experiments attempting to drive expression of Orf3
from the plasmid, pEXP4, proved unsuccessful. It would appear that in this system,
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the CMV promoter of the pcDNA3.1 plasmid backbone is a more potent means of
driving expression of E40rf3 than the SV40 promoter provided by pEXP4.
Through the use of Immunofluorescence microscopy, it was possible to demonstrate
that a subset of HEp-2 cells transfected with pcDNA3.1/0mwt were expressing om
in detectable quantities. using antibody 6All to detect the Orf3 protein. By staining
transfected cells with DAPI, it was possible to define the nuclei of cells, and so
demonstrate that E40rf3 localised exclusively to these structures and was not present
in the cytoplasm. By co-staining cells for Orf3 and endogenous PML (using mAb
SE10), it was possible to demonstrate that these two proteins apparently colocalised
within the nuclei. What is more, the PML staining pattern appeared to be altered in
cells expressing om as compared to neighbouring cells where the presence of om
was not in evidence. In transfected cells, PML was reorganised from the usual
"nuclear dots" ; Ito track-like structures, and om apparentlycolocalised with PML,
to these nuclear "tracks". This pattern of PML redistribution is characteristic of
alterations consequent to wild-type AdS infection. Indeed, the use of adenoviruses
lacking the E40rf3 region have demonstrated that this protein is necessary for track
formation (Carvalho et al., 1995;Doucas et al.,1996).
These experiments, making use ofpcDNA3.1I0rf3wt to deliver om to HEp-2 cells
in isolation from other viral proteins, were able to demonstrate that the E40m protein
is not only necessary, but also sufficient for an alteration in PML localisation, similar
to that observed during infection.
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4. Construction and expression of mutants in pcDNA3.1/0rfwt
Having demonstrated by immunofluorescence that the vector, pcDNA3.1I0rf3wt, was
capable of expressing E40rf3 in eukaryotic cells to give a pattern of localisation
essentially indistinguishable from that seen for AdS-infected cells, it was of interest to
try and identify the regions of the protein necessary for nuclear localisation and track
formation, and to use this information to explore the nature of the interaction with the
cell in general and PML in particular through the construction of mutant Orf3
expressing plasmids.
4.1. Generation ofOrfJ mutants in pcDNAJ.l Vector
The E40rf3 sequences from five adenovirus serotypes were obtained from the
Genbank database and aligned and examined for conserved sequences. Since these
proteins are expected to have similar functions during their respective virus infections,
sequence conservation would be predicted to indicate a gene region important to
correct functioning of the protein product. In this way, four ',Vl1served regions were
identified as potential candidates for functional analysis (see fig.4.1.). It was decided
to investigate the significance of each of these regions in E40rf3 function, by
mutational analysis of individual bases within these regions. Initially, three Orf3 point
mutants and three deletion mutants were generated by mutational peR (fig.4.2.). All
point mutations were designed to substitute alanine for the existing residue. Alanine is
a relatively small and non-reactive amino acid, and consequently is commonly used in
this way to investigate loss of function without interfering in a positive manner. The
mutants were as follows; 0rf3G42A, 0rf3R68A, Orf3RlOOA, 0rf3de19-13,
0rf3deI38-42 and Orf3deI96-100. The E4orf3 gene was amplified from
pcDNA3.1I0rf:.. rather than from the viral genome. This was advantageous, as it
preserved com :,li~nt restriction sites in proximity to the gene, for cloning of the final
product back h"'~f'lthe vector. Mg2+ concentrations needed to-be optimised for each
reaction. An ex-raple of this optimisation is shown in figure 4.~, which illustrates the
priming results :',r primer pairings JDlIJD4 and JD2/JD3, to generate Orf3042A.
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68 96-100
OS FSLYVHLDWA VCLLEA:rvQHLTNAIICSLAVEFDHATGGERVHLIDLHFEVLDNLLE
02 FSLYVHLDWAVCLLEA:rvQHLTNAIICSLAVEP'DHATGGERVHLIDLHFEVLDNLLE
09 FNVILMLDVRVEPLLEATVEHLENRVGFDLAVCFHQ OOBRLHLRDLHFIVLRDRLE
12 FALLLP'IEI VALLEAVVBHLENRLQFDLAVIFHQHSGODRCHLRDLRIQILADRLD
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ch cpncpcpcpcp-cp+cp ncpcp-A cpnncpnnncp cpncpAcp cpnnnnGG-+ ncp -cp+cpn cpnn cp-
Fig.4.1: Alignment of E4orf3 sequences from 5 adenovirus serotypes. E4orf3 sequences
from adenovirus serotypes 5, 2, 9, 12, and 40 are aligned above. The conserved sequences
picked for further investigation, are highlighted in red. The line marked eN shows
functional conservation across a1l serotypes. On the consensus line (eh), cp stands for
hydrophobic, - stands for acidic, + stands for basic and n stands for polar.
NCBl BLAST accession numbers: Hu Ad2, AAA92224.1; Hu AdS, CAA267S7.1; Hu
Ad12, CAASI903.1; Hu Ad9, AAB37S06; Hu Ad40, AAC13983.1.
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Fig.4.2: Schematic diagram of mutational peR. Mutational peR is a two step peR reaction. In
the primary peR reaction (i), an internal primer spanning the region of interest and carrying
the desired mutation (B or D), is paired with an appropriate outside primer (A or C, matching
colours denotes a primer pairing). This reaction generates truncated copies of the template,
carrying the mutation (ii). A second, similar primary PCR reaction is carried out in the other
direction. The internal primers are designed to provide some overlap at this point between both
products of the primary peR reactions. The products of these primary reactions are mixed, and
annealed at the point of overlap by heating and cooling of the mix (iii). These paired strands
then use their partner as the template during strand lengthening (broken line arrow indicates
direction of lengthening), generating double stranded DNA fragments bearing the mutated
gene of interest. peR with primers A and e is then used to amplify the DNA as usual.
Lanes 2 and 3 of panel A show that at suboptimal MgCh concentrations there is no
PCR product for this reaction, while lane 4 shows that at optimal conditions the
desired product is generated. The sizes of the primary reaction products were
expected to be different for each primer pair used. The primers used to generate each
mutation, and their expected primary reaction product are listed in a table in Appendix
I. Samples of the 1° PCR reactions containing the desired fragments were used in the
second stage amplification.
The products of the 2° PCR reactions were loaded onto agarose gels (fig.4.4.).
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Fig.4.3: Agarose gels showing an example of mutational peR I ° products. Panel A shows a 1%
agarose gel. Lane I shows I Kb ladder. Lanes 2 to 4 show peR products generated using primer
pair ID I and ID4 at increasing MgCh concentrations. Lanes 5 to 7 show the negative controls
for the reaction. Lane 8 is loaded with the product of an adenoviral DNA positive control. Panel
B shows a 2% agarose gel loaded with the complementary peR reaction products. Lane I shows
IKb ladder. Lanes 2 to 4 show peR products generated using primer pair ID 2 and ID3 at
increasing MgCl, concentrations. Lanes 5 to 7 are loaded with the negative controls for this
reaction.
FigA.4: A 1.4% agarose gel showing mutational peR 2° products. Lane I shows I Kb ladder.
Lanes 2 and 4 show the products of different 2°peR reactions, each using the I ° peR reaction
products shown in fig.3.l7, lane 4 of both panel A and panel B. Lanes 3 and 5 show negative
controls, and lane 6 is loaded with the standard positive control for peR. The position of the
desired Orf3G42A product is indicated with an arrow.
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nt34590
I
nt24569
I
GAATTATTTGGCTATGGTTGAA
Fig.4.5: A Section of a sequencing chromatogram of the mutant E4ort3 plasmid,
pcDNA3.I/0rt3G42A is shown here. The numbers above the chromatogram denote the position
of the indicated nucleotide in the Ad5 sequence. The triplet comprising nt34578-34580
(underlined in red) has been mutated from GGC, coding for Glycine, to GCT, coding for
Alanine. Sequence chromatograms are presented in Appendix II-XII.
The desired fragments were excised and electroeluted from the agarose gels,
phenol/chloroform purified and resuspended in H20. The purified DNA was then
"trimmed" using EcoRI and HindIII restriction enzyme digestion, to generate
fragments suitable for cloning into the pcDNA3.1 plasmid backbone. Cloning of the
fragments into the vector was carried out using standard procedures as described
above (see section 3.2) and plasmid amplified in bacteria, and purified for analysis by
the maxiprep method. All plasmids were sequenced across the E40rf3 gene to ensure
that they carried the desired mutation, and that no additional alterations had occurred
to the gene (see appendices IT-XII). An example of sequence data obtained from the
plasmid, pcDNA3.1/G42A (refer to figs.4.3 and 4.4), is shown in figure 4.5.
4.2. Transient transfection of HEp-2 cells and Immunofluorescence using
eukaryotic expression vectors ofE4orf3 mutants
In order to determine whether any of the E40rf3 mutants resulted in an abnormal
phenotype when expressed in eukaryotic cells, the mutant Orf3 expressing plasmids
were transfected by the calcium-phosphate method into HEp-2 cells grown on glass
covers lips, as before. These were then fixed, double-labelled for E40rf3 and PML,
and examined under immunofluorescence microscopy (fig.4.6). In the cells
transfected with each of the point mutants (4.6A), E40rf3 could be seen as a nuclear
stain in track-like formations, as had previously been observed using
pcDNA3.1/0rf3wt (4.6A) and by wild-type infection (4.6C). However, the remaining
deletion mutants showed aberrant staining for OrO.
92
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Fig.4.6 B. Anti-E4orf3 Anti-PML Double-stained
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Fig.4.6 C. Anti-E4orf3 Anti-PML Double-stained
Mock
Infection
AdS wtJOO
infection
Fig.4.6: E4orf3 and PML co-staining in transfected HEp-2 cells, compared with AdSwt300 and
mock infected controls.Fluorescence microscope images were taken using a xlOOviewing objective.
Each series of panels from left to right show the same field of HEp-2 cells transfectedJinfected as
indicated on the left, and probed as indicated at the top. Cells were probed with mAb SElO against
PML and with 6All against E4orf3.
Transfection with pcDNA3.1I0rf3deI9-13 or pcDNA3.1I0rf3deI38-42, did not
produce any visible Orf3 stain (4.6 B, upper six panels). This was perhaps to be
expected, as these deletions could have significantly disrupted the tertiary structure,
destabilising the protein or concealing the antibody-binding site. Nevertheless, the
GOR secondary structure prediction method (version IV, Gamier et al., 1996), does
not predict these regions to be in structurally important alpha helical regions and
consequently, these deletions might not be thought to have a major impact on protein
structure and function. It was also possible that these deletions directly impacted on
the antibody epitope. Transfection with the OrDde196-100mutant was however, more
interesting, in that E40rD staining was visible, but in contrast to the well defmed
nuclear tracks previously observed, it was found in both cytoplasmic and nuclear
compartments as a diffuse stain (4.6B, lower six panels). In cells expressing this
protein, green fluorescence was observed as a diffuse signal, apparently overlaying
discrete, nuclear foci of green fluorescence. In transfected cells, the green
fluorescence equated with the presence of PML, is apparently stronger than that of
surrounding, non-transfected cells. As it is unlikely that expression of Oro causes a
95
corresponding overexpression of PML in transfected cells, it seems probable that the
apparent increase in green fluorescence represents a "bleed through" of fluorescence
from the red spectrum. This was not usually problematic to our assay, as the
formation of PML tracks, and the loss of the discrete PODs can clearly be seen in
infected cells, and in those expressing E40rf3wt. However, where cells were
transfected with pcDNA3.1I0rf3deI96-100, the bright, diffuse green signal
corresponding to bleed-through of red signal, did to some extent obscure the
localisation of PML. Nevertheless it is possible, referring to fig.4.6B. to distinguish
discrete structures beneath the diffuse green stain. These represent PODs that have not
undergone reorgamsation, and are features not observed in infected cells, or those
transfected with plasmids that generate Orf3 tracks. Seemingly, PML did not
colocalise with the diffuse E40rf3 mutant, and the PODs were not disrupted to
generate PML tracks or other structures. This would suggest that in order to interact
with PML, OrO must first localise to the PODs. That is to say, PML interaction with
Orf3 cannot occur outside of the PODs, and E40rf3 must be concentrated in discrete
subnuclear regions to associate with PML.
4.3. Generation of further OrfJ mutant. in pcDNA3.1 Vector
The immunofluorescence microscopy data on the initial panel of six mutants for
E40rf3, revealed that one deletion mutant, 0rf3deI96-100, displayed aberrant Orf3
localisation when expressed in eukaryotic HEp-2 cells, implicating residues 96-100 in
the correct localisation of Orf3. In an attempt to further characterise the motif
responsible fo- r'1is phenotype, further point mutants were designed to substitute
alanine for each amino acid in this region. Orf3RIOOA had already been constructed,
so only the following four mutants had to be constructed; 0rf3T96A, 0rf3G97A,
0rf3G98A ane )rf3E99A. As before, DNA fragments coding for mutant Orf3s were
generated by using mutational peR, and these were subsequently cloned into the
pcDNA3.l vector backbone, and amplified in bacteria. Again. all final constructs
were sequencec'scross the Orf3 gene region (see appendices II-XII).
4.4. Transient tranlfection of HEp-l cells and Immunofluorescence using E40rfJ
point mutants spanning residues 96-100
The four plasmids, pcDNA3.l/0rf3T96A, G97A, G98A and E99A were transfected
into HEp-2 cells grown on glass coverslips, as before. These were fixed and stained
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for E40rD expression, 24 hrs post-transfection, and observed by immunofluorescence
microscopy. In all cases, Orf3 staining was observed in the nuclei of trans feeted cells
in track-like structures (Fig.4.7A.). In the case of cells expressing E4orflT96A, there
also appeared to be notable concentrations of OrfJ outside the nucleus in several cells,
in addition to the tracks within. This phenotype is demonstrated in figure 4.7B, where
DAPI staining was used to stain the DNA and define the bou;..daries of the nucleus.
Here, Orfl staining appears as a punctate stain apparently outside of the nuclei of any
of the surrounding cells. This point mutant appeared to share a milder version of the
phenotype observed when the deletion mutant, 0rf3deI96-100, was expressed.
However, an inherent difficulty with the technique used, is the variability in
expression from cell to cell as can be seen by comparing the apparent pattern of Orf3
expression between the pcDNA3.1I0rDT96A transfected cells shown in figures 4.7A
and 4.7B. One cell may have been transfected with more plasmids than its neighbour,
and consequently express the protein to a greater extent. This can render results
misleading. It may have been the case that OrD was only present in the cytoplasm of
cells expressing T96A because the cells observed were greatly overproducing the
protein in comparison with other transfections. In this case, despite a fully functional
protein, some Orf3 might have "leaked" or been transported into cellular
compartments where it might not normally be found in these ;jiwttities. A number of
cells were viewed, and only those considered representative of the "average" cell in a
transfection were recorded. By this means, it was hoped to eliminate out the effects of
overexpression. However, the problems associated with achieving consistent and
standard expression of orO were inherent to the transient transfection method.
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Fig.4.7 A. Anti -E4orf3 Anti-PML Doub le-stained
pcDNA3.1I
0rf3E99A
pcDNA3.
0rf3G97A
Fig.4.7 B.
pcDNA3.1I
0rf3T96A
Fig.4.7. E4orf3 and PML costaining in transfected HEp-2 cells. Fluorescence microscope images were
taken using a xl 00 viewing objective. Each series of panels from left to right show the same field of
HEp-2 cells transfected with the plasmid indicated on the left, and probed as indicated at the top. Cells
were probed with mAb 5ElO against PML and with 6All against E40rf3.
In figure 4.7B, DAPI staining was also used to stain DNA and defme the boundaries of the nucleus.
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4.5. Western Blotting ofHEp-2 derived samples with pcDNA3.1IOrf3wt
Having demonstrated that it was possible to detect E40rt3 expression in eukaryotic
HEp-2 cells by IF microscopy using the vector, pcDNA3.1I0rOwt, it was of interest
to determine whether this plasmid system could be used as the basis for a western
blotting assay into effects of AdS E40rf3 upon the biochemical properties of PML. As
previously discussed, it has been demonstrated that E40rG is necessary for the
generation of an infection-specific PML banding pattern in Western blot assays, and it
has been postulated that this biochemical alteration ofPML is necessary for, or results
from the formation of PML "tracks". The immunofluorescence microscopy results
shown above, confirmed the observation that E40rt3 alone was necessary and
sufficient for the formation of "tracks" (Carvalho et al., 1995; Doucas et al., 1996). A
biochemical alteration of PML in the same system would link the two phenomena.
Firstly, it was necessary to determine whether OrG could be detected by Western blot
in samples derived from transfected HEp-2 cells, with samples from AdS-infected
cells as positive controls. An Ad5inorf3 infection was included as a negative control
for orO expression. This mutant virus does not produce OrG, but is otherwise wild-
type. Accordingly, samples were taken at 24 hours post-transfection and infection,
and run on 15% SDS-PAGE. The protein was then blotted onto nitrocellulose, and
detected using antibody to E40rf3 (Fig.4.8.)
1 2 3 4 5
50-
35-
30-
15-
10-
Fig.4.8: Presence ofE40rt3 in transfected and infected HEp-2 cells. Approximately 3.5 x 104
HEp-2 cells were transfected with pcDNA3.I/OrSwt (lane I), pcDNA3.llHisBI/acZ, mock-
transfected (lane 2), infected with wt300 (lane 4), Ad5inort3 (lane 5) or mock-infected (lane 3)
at 37°C. Total cell extracts were prepared at 24 hours post-transfection and infection. Extracts
were separated by SDS-PAGE on a 15% gel, blotted and probed for E40rt3 with antibody
6AII. The positions to which proteins of known molecular mass migrated are shown at the left
(kDa).
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As can be seen in lane 4 of figure 4.8, a band of approximately 11K corresponding to
E40rf3 is clearly discernible in cells infected with wild-type adenovirus (wt300). A
band of similar mobility is also present in lane I, comprising the contents of cells
transfected with pcDNA3.1/0rBwt. This band is not present in either the mock-
infection, Ad5inorf3 infection, or mock-transfection (lanes 3, 2 and 5, respectively).
The faint banding in lane 5 is probably due to "spillover" from lane 4. Note the lower
mobility band in lane 1 (approx. 20K). This may be an artefact, or represent an
altered, possibly SUMO-l modified form of E40rf3. These results demonstrated that
the E40rf3 protein was produced in HEp-2 cells transfected with pcDNA3.1I0rf3wt
however, repeat experiments using standard conditions showed that this system was
unreliable in generating a strong Orf3 signal from transfected cells (see fig.4.9).
Here, despite a strong E40rB signal in samples taken from HEp-2 cells infected with
wild-type adenovirus (lane 4 of both blots), cells transfected with pcDNA3.1I0rf3wt
only yielded a very weak E40rf3 signal (fig.4.9 panel A, lane 1) or none at all (panel
B, lane 1).
1 2 3 4 1 2 3 4
FigA.9: Two separate Western blot assays of total protein samples taken from HEp-2 cells
transfected with pcDNA3.I/0rf3wt, compared with cells infected with wild-type AdS.
Approximately 2 x 104 HEp-2 cells were transfected with pcDNA3.I/Orf3wt (lane I of blots A
and B) or mock-transfected (lane 2 of blots A and B). Approximately I x 104 cells were mock-
infected (lane 3 of blots A and B) or infected with Ad5 wt300 (lane 4 of blots A and B). The
positions to which proteins of known molecular mass migrated are shown at the left (kDa).
Despite the difficulties involved in maintaining comparable OrB expression levels
between transient transfections, it was decided to attempt a blot of transfected
samples, probing against PML. Samples of HEp-2 cells transfected with
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pcDNA3.1/0rDwt were loaded on 7.5% SDS-PAGE gels along with Ad5 infected
controls and transferred onto nitrocellulose membranes (fig.4.1 0).
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Fig.4.10: PML isofonns in transfected and infected HEp-2 cells. Extracts were separated by
SDS-PAGE on a 7.S% gel, blotted and probed for PML with antibody SElO. Each lane is loaded
with the equivalent of 4 x 104 HEp-2 cells. Lane I is loaded with a sample of cells transfected
with pcDNA3.l/0rt3wt. Lane 2 is loaded with mock infected samples. Lane 3 is loaded with
samples derived from cells infected with wild type 300 AdS. Arrow A indicates the major PML
band at approximately 140kDa. Arrow B indicates the infection specific PML isofonn just
above the 140kD band. The positions to which proteins of known molecular mass migrated are
shown at the left (kDa).
The best results were obtained when the blot was carried out overnight using low
current. As can be seen in samples taken from cells infected with AdS wt300, it was
possible to recreate the distinctive, adenovirus infection-specific pattern of PML
species distribution previously demonstrated by Leppard and Everett (1999).
Comparing the extracts of infected cells (lane 3), with mock infected cells (lane 2), it
can be seen that three low mobility PML bands were lost and a novel band, indicated
by arrow B appeared, migrating just above the major 140kD band, indicated by arrow
A. However, those lanes loaded with extracts of pcDNA3.1/0rDwt transfected HEp-2
cells (lane 1) do not show this distinctive PML banding pattern, displaying a similar
pattern to mock-derived samples in this assay. Taken on face value, these results
suggest that E40rf3 alone is not sufficient for the observed biochemical alteration of
PML upon infection, and thus this process and track formation are not directly related.
However, due to the variable nature of transfection efficiency in these assays, it is
difficult to argue tbat the above results are meaningful. More importantly, an obvious
criticism of tbis experiment is simply that even at its best, transfection efficiency is
still too low to generate meaningful results. At best, transfection efficiency was
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probably below 5%, as determined by immunofluorescence microscopy on cells
processed in parallel. The relatively high total levels of OrD observed in a
"successful" transfection by western blotting, actually only represents a subset of
cells, which are vastly overexpressing E40m in relation to infected cells. As surplus
om is not transported outside of the producing cell to its neighbours, total om
protein level in this assay is not related to the number of cells ( .(~"sed to the effects of
om. Thus, if only 1 in 20 cells are transfected, only 1 in 20 cells might be expected
to contain "infection specific" PML species. This amount of altered protein could well
be lost amongst the vast majority of unmodified PML. Indeed, it was never likely that
transfection would visibly reduce the levels of the three low mobility isoforms as
occurs during infection, but it was hoped that it might be possible to visualise the
appearance of the novel band above 140kD. However, this was not the case, and the
results of this experiment were consequently inconclusive.
4.6. Western hlotting of HEp-2 derived samples using the panel of
pcDNA..l1I0rfJ mutants
Despite the discouraging results obtained from SDS-PAGE and Western blotting
using samples taken of HEp-2 cells transfected with pcDNA3.1I0mwt, it was hoped
that it would be oossible to visualise om in samples taken from cells transfected with
,
the panel of C!. 3 mutants, and relate this to any biochemical alterations observed in
PML in the same samples. For example, it would useful to determine that the novel,
infection-specific PML band appeared when tracks were generated (by the majority of
mutants), but that PML was not altered where om localisation was disrupted (using
deI96-100). It would have been interesting to note whether any of the constructs when
expressed were mutant for PML biochemical alteration, but not track formation. It
was hoped that these results would help tie track formation and PML modification
together, or demonstrate that the two were indeed separate processes. Unfortunately it
proved difficult to visualise om on the blots and impossible to visualise it for all
transfections at the same time. thus there were no grounds for comparison between
samples. Figure 4.11 is typical of such a result. Here, a band corresponding to E40m
can only be vi." alised in cell extracts of AdS-infected HEp-2 cells. Analysis of PML
banding pattern in the same samples did not show any modifir ~Til)n,other than in the
virus infected samples. As Figure 4.12 shows, extracts ofHEp-2 cells transfected with
om expressing plasmids appeared to be in all ways similar to extracts of mock
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transfected cells. Three SUMO-I-modified PML isoforms were visible above the
major band of 140kDa (arrow A), and no novel bands had appeared. However, where
HEp-2 cells were Ad5-infected, these three lower-mobility PML isoforms were lost,
and in addition, the infection-specific band appeared above 140kDa (labelled with
arrow B).
As before, these results were largely inconclusive, due to the lack of consistency
between assays and the low overall transfection efficiency. Multiple approaches were
utilised to address this problem. One was to try and improve transfection efficiency to
a level where the novel, infection-specific PML isoform, if produced, would be
present in sufficient quantities to be visualised by western blotting. The other
approach was to assume that E40rf3 was present in sufficient quantities to generate
the novel band, but had not done so as Orf3 alone was not sufficient for this
phenomenon, but required additional viral input. If this could be shown to be the case,
it would not be necessary to elaborate on the existing technique. In addition, it was
considered desirable to construct recombinant Ad5 viruses substituting selected
E40rf3 mutants for the wild-type gene, so that 100% of cells in a culture could be
made to express mutant OrD and overcome the problems of trans feet ion.
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Fig.4.11: Each of the mutant E40rf3 expressing plasmids was transfected into 2 x io' HEp-2 cells
at 37°C and total cell extracts prepared at 24 hours post-transfection. HEp-2 cells were infected
with AdS wt300 as a positive control for E4orf3 expression. Extracts were separated by SDS-PAGE
on a IS% gel, blotted and probed for E4orf3 with antibody 6AII. E4orf3 expression can only be
visualised in samples infected with AdS wt300 (indicated by the arrow). The positions to which
proteins of known molecular mass migrated are shown at the left (kDa).
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Fig.4.12: PML isofonns in transfected and infected HEp-2 cells. Each of the mutant E40rD
expressing plasm ids was transfected into 2 x 105 HEp-2 cells at 37°C and total cell extracts
prepared at 24 hours post-transfection. HEp-2 cells were infected with AdS wt300 as a positive
control for E40rD expression. Extracts were separated by SDS-PAGE on a 7.5% gel, blotted
and probed for PML with antibody SEIO. Arrow A indicates the major PML band at
approximately 140kDa.The positions to which proteins of known molecular mass migrated are
shown at the left (kDa).
4.7. The use of293 cells in transfection and infection assays
It was decided to investigate the suitability of using 293 cells rather than HEp-2 cells
as a potential means of increasing transfection efficiency. 293 cells are adenovirus-
transformed human embryonic kidney cells expressing the adenoviral Elb-SSK
product (Graham et al., 1977), and are known to be highly transfectable. However, it
was not known whether it would be possible to detect the desired PML banding
pattern in samples derived from these cells. Initially, it was necessary to perform a
simple comparison between the E40rf3 and PML banding patterns of 293 and HEp-2
cells in samples derived from infected and non-infected cells. Using Western blotting,
it was possible to visualise OrfI expression in both 293 and HEp-2 cells (fig.4.13).
Here, a band corresponding to E4orf3 can be seen in lanes 2 and S, where 293 and
HEp-2 cells respectively, were infected with AdS wt300. This band is not visible in
the mock infections (lanes 3 and 6) or infections with the virus inorf3 which carries an
insertional mutation of E4orf3, rendering the gene non-functional (lanes 1 and 4).
104
1 2 3 4 5 6
35-
30-
25-
15-
10-
Fig.4.13: The presence of E4orf3 in infected 293 or HEp-2 cells. 2 x 105 cells were infected
with Ad5 wt300 (lanes 2 and 5), Ad5 inorf3 (lanes I and 4) or mock infected (lanes 3 and 6) at
37°C and total cell extracts prepared at 24 hpj. Extracts were separated by SDS-PAGE on a
15% gel, blotted and probed for E40rf3 with antibody 6AII. Lanes I to 3 show samples derived
from 293 cells. Lanes 4 to 6 show samples derived from Hep-2 cells. The positions to which
proteins of known molecular mass migrated are shown at the left (kDa).
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Fig.4.14: PML isoforms in infected HEp-2 or 293 cells. 2 x 105 cells were infected with Ad5
wt300 (lanes 2 and 5), Ad5 inorD (lanes I and 4) or mock infected (Janes 3 and 6) at 37°C and
total cell extracts prepared at 24 h p.i. Extracts were separated by SDS-PAGE on a 7.5% gel,
blotted and probed for PML with antibody 5EI0. Lanes 1 to 3 show samples derived from 293
cells. Lanes 4 to 6 show samples derived from Hep-2 cells. Arrow A indicates the major
140kDa PML band. Arrow B indicates the adenovirus infection specific isoform just above
140kDa. The positions to which proteins of known molecular mass migrated are shown at the
left (kDa).
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Probing of the same samples for PML demonstrated that 293 and HEp-2 cells were
equivalent in relation to this protein (fig.4.l4.). The diagnostic infection-specific band
(indicated by arrow B) just above 140kDa could be seen in the content of wt300
infected cells of both types (lanes 2 and 5), but not in mock infections (lanes 3 and 6),
or infections with inorfl (lanes 1 and 4). The absence of the infection-specific band in
cells infected with inorfl, demonstrates that om is necessary for this PML
modification to occur.
4.7.1. Transient transfection of 193 cells and Immunofluorescence using
plasmids vectors 01wild-type E40rfl and a panel of Orfl mutants
293 cells grown on glass coverslips were transfected by the calcium phosphate
method, with all E40rfl expressing plasmids previously described, alongside
appropriate controls. At 24hrs post infection, these were formaldehyde fixed, blocked
and probed with mAb 5ElO against PML, and rat 6All against E40rO. The results
are shown in figure 4.15. Here, the results essentially mirrored those obtained using
HEp-2. Again, Orfl is visualised as nuclear tracks for all mutants except for de196-
100, and to a lesser extent in OrOT96A. Importantly, 293 cells proved to be much
more transfectable than HEp-2 cells, giving a typical transfection efficiency of 20-
25%. This made 293 cells much more suitable for the Western blot assay of PML
isoforms. With relatively high levels of orO expression in as large a fraction as a
quarter of cells, we might expect to see the presence of a novel protein isoform in
addition to ur..r.ouified PML reflected in blots. The drawback of using 293 cells
proved to be r weaker PML stain under immunofluorescence. Nevertheless, the
important properties of OrOlPML colocalisation could still be discerned. It is worth
noting that E4."f3 has been shown to bind to and colocalise at nuclear tracks with
EIB-55kDa, also present in 293 cells. Recent evidence suggests that in doing so, orO
liberates p53 fr., n 55K induced inhibition of transcriptionalectivity (Konig et al.,
1999). While, it :8 worth considering the effect 55K might have on the experimental
system being studied, it seems unlikely that the presence of this viral protein would
adversely affect our assay when we consider that both viral proteins are present in the
wild-type Ad5-infected cells in which the alteration of PML banding patterns and
ND 1Oswas characterized.
Interestingly, IF microscopy analysis of 293 cells transfected with
pcDNA3.1/0rf3deI38-42, revealed nuclear Orf3 "tracks" similar to those observed in
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cells expressing wild-type OrB. It had previously not been possible to observe
expression of this protein in transfected Hep-2 cells, suggesting that some intrinsic
property of 293 cells may have been stabilising the protein in some way. One obvious
difference between Hep-2 cells and 293 cells is the presence of the adenovirus
protein, Elb-55kDa in the latter. This protein is known to form a complex with
E40rB at early stages in infection, and it was of interest to determine whether 55K
was responsible for stabilising om in 293 cells. To test this, HEp-2 cells were co-
transfected with both pcDNA3.1/0rfJde138-42, and the E1b-SSkDa expressing
plasmid, XhoI-C (fig 4.16). These cells were then co-stained against om and 55K
(fig.4.17). In this assay, the Omde138-42 protein appeared to be present, forming the
typical nuclear tracks. These OrD tracks apparently colocalise with the S5K protein.
On the basis of this result, it would appear that Omde138-42 was indeed "stabilised"
in some way by the presence of EIBSSkDa.
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Fig.4.15 A. Anti-E4orf3
pcDNA3.1I
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pcDNA3.1I
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FigA.15 B. Anti-E4orf3 Anti-PML Double-stained
pcDNA3.lI
OrORIOOA
pcDNA3.lI
OrOG98A
pcDNA3.lI
OrOE99A
pcDNA3.1I
OrO_69-13
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Fig.4.l5 C. Anti-E4orf3 Anti-PMT. Double-stained
AdS
wt300
infection
pcDNA3.lI
Orf3M6-
Fig.4.1S: E4orf3 and PML costaining in transfected 293 cells, compared with Ad5wt300 and mock
infected controls. Fluorescence microscope images were taken using a x I00 viewing objective. Each
series of panels from left to right show the same field of 293 cells transfectedlinfected as indicated on
the left, and probed as indicated at the top. Cells were probed with mAb 5ElO against PML and with
6All against E4orf).
4.7.2. Western blotting of 293-derived samples using the panel of pcDNA3.1I0rf3
mutants
Having demonstrated expression of E40rf3 in 293 cells by immunofluorescence, it
was of interest to repeat the Western blot assays described above (section 4.S.) using
this cell line. Again, cells underwent calcium-phosphate transfection, and total cell
lysates were harvested at 24 hours post transfection or infection in SDS-PAGE lysis
buffer and analysed on 15% mini gels for E40rf3 and 7.5% minigels for PML. The
protein was then blotted onto nitrocellulose, and detected with antibodies SElO and
6All against PML and E40rf3 respectively (figsA.18 and 4.19).
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Figure 4.16. Plasmid Xho I-C.
pBR322-based plasmid, bearing Ad5 sequences from 1-5788 of AdS. The tetracyclin
resistance gene tet is lost from parental BR322. Abbreviations: amp, ampicillin
resistance gene.
Fig.4.17: E40rt3 and EIB55kDa staining in transfected Hep-2 cells. Fluorescence microscope images were
taken using a x 100 viewing objective. Panel A shows cells probed with mAb 2A6 against El B55kDa. Panel B
shows the same cells probed with 6All against E40rt3.
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Fig 4.18: Each E40rf3 expressing plasmid was transfected into 2 x 105 293 cells at 37°C. Mock
transfections and infections with Ad5 wt300 were carried out in parallel, to provide negative
and positive controls for E4orf3 expression, respectively. Total cell extracts were prepared 24 h
p.i. Extracts were separated by SDS-PAGE on a 15% gel, blotted and probed for E40rf3 with
antibody 6All. The positions to which proteins of known molecular mass migrated are shown
at the left (kDa).
As figure 4.18 illustrates, E40rD expression can be visualised in all samples other
than those transfected with pcDNA3.1/0rf3deI9-13, and the mock transfection. In
addition, the Orf3RIOOAprotein, which falls within the deletion region of interest,
appears to have a markedly different electrophoretic mobility than wild-type Orf3.
The absence of a band corresponding to E40rf3 in cells transfected with
pcDNA3.1/0rDdeI9-13 tallies with the observations by microscopy, in which it was
not possible to detect the presence of OrB in cells transfected with this construct
using the same anti-Orf3 antibody. Possible explanations for this observation would
be that the gene is so disrupted by this deletion, that no stable protein is produced, or
that the antibody epitope is concealed, altered or deleted. Also of interest is the visibly
reduced level of detectable protein where cells are expressing Orf3deI96-100. This
reduction in staining intensity might represent less efficient Orf3 expression, reduced
protein stability, or reduced affinity with the antibody. Perhaps OrBde196-100 IS
targeted for degradation upon losing the association to the PODs.
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Fig.4.19: Each E40rf3 expressing plasmid was transfected into 2 x 105 293 cells at 37°C. Mock
transfections and infections with AdS wt300 were carried out in parallel, to provide negative
and positive controls for E4orf3 expression, respectively. Total cell extracts were prepared 24 h
p.i. Extracts were separated by SDS-PAGE on a 7.S% gel, blotted and probed for PML with
antibody SElO. The positions to which proteins of known molecular mass migrated are shown at
the left (kDa).
As can be seen in figure 4.19, the PML banding pattern of transfected 293 cells was
not visibly modified in comparison to mock transfected cells despite achieving high
levels of Eaorfs expression (figA.18), and approximately 25% transfection efficiency.
In comparison with cells transfected with pcDNA3.1/0rDwt, only the extracts of
infected cells have the diagnostic band (arrow A) just above the major 140kDa PML
band (arrow B). The three SUMO-l modified PML isofonns between approximately
ISO and 2S0kDa can be seen in extracts ofE40rD and mock transfected 293 cells, but
have been reduced or lost where cells were Ado-infected. These observations can be
explained if the transfection efficiency was still too low to generate enough modified
PML for visualisation, or if E40rf3 alone was not sufficient for this effect. In short,
despite the increase in transfection efficiency made possible by the use of 293 cells, it
was still not possible to say whether E40rf3 was sufficient for the PML biochemical
modification observed in infection.
4.7.3. Transfection and superinfection of 293 cells
To address the question as to whether too few cells were expressing E40rD in a
transfection to generate visible levels of infection specific PML, or whether E40rD
required extra viral input, 293 cells were transfected with the panel of OrD expressing
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plasmids as before, and subsequently superinfected with Ad5inorf3. This mutant virus
does not produce Orf3, but is otherwise wild-type. Following a successful transfection
and subsequent infection with inorf3, a cell would be provided with the full
complement of viral proteins. It was to be expected that the infection specific PML
band would be visualised in Western blots of these samples, if enough cells expressed
OrD but if other viral factors were also required (fig.4.20). As can be seen, neither
cells transfected with pcDNA3.1I0rf3wt (lane 1), nor those transfected and
superinfected with inorD (lane 2), showed any alteration in the pattern of PML
isoform distribution, in comparison with mock infected 293 cells (lane 4). Cells
infected with inorf3 alone did not demonstrate any PML biochemical alteration (lane
3), demonstrating that the Orf3 protein is necessary for the generation of the infection
specific isoform. Given that a successfully transfectedlsuperinfected cell would be
expected to contain all adenovirus proteins, this result demonstrated that the
transfection efficiency was not high enough to enable the observation of the infection
specific band by this method. Consequently, it was not possible to determine whether
or not E40rf3 alone was sufficient to generate the altered distribution of PML
isofonns, and whether this PML biochemical alteration was linked directly to the
generation of PML tracks, observed upon expression of Orf3 in HEp-2 or 293 cells.
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Fig.4.20. Each lane is loaded with the equivalent of 4 x 104 293 cells grown at 37°C. Lane 1
was loaded with the lysate of cells transfected with pcDNA3.1 /Orf3wt. Lane 2 was loaded with
the lysate of cells transfected with pcDNA3.1I0rf3wt and superinfected with Ad5 inorf3. Lane 3
is loaded with the lysate of cells infected with Ad5 inorf3. Lane 4 is loaded with mock infected
cells. Extracts were separated by SDS-PAGE on a 7.5% gel, blotted and probed for PML with
antibody 5EIO. The positions to which proteins of known molecular mass migrated are shown at
the left (kDa).
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4.8. Discussion
Having demonstrated that the successful expression of E4orf3wt in eukaryotic HEp-2
cells resulted in the redistribution of endogenous PML from nuclear "dots" to "tracks"
similar to those observed during wild-type AdS infection, it was of interest to
determine which regions of the protein were important for this function. Using
mutational PCR, the E40rf3 gene was amplified from the viral genome, and point and
deletion mutants of certain conserved regions were incorporated into the amplified
DNA strands. These were then cloned into the pcDNA3.1 plasmid backbone to place
expression of these modified genes under the control of the same CMV promoter used
successfully in :x'DNA3.1I0rf3wt. These mutants were transfected into HEp-2 cells,
and these were then viewed for OrfI expression and PML localisation under
immunofluorescence microscopy. The results generated showed that in most cases,
\ '
the point mutations had no discernible effect upon Orf3 expression and colocalisation
with PML. H0\IeVer, the deletion mutants of Orf3 demonstrated markedly different
patterns of Orf3 distribution. In HEp-2 cells, neither the deletion spanning residues 9
to 13, nor that spanning residues 38 to 42 expressed any detectable E40rf3. In these
cases, it was possible that the deletions had a major impact on the structure or stability
of the protein, possibly even compromising the antibody-binding site. The deletion
spanning residues 96 to 100was interesting, representing a shift in the pattern of 0rf3
localisation from nuclear tracks, to a diffuse stain apparently present throughout the
cell. Further point mutants were made to cover the region represented by this deletion
mutant. Of these, 0rf3T96A appeared to demonstrate to a lesser extent, something of
the phenotype of 0rf3deI96-1 00, with discernible extranuclear localisation. However,
due to the inadequacies of transient transfection, it was not possible to unequivocally
identify this phenotype. Nevertheless, this mutant was flagged for further
investigation, having potentially interesting characteristics.
It was of interest to try and determine whether the presence of orO alone, while
sufficient for PML track formation and POD disruption, was sufficient for the
biochemical alteration of PML also seen during infection, and whether this process
was linked to POD disruption. The biochemical alteration of PML is determined by
Western blotting. No alteration in the distribution of PML isoforms could be detected
in samples from transfected HEp-2 cells, however, Western blotting revealed that
Orf3 was difficult to detect in these same samples, suggesting a poor transfection rate,
and providing an potential explanation for the lack of observable PML alteration.
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Consequently, in an attempt to improve transfection efficiency, 293 cells were used as
an alternative to HEp-2 cells. These assays proved much more successful, and
Western blotting confirmed that 0rf.3 was routinely and reliably detectable in samples
derived from 293 cells, at levels roughly equivalent to those. obtained from samples
infected with wild-type adenovirus. Immunofluorescence microscopy analysis of
transfected 293 cells revealed much the same pattern of 0rf3 distribution and PML
localisation as those using HEp-2 cells, although Orf3T96A did not seem to generate
a mutant phenotype in these cells. One notable exception was the clear presence of
Orf3/PML colocalisation to nuclear tracks in 293 cells transfected with
pcDNA3.1I0rf3deI38-42. 0rf3 protein was not detectable by IF in HEp-2 cells
transfected with this plasmid, and these results suggest that perhaps in the case of this
mutation, an unstable protein was produced which required an additional protein to
stabilise the structure. 293 cells have been engineered to express the adenovirus El b-
55kDa protein, which is known to be capable of complex formation with E4orf3.
Interestingly, when cotransfected with a 55K expressing plasmid, Orf3de138-42 was
detectable in Hep-2 cells, exhibiting apparently wild-type characteristics. This
suggests a mechanism whereby 55K is capable of stabilising this mutant 0rf3 protein,
perhaps within a complex.
Despite enhanced 0rf3 expression using 293 cells, it was not possible to detect any
alteration in the distribution of PML isoforms by Western blotting. This could mean
that despite high levels of Orf3, the number of individual cells expressing 0rf3 was
not sufficient to generate detectable levels of "infection-specific" PML, as 0rf3 is not
apparently transported between neighbouring cells. Alternatively, these results could
indicate that although known to be necessary for the generation of the infection
specific PML species (Leppard and Everett, 1999), 0rf3 is not sufficient to drive this
alteration without extra viral input. In this scenario, the disruption of the PODs and
PML biochemical alteration would represent separate processes. To attempt to
address this question, 293 cells were first transfected with pcDNA3.1I0rf3wt, and
then superinfected with Ad5 inorf3. Cells infected with inorf3 alone would not be
exposed to the effects of Orf3. Those both transfected and infected, would have the
full complement of viral proteins. In these experiments, the infection- specific PML
band could not be visualised by Western blotting, supporting the suggestion that
transient transfection efficiency was simply too low to generate meaningful results
relating to the effect of 0rf3 upon transfected cells.
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5. Construction of cell cultures permanently expressing adenovirus
serotype 5 E4ort3 protein
In an attempt to address some of the limitations of our transient transfection assay, it
was decided to attempt to generate mixed cell cultures enriched for E4orf3 expressing
cells and, later. cell lines that were permanently expressing Orf3. It would be
advantageous to generate a cell line in which every cell expressed levels of Orf3
comparable to those expressed during an infection. This would allow us to
characterise with confidence the phenotype of each mutant. It would also be simple to
extract total celt lysates from these cells and examine the PML banding pattern in
Western blots to determine whether Orf3 alone had an effect on the distribution of
PML species. If this proved not to be the case, the OrD expressing cell line could be
used in subsequent infection or transfection experiments to determine which other
viral protein(s) acted as partner(s) in this modification and to investigate other
E4orf3:virus:h.} ,t interactions.
S.l. Cell cultures "eDri~bed" for E40rB espreiliDI ~elJl.
It was first decided to generate cell cultures "enriched" for E40rf3 expressing cells. In
this case, each cell in the culture would not be equivalent, in that they would be the
products of multiple transfection events. This was deemed sufficient for our needs,
provided that a large proportion of the cells expressed high levels of E40rf3. Indeed,
this approach had the advantage that effects on PML due to the selection of a specific
host cell variant would not have to be excluded as an explanation for any effects
observed. This was achieved by transfecting pcDNA3.1I0rf3w/ into HEp-2 cells as
before, by the c.slcium-phosphate method. This vector contains a neomycin resistance
marker, al10w11 ; the use of 0-418 to select cells which are expressing proteins from
"
the vector in eio.aryotic cells, in much the same way as ampicillin resistance is used to
select for transformed bacterial cells. Accordingly, 0-418 was added to the growth
medium oftransrected cells, approximately 24 hours after infection. Subsequently, the
medium was replaced every 3 days with DMEMlI0% Nes containing 0-418. After
optimisation, 0-418 was always added to yield a final concentration of 500J.1g/ml.At
this concentration. non-transfected Hep-2 failed to plate successfully after 5-6 days.
After approximately two weeks of 0-418 treatment, surviving clones had become
established, and these were all trypsinized and pooled onto smaller dishes ie. the
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equivalent of a transfected 90mm dish was eventually pooled onto one well of a 6
well dish. Often, these cells required further concentrating onto smaller wells yet.
This mixed culture was then grown on a larger scale, and samples were taken for
SDS-P AGE, and cells were also grown on glass covers lips for immunofluorescence
microscopy (IF) analysis.
10-
Fig.S.1: Extracts of mock transfected, Orj3wt-enriched and AdS wt300 infected HEp-2 cells
were separated by SDS-PAGE on a 15% gel, blotted and probed for E40rD with antibody
6AI1. The positions to which proteins of known molecular mass migrated are shown at the left
(kDa).
In the first instance, Western blotting analysis confirmed expression of'EqorfI in cells
transfected with pcDNA3.1I0rf3wt and enriched as above, (fig.5.1) and IF analysis
confirmed that a very high percentage of cells were expressing E40rf3 in high
quantities (fig.5.2). In panel A of figure 5.2, endogenous PML can be seen in the
track-like structures observed during wild-type Ad5 infection and transient E40rf3
expression. Panels B and C show colocalisation of Orf3 in tracks with PML. A high
level of Orf3 expression was observed, corresponding with a somewhat diffuse stain
outside of the nuclei (panel D) in addition to the nuclear tracks. This may reflect a
positive selection for stronger expression from the plasmid, corresponding to demands
for cellular survival in the presence of G-418. The IF results also showed the cells to
be piled up on top of each other, in contrast to the usual cell monolayer. This might
have been a phenotype consequent to continual E40rf3 expression, or may have been
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an artefact. However, as this cell line was not sustainable in culture (see below), the
former explanation perhaps deserves further investigation.
Fig.5.2: Immunofluorescence micoscopy data of HEp-2 cells enriched for those permanently
expressing E4orf3. The data above show a representative sample of HEp-2 cells selected with
0-418 for those with active and permanent expression from pcDNA3.1/0rf3wt DNA. Panel A
shows cells stained with SElO anti-PML. Panel B shows strong E4orf3 expression in the same
cells, using antibody 6All. Panel C is double stained for both PML and Orf3. Panel D is DAPI
stained to show the locations of the nuclei of the cells in this field of vision.
Approximately 5 weeks after initial treatment with G-418, the Orf3wt-expressing
mixed culture generated by this method began to become less healthy, and
ultimately it was not possible to maintain these cells in culture. Cells that had been
frozen as soon as the mixed culture was established were successfully revived, but
these only survived for a short period of time. There were no obvious signs of
contamination. A possible explanation for the lack of survival would be that
cumulative G-418 treatments at the concentration used ultimately inhibit cell survival,
or perhaps permanently high levels of E40rf3 disrupt cellular function to such an
extent that, eventually, they can no longer survive. Subsequent attempts to generate
Orf3 expressing mixed cultures were less successful. The same high percentage of
Orf3 expressing cells was not recreated. Essentially the same technique was used to
generate cell cultures derived from HEp-2 cells transfected with the panel of mutant
Orf3 expressing plasmids, and total cell lysates from these G-418 selected cultures
and the original wild-type Orf3 expressing culture were analysed for PML banding
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pattern by Western blotting (fig.5.3). As can be seen, all samples have a similar PML
banding pattern as the mock infection, none having the AdS infection specific band
just above 140kDa. IF microscopy analysis showed that these later attempts to
generate OrB expressing mixed cultures were less successful than the first attempt
(data not shown). Although it was possible to grow these later cultures indefinitely,
they did not have a similar, high percentage of OrB expressing cells.
2So--
160--
lOS-
Fig.S.3: Western blot showing distribution of PML species in Hep-2 cells enriched for
permanent OrB expression using G-418 selection. The positions to which proteins of known
molecular mass migrated are shown at the left (kDa).
This supports the idea that continuous Orf3 expression is detrimental to cell health.
This could explain the apparent loss of Orf3 expression over time in the mixed
culture. Individual cells might incorporate varying and partial sections of the plasmid
DNA, and this DNA could incorporate into different regions of the HEp-2 genome
during individual events, influencing the strength of expression from the insert, and
also potentially disrupting certain cellular processes. It is not difficult to envision a
scenario whereby certain cells acquire resistance to G-418 without the potentially
disadvantageous Orf3 gene. These cells might then have a selective advantage over
cells expressing. Alternatively, strength of expression from the incorporated DNA
might have an effect on cell viability. There may be a limit of tolerance up to which
point increasing expression from the insert would be advantageous by increasing
resistance to G-418, but beyond which the relatively higher levels of OrB would
inhibit cell survival.
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5.2. HEp-2 cell lines stably expressing E4orf3wt and E4orf3R68A
As it was not possible to develop mixed cell cultures containing a high percentage of
om expressing cells, it was decided to grow clones of individual cells, picked
subsequent to transfection and primary 0-418 selection. Assuming that each cell in
the colony was equivalent in terms of OrD expression. an om expressing cell line
would have the advantage of eliminating competition between cells expressing more,
less or no om. Cells were transfected as before on 60mm dishes with
pcONA3.l/0rDwt and pcONA3.1I0rDR68A. It was not deemed necessary at this
point to attempt to generate cell lines expressing all the om mutants, and R68A was
selected as subjectively, it had appeared that mixed cultures expressing this protein
had been more viable. G-418 was added to the medium to a final concentration of
500J.1g1ml.After approximately three weeks, individual clones were picked using
trypsin/versene sterile cloning disks. These were then dropped into individual wells of
a 96 well plate, and allowed to grow in G-418 selective medium for one week.
Surviving cell iines were then plated into individual wells of a 24 well dish. After this
point, cell lines were trypsinized and plated onto larger dishes as appropriate. Cell
lines were maintained in the wells of 6 well dishes. These clones were analysed for
om expression by immunofluorescence microscopy, and cell lines expressing
appreciable levels of OrD were maintained (data not shown). Other cell lines were
discarded. SOS-PAGE samples of the selected cell lines were prepared at
approximately five weeks after initial IF screening. These samples analysed by
Western blotting (see fig.S.4). These data show that E40rf3 could not be visualised by
this technique it samples derived from any of these clones. A band in lane 13 just
above the 10kD t narker is an artifact and does not represent om.
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Fig 5.4: Extracts of cell lines developed from HEp-2 cells transfected with either
pcDNA3.1IOrf3wt (lanes 1-20), or pcDNA3.1I0rf3R68A (lanes 21-24), and selected with G-
418. Each lane is loaded with the equivalent of 4 x 104 cells. Extracts were separated by SDS-
PAGE on a 15% gel, blotted and probed for E4orf3 with antibody 6All. The positions to which
proteins of known molecular mass migrated are shown at the left (kDa). Blots were overexposed
to allow for weak signals. Apparent ''band'' in lane 13 is an artifact.
Despite these results, it was still thought possible that OrB was present in each clone,
even if in minimal quantities. Accordingly, if Orf3 was sufficient for the observed
PML modification, some modified PML would also be present. If this were true, and
assuming that aUcells were equal, it was thought possible to detect modified PML in
samples of these cells. Thus, three "Orf3wt expressing" and three "0rf3R68A
expressing" cell lines were retained, and samples harvested in SDS-PAGE sample
buffer. These samples were analysed for E40rf3 expression by Western blotting
analysis (fig.5.5). As can be seen, there is a faint band corresponding to the Orf3
protein in samples derived from one of the HEp-2.0rf3wt cell lines (lane 3), and in
samples derived from one of the HEp-2.0rf3R68A cell lines (lane 6). While the level
of om expression was much lower than that obtained during transient transfection,
every cell in these cell lines should have been equivalent, and any alterations to
endogenous proteins would be expected to be present in all cells, rather than a subset.
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The samples with detectable om (fig 5.5, lanes 3 and 6), were analysed for PML
species distribution by Western blotting analysis (fig.5.6, lanes 1 and 2).
1 2 3 4 5 6 7
Fig 5.5: Extracts of cell lines developed from HEp-2 cells transfected with either
pcDNA3.1/0rf3wt (lanes 1-3), or pcDNA3.1/0rf3R68A (lanes 4-6), and selected with 0-418.
Each lane is loaded with the equivalent of 4 x 104 cells. Lane 7 is loaded with the extract of
HEp-2 cells infected with Ad5 wt300, as a positive control for E40rf3 expression. Extracts were
separated by SDS-PAGE on a 15% gel, blotted and probed for E40rf3 with antibody 6All. The
positions to which proteins of known molecular mass migrated are shown at the left (kDa).
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Fig 5.6: Extracts of cell lines developed from HEp-2 cells transfected with either
pcDNA3.I/Orf3wt (lane I), or pcDNA3.I/0rf3R68A (lane 2), and selected with 0-418,
compared with samples derived from transfected, infected or mock infected cells. Each lane is
loaded with the equivalent of 4 x 104 cells. Lane 3 is loaded with the extract of HEp-2 cells
transfected with pcDNA3.I/Orf3wt. Lane 4 is loaded with mock infected samples. Lane 5 is
loaded with samples derived from cells infected with Ad5 wt300. Arrow A indicates the major
PML band at approximately 140kDa. Arrow B indicates the infection specific PML isoformjust
above the 140kD band. Extracts were separated by SDS-PAOE on a 15% gel, blotted and
probed for Orf3 with antibody 6A11. The positions to which proteins of known molecular mass
migrated are shown at the left (kDa).
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Comparison of the PML banding patterns of the "OrfJwt expressing" and "OrfJR68A
expressing" celt lines with the banding pattern of pcDNA3.l/0rfJwt transiently
transfected, mock infected or wt300 infected HEp-23 cells (provided in lanes 3-5),
reveals that the pattern of PML isoform distribution was not altered in these cell lines.
This suggests that either the level of OrfJ expression was too low to alter PML
biochemistry, or that 0rf3 alone is not sufficient to generate the altered pattern. The
former explanation appears more likely, as the level of OrfJ expression was too low
to be detected reliably and repeatedly, suggesting very low levels indeed in
comparison with either a wild-type infection, or transient transfection.
5.3. Discussion
Transient transfection of OrO expressing plasmids into HEp-2 and 293 cells,
confirmed that OrfJ expression Was capable of producing PML and OrfJ
colocalisation in nuclear structures, similar to the "tracks" observed during infection
with wild-type adenovirus. An OrfJ mutant of this function was identified, and it was
desirable to investigate any links between 0rf3 function, POD reorganisation and
PML biochemical modification. However, due to the relatively low percentage of
cells in a culture exposed to the effects of Orf3 when comparing transient
transfections with infections, this technique could not be used to answer these
questions. It was hoped that the problem could be addressed by producing cell
cultures in which all cells expressed E40rf3, and that this could be achieved by
selecting against those cells which had not successfully incorporated plasmid DNA
into their genoraes and which therefore did not express E40rf3. Initially, this seemed
to be an effective tactic, and a mixed culture was produced in which a high percentage
of cells expressed E40rf3. However, this culture could not be sustained, and
subsequent attalpts to repeat this experiment failed to produce high percentages of
Orf3 expressing.cells, It was thought possible that even 0-418 resistant cells might
eventually SUC(: J,pb to the detrimental effects of the chemical. However, it was
possible to pi «luce cultures that remained resistant to the effects of 0-418
indefinitely, despite the lack of high, or even detectable Orf3 expression. This
observation would argue against 0-418 induced "slow-death". Rather, it seems likely
that the 0rf3 protein itself is antagonistic to continued cell survival, or at least, can
only be tolerated for any length of time at low concentrations. It had been suggested
that within the environment of a mixed culture, cells expressing a higher level of Orf3
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might have a selective disadvantage in competition with other ~ells expressing less of
the protein. If this were the case, it might still have been possible to generate a culture
expressing high levels of Orf3, if this element of competition was removed.
Accordingly, cell lines were developed from individual clones. However, in this
instance only those expressing low or undetectable levels of Orf3 survived. This
observation, coupled with the demise of the first mixed' culture to successfully
produce high levels of stable Orf3 expression, argue that the protein, in high levels, is
not mildly detrimental, but lethal to cell survival.
Western blotting analysis of samples taken early in the selection process revealed that
at this stage, certain cell lines were expressing Orf3 at detectable, if low, levels.
Further Western blotting analysis of these samples could not identify any alteration in
the distribution of PML species when compared with samples taken from standard
HEp-2 cells. This pattern is similar to that observed in samples taken from HEp-2 and
293 cells transiently transfected with the plasmids, and together, these results would
suggest that, while capable of POD disruption, Orf3 alone eannot bring about the
alteration in PML observed during infection. However, the mixed cultures and cell-
lines constructed to express Orf3 did not, ultimately, address the concerns associated
with transient transfection. All the cells in a culture were not necessarily equivalent
and exposed to the Orf3 protein. The evidence suggests that the Orf3 protein was
detrimental to cell survival. Accordingly, individual cells within a clone, or clones
within a mixed culture, that expressed little or no Orf3 would have had a competitive
advantage over surrounding cells, providing resistance to 0-418 was retained.
Therefore cells expressing and exposed to Orf3 may have been in the minority, even
in a supposed. ,'U "line".
The inability to maintain high levels of Orf3 expression in these cell-lines, means that
the above result" cannot be used as the basis of any hypothesis regarding the potential
link between Or.J function, POD redistribution and PML biochemical alteration.
125
6. Construction of whole. infectious virus. expressing mutant E4orf3
protein.
A further method of addressing some of the limitations inherent to transient
transfection would be to generate whole infectious viruses expressing the mutant
forms of E40rf3. A virus generated in this method would provide an efficient means
of expressing the desired protein in every cell in a monolayer, and in addition would
enable a more meaningful evaluation of the role of the protein in an environment
more closely approximating that observed in nature. A gross disruption of the normal
Drf3 nuclear localisation pattern had been observed by IF microscopy in cells
expressing the de196-100 mutation. A similar, if less well defined phenotype had been
observed in cells expressing the DrDT96A mutation into eukaryotic cells (see
sections 4.1, 4.3 and 4.6.1), although this was not an unambiguous result.
Accordingly, it was attempted to construct two recombinant viral genomes, one
carrying each of the above mutations.
6.1. Re~onstrudion of mutant adenovirus by in vivo re~ombiDation.
A schematic diagram of the steps involved in the in vivo reconstruction of a mutant
adenovirus geiv.ne is provided in figure 6.1 (panels A and B).
Initially, a 48:V)i)pfragment between Nde I (AdS 31088) and Cla I (added at end of
\
viral genome ir plasmid, relative position 35938) sites was stoned by restriction
digest from the .lght hand end of the viral genome, into the vector, pBR322 (fig 6.2).
The resultant construct of approximately 7Kbp was amplified in bacteria, and
designated pBR322Ndefrag (see fig 6.3). Oligonucleotides were designed to amplify a
region containing the E40rf3 region from the viral genome, ensuring that BstE II(AdS
35233) and EcoR V (AdS 33754) restriction sites were retained at either side of the
gene. These outside primers were coupled with the mutational primers already used
(see sections 4.0 and 4.2), to generate complementing DNA fragments containing
E40rf3deI96-100.or.E40rf3T96A by primary mutational peR reactions. Samples of
these reactions were analysed on agarose gels prior to further steps. Bands of 735bp
and 877bp were expected from the primary reactions during construction of
E40rf3T96A, and these can be seen in lanes 2 and 3 of the gel shown in fig.6.4,
respectively. Several extraneous DNA fragments were generated during the peR used
to generate the "15bp fragment (lane 2). These can result froo talse-priming, where
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the annealing temperature used during peR is too low to eliminate all non-specific
hybridisation between primer and template. Nevertheless, the desired fragment was by
far the most common product, and samples of the 10 peR reactions containing the
I
desired fragments were used in the second stage amplification as before. The products
of the 20 peR reactions were loaded onto agarose gels. Figure 6.5, shows the 20 PCR
product of a reaction using the 10 PCR products shown in lanes 2 and 3 of figure 6.4.
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Fig.6.2. Plasmid pBR322.
Map show unique restriction sites. Abbreviations: amp, ampicillin resistance gene; tet,
teracyclin resistance gene; ori, plasmid origin of replication.
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Fig. 6.3. Plasmid pBR322Ndefrag.
pBR322-based plasmid containing adenovirus serotype-5 sequences between virus
base-pair positions 31088 and 35938. Abbreviations: amp, ampicillin resistance gene;
AdS, cloned AdS sequences; on, plasmid origin of replication.
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Size 1 2 3
(kbp)
2.0
1.6
1.0
0.S2
Fig.6.4: 0.8% agarose gel showing an example of mutational peR 10 products. Lane I shows
1Kb ladder. Wide lanes 2 and 3 show 10 peR products.
1 2 3
2.0
1.6
Size (kbp)
1.0
0.S2
0.4
Flg.6.S: 1% agarose gel showing an example of mutational peR 20 products. Lane 1 shows lKb
ladder. Lane 2 is loaded with negative control for 20 peR. Wide lane 3 shows 20 peR products.
A band of approximately 1.6 kbp was expected, and this can be seen in lane 3.
However, a band of this size can also be seen in the negative control, loaded in lane 2.
The negative control comprised of the 10 peR product shown in lane 2 of fig.6.4,
without the complementary fragment shown in lane 3. This 10 reaction would have
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carried forward some full length template into the 2° reaction, and so could have
given a 1.6 kbp fragment with the pair of outside primers used. This is not desirable,
and could be eliminated by reducing the input of 1° reaction product into the 2°
\' . ,
reaction. In this instance, that was not found to be necessary. A BstE II and EcoR V
double restriction digest was then used to excise a region spanning the om gene from
pBR322Ndefrag, and the products of the secondary PCR reactions were cut at the
same sites The vector and insert thus prepared were ligated together to generate
pBR322Ndefrag96-100 and pBR322NdefragT96A. These plasmids were amplified in
bacteria, and sequencing reactions performed to verify that the desired mutations had
been generated in an otherwise intact region of the viral genome within the vector
plasmid. Having shown that plasmids carrying the desired stretches of mutant viral
genome were successfully cloned into pBR322, these plasmids underwent Nde I
restriction digest to linearise the DNA, and ClAP treatment to prevent self-ligation.
The linearised DNA was then purified from agarose gels. Intact viral genome
underwent a Nde I restriction digest to liberate a 11S40bp fragment between positions
. .:'.
19548 and 31088 from the viral genome (Sea I was also used to help resolve the
.;
desired band). These two fragments were ligated together to generate plasmids
containing the AdS genome between 19s48bp and 3s938bp. An Eeo RI and Pvu I
double restriction digest was used at this stage to ensure the correct orientation of the
inserts. The resultant plasmids were designated pBr322rtAdsde196-100 and
pBR322rtAdST96A (fig.6.6). Next, each plasmid underwent Cia I restriction digest,
to linearise the DNA at the end of the viral insert. Viral genomic DNA underwent Spe
I and EcoR I double restriction digest, to generate a DNA fragment spanning the
entire left end (,J:.,;:~ral genome as far as position 27082. The linearised plasmid DNA
and virus DNA.i'tgments were purified, and the two co-transfected into 293 cells in 6
well dishes, by .i .nodified calcium-phosphate transfection method (see methods). The
linearised plasmid and 27083bp viral fragment share a 7534bp region of overlapping
sequence between positions 19548 and 27082. In principle, these two DNA
fragments, when co-transfected into a recipient cell, would rec .mbine at the region of
homology, to g -nerate full-length viral genome, as well as a by-product containing
plasmid DNA. The intact viral genome thus generated would contain the mutated
gene of interest, and would be capable of replication and the synthesis of new virus
particles, as the lack of Orf3 function does not significantly impair virus growth
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(Huang and Hearing, 1989a). In this manner it would be possible to harvest virus
particles mutant for the gene of interest, and amplify these further in HEp-2 cells.
Approximately 24 hours post-transfection, the liquid medium was removed and
replaced with solid noble agar containing medium. Staining overlay was added to the
cells 10 days post transfection, and a sterile pasteur pipette was used to remove any
plaques to 0.5ml TS/2% CS. These were then placed at -70°C. The presence of
plaques is indicative of replicating virus. As plaques were observed in co-transfected
wells, it was possible that viral recombination had successfully occurred. However,
negative controls consisting of cells transfected only with "cut" virus fragments also
produced similar numbers of plaques, indicating that viable virus DNA was present in
the mock control and therefore that the digest of viral DNA had not gone to
completion. Nevertheless, it was decided to progress with the "recombinant virus"
plaques, in the hope that some recombinant viruses were present.
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Fig.6.6. Plasmid pBR322rtAd5.
pBR322-based plasmid containing Adenovirus serotype-S sequences between virus
base-pair positions 19548-35938. Abbreviations: amp, ampicillin resistance gene;
AdS, cloned AdS sequences; ori, plasmid origin of rep lication.
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The plaques in TS/CS were freeze thawed three times to liberate virus particles from
the cells. O.2ml of each lysate was used to infect a well of a-12 well dish of HEp-2
cells. The cells reached full c.p.e. 4 days later, and were harvested into a microfuge
tube. These samples were used to purify DNA for sequencing (see methods, 2.3.5.6).
However, insufficient DNA was obtained by this method for sequencing. To obtain
more viral DNA, 90mm dishes of HEp-2 cells were infected with O.2ml of the plaque
containing lysates. These cells were harvested at full c.p.e. 8 days post infection, and
the DNA purified by the adenovirus DNA rapid preparation method (see methods,
2.3.5.5). Samples were prepared for sequencing reactions, but once again no results
were obtainable. Whether this was due to low DNA concentration, or a low quality
DNA preparati '!'! 's not known. The sequencing reactions have not currently been
repeated, and n', further experiments have been performed using these viruses due to
lack of time.
6.2. DiscussjOT'
In order to investigate the effect of E40rf3 upon the distribution of PML isoforms in
eukaryotic eel's it was necessary to express these viral proteins in a high percentage
of cells in a culture. It would then be possible to further characterise the nature of the
OrfJdeI96-100 mutation that resulted in a loss of the typical OrfJ nuclear localisation.
Transient transfection was effective at generating high levels of OrfJ expression, but
this was limited to a small subsection of the cells in a culture. Further, it was not
possible to generate cell lines permanently expressing sufficiently high levels of OrfJ.
A viable third alternative was to engineer whole infectious virus, in which OrfJ
mutants of inte ...·~~were substituted for the wild-type protein. This technique would
not however, J: ~,mit the study of orO in isolation from all other viral proteins.
Nevertheless, it would have been interesting to determine whether the OrfJde196-100
mutant was ca;:vable of restoring the infection specific PML banding pattern, lost in
AdS mutants lacking a functional OrfJ. A virus carrying this mutation would help to
address the question as to whether the typical OrfJ nuclear I ,~,.lisation pattern was
linked to PML biochemical modification, and important to OrfJ function in infection.
The initial steps in the process of construction were successful, and plasmids
containing 16.4Kbp of the adenovirus genome including the chosen mutants of
E4orO, were generated. Unfortunately, early attempts to use these plasmids for in
vivo reconstruction of whole viral genome were not successful. Nevertheless, these
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constructs could be used to complete construction of mutant viruses, which could then
be used as described above to investigate the exact nature of the localisation mutants
of Orf3, in a setting closely related to that found in nature.
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7. General Discussion
7.1. Introduction
Recently, it has become clear that the PODs and the PML protein, may play important
roles in several cell processes, including regulation of the levels of active proteins in
the nucleus, transcriptional regulation, suppression of growth and transformation,
antiviral response, cell-cycle regulation and apoptosis (see 1.2.3.). Disruption of the
PODs, and redistribution of PML from the PODs, is observed in several malignant
tissues, at the beginning of mitosis, as a result of non-virological stress such as heat-
shock and during infection with several viruses (see 1.2.4.),
During wild-type adenovirus infection, PML is redistributed from the normal
punctate, nuclear bodies, into "track-like" structures, which colocalise with the viral
protein, E4orf3. Early in infection, the viral protein EIB-SSK, implicated in the
deregulation of cell cycle control and viral mRNA transport (see 1.1.5.2.), also
localises to these tracks. The E4orf3 protein was found to be necessary and sufficient
for redistributio.i of PML into these nuclear tracks. Interestini.;, E4orf3 was shown
to stimulate the efficiency of viral propagation >2000-fold, and cell lines engineered
to stably overexpress PML showed an inhibition of track formation by E4orf3,
concomitant with a decrease in replication of the virus (Doucas et al., 1996). These
results suggested that the function of E4orf3 in POD reorganisation is responsible at
least in part, for the ability of the protein to enhance viral propagation.
Analysis of the biochemical status of PML by Western blotting, demonstrated a
similar redistribution of PML species during mitosis and adenovirus infection. Three,
lower mobilits ~~Iorms, generally held to represent SUMO-l conjugated isoforms,
were reduced or lost, and a novel band migrating just above the major 140kDa
isoform, appeared (see 1.2.4.2. and 1.2.4.7.3). The E4orf3 protein was found to be
necessary for ·h·e-sealterations, through the use of virus mutants lacking functional
E4orf3 (Everett et al.• 1999). 'l'.
It was of interest to determine whether PML biochemical .t',',dification and POD
redistribution w.e directly linked, the one leading to the other, and to determine the
role E4orf3 played in these processes. This thesis aimed primarily to determine
whether E4orf3 alone was capable of generating the infection-specific PML banding
pattern, and which regions of the protein were responsible for POD protein
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redistribution and/or PML biochemical alteration. By first developing a technique to
express E40rf3 alone in eukaryotic cells, and then generating mutants of E40rD for
use in this system, it was hoped that it would be possible to investigate aspects of the
function of this protein in relation to the cellular protein, PML, in an environment free
of other viral factors.
7.2. Transient transfection assays and IF analysis
Using a eukaryotic expression vector, it was possible to express wild-type E40rO in
eukaryotic HEp-2 cells using calcium-phosphate transient transfection. IF microscopy
analysis demonstrated that transfected cells were expressing the orO protein, and that
this resulted in PMUOrD track formation, similar to that observed during wild-type
infection. This .observation reinforced the work of Carvalho et al. (1995) and Ishov
and Maul (1996), demonstrating that E40rO was not only necessary, but also
sufficient for P) iL redistribution into nuclear tracks.
In an attempt t~lidentify regions of the protein important to this function, several point
and deletion mutants were generated in conserved regions of ..ae gene, by mutational
peR. These mu-ant E40rO proteins were then expressed in HEp-2 cells as before by
transient transfection. IF microscopy analysis demonstrated that in the majority of
cases, these mutations had no observable effect upon the pattern of om and PML
distribution when compared to wild-type OrD. The regions these mutations
represented were effectively ruled out as singularly important to this aspect of orO
function. However, at least one mutation caused a significant alteration in the normal
pattern of OrO distribution. The 0rf3deI96-100 mutation, when expressed in
eukaryotic eel: ~~enerated a diffuse, cytoplasmic stain. The alteration in om
localisation app ...~red to affect colocalisation with PML. The PML protein appeared to
remain in punctate, nuclear bodies, rather than form nuclear tracks, or colocalise with
Omde196-100 as a diffuse, cytoplasmic stain. This was not an unambiguous result, as
the strong Orf3 stain seemed to result in some "bleed-through" into the green
spectrum where PML staining is observed. Nevertheless, pu l~t:lte bodies could be
observed beneath the diffuse stain, suggesting that the PODs had not, in fact, been
redistributed.
This result provides an insight into how E40m functions in relation to PML, and
perhaps as to how the various potential processes involving this protein could be co-
ordinated and regulated. It would appear that om must first localise near to or at the
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PODs, before commencing to interact with PML. 0rf3 is well below the diffusion
limit for nuclear pores, and consequently does not require a nuclear localisation signal
(NLS) to enter the nucleus. However, it would be observed as a diffuse, cellular
component were there not some interaction, tethering the protein to the nucleus.
Perhaps the Orf3deI96-100 mutant lacks this ability to interact with the appropriate
nuclear components and thus is not retained in the nucleus. This would be consistent
with experimental observations. If regions of 0rf.3 required for the nuclear retention
of the protein were intact, we would expect nuclear localisation, even if a further
interaction with PML was compromised. It is possible that the interaction with PML
results in the nuclear localisation of Orf3. Interestingly, the region spanning residues
96-99 of the gene was identified by ScanProsite as a potential casein kinase II
phosphorylation site. This is of interest, considering the central role of
phosphorylation in control of POD related processes. For example, the tumour
suppressor pRB, will only localise to PODs in the inactive, phosphorylated form
(Alcalay et al., 1998). Also, SUMO-l is covalently linked to a subset of PML in a
phosphorylation-dependent manner. Phosphatase inhibitors such as calyculin A,
inhibit SUMO-l and PML conjugation, resulting in the stabilisation of the PML
isofonn typically only present during mitosis, and possibly, AdS infection (Milller et
al., 1998). Perhaps phosphorylation at this region of the 0rf3 protein is necessary for
nuclear localisation to the tracks, as is the case for pRb.
It must be stated, however, that the assertion that residues 96-99 comprise a casein
kinase II phosphorylation site is by no means unequivocal. The combination of
residues identified is not an uncommon one, and the presence of glycine in this
region, commonly found at turns in the secondary structure of proteins, might suggest
that the deletion in this region simply caused a gross structural deformity. In this case,
we might expect to identify the protein with antibodies assuming the antibody-binding
site remains intact, but could to all intents and purposes, be identifying a completely
non-functional protein, without identifying any active sites. Nevertheless, the GOR
secondary structure prediction method (version IV, Garnier et al., 1996), indicated
that this deleted region is likely to comprise a random coil region of the protein. Only
the last residue (Rl00A), is predicted by this method to be part of an alpha helical,
structural region. If the predictions of this method were true, we might not expect the
deletion of residues 96-100 to have a major impact on the structural integrity of the
protein. In addition, proteins that misfold are normally recognised and degraded by
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the cell. The high level of protein detected by Western blotting argues that this is not
the case.
Each of the 0rf3 expressing plasmids was also transfected into 293 cells in an attempt
to increase transfection efficiency (see 7.3). Interestingly, IF microscopy analysis of
these cells upon transfection with Orf3deI38-42, revealed a difference between HEp-2
and 293 cells. Itwas not possible to visualise this protein in Hep-2 cells, and yet when
expressed in 293 cells, the protein was visible and formed nuclear tracks. This
suggested that some intrinsic property of 293 cells may have been stabilising the
protein in such a manner as to reveal the antibody binding site for detection by
antibody. One obvious difference between Hep-2 cells and 293 cells is the presence of
the adenovirus protein, Elb-55kDa in the latter. This protein is known to form a
complex with E40rfl at early stages in infection, and it was of interest to determine
whether 55K was responsible for stabilising this 0rf3 mutant in 293 cells. To test this,
HEp-2 cells were co-transfected with both pcDNA3.1I0rf3wt, and a plasmid
expressing Elb-55kDa. These cells were then co-stained for 0rf3 and 55K, and it was
found that the presence of 55K enabled detection of the 0rf3 protein in HEp-2 cells.
These observations suggest that the region spanning residues 38-42 was not directly
linked to 0rf3 nuclear localisation and POD disruption, as the protein was still
capable of generating tracks. In addition, they demonstrate that this region of 0rf3
was not required for interaction with the Elb-55kDa protein, as this protein was
redistributed from a diffuse, cytoplasmic distribution, to colocalise with 0rf3 at
nuclear tracks. This mutation might, however, be implicated in antibody binding or
the structural stability of the protein. Although not predicted to be within a
structurally important alpha-helical region by the GOR secondary structure prediction
model (version IV, Gamier et al., 1996) this deletion might cause a modification in
protein structure, concealing the antibody-binding site. If this were the case, binding
of 55K could cause a conformational change, resulting in the exposure of the
antibody-binding site, ultimately allowing detection of 0rf3 in our assay.
As well as the Elb-55kDa protein, 293 cells also express the adenovirus EIA protein,
known to localise to the PODs (Carvalho et al., 1995). Although this protein was not
investigated in this research, a possible link with the altered expression of the mutant
0rf3 protein in 293 cells and expression of EIA cannot be discounted, and further
work to look at potential EIAlOrflPML interactions in this system would be valuable.
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7.3. Western blotting analysis of transiently transfected cells
In an attempt to determine whether Orf3-induced track formation was directly linked
to an altered distribution of PML biochemical species, Western blotting was used to
analyse samples derived from HEp-2 cells transfected with all E40rf3 expressing
plasmids. The results obtained did not demonstrate the loss of those PML isoforms
generally considered to be SUMO-I-conjugated, nor was the infection-specific band
migrating just above 140kDa identifiable. These results however were flawed, in that
only a low transfection efficiency was obtainable. Other than the major band
migrating at approximately 140kDa, both the SUMO-conjugated isoforms of PML,
and the infection-specific band are relatively uncommon and difficult to detect by this
method. With a low transfection efficiency, the difficulties of detecting any alterations
in the status of these isoforms are amplified, and indeed, proved insurmountable.
Through replacing HEp-2 cells with 293 cells in this system, it was possible to greatly
improve the transfection efficiency. Nevertheless, samples of transfected 293 cells
yielded the same pattern of PML species as mock controls. Once again, though the
transfection efficiency was improved, it was not possible to draw positive conclusions
here from negative results.
7.4. Problems associated with permanent cell lines expressing E4orf3
One of the major drawbacks of transient transfection, was that only a small percentage
of cells in a sample could be considered to be expressing and exposed to E4orf3. In
earlier experiments investigating the biochemical alteration of PML during the
progress of the cell cycle, Everett et al. (1999) found it necessary to synchronise cells
to ensure that a high proportion of the cells under observation had the same PML
species. Only then. was it possible to observe the mitosis-specific band by Western
blotting. The infection-specific PML isoform of interest is similar in mobility and
abundance to the mitosis-specific isoform, and it was to be expected that a similar
percentage of cells would need to have this PML isoform in order that it could be
observed by Western blotting analysis, as was required during the studies of Everett et
al. Therefore, in order to determine whether or not E40rf3 could generate the
infection-specific PML band, it was necessary to increase the percentage of cells in a
sample that might be expected to have this PML isoform. To address this problem,
celllines were developed to pennanen.tly express the viral protein. It was hope that
this measure would facilitate observation by Western blotting of any 0rf3 induced
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biochemical alteration of PML. Unfortunately, this technique encountered several
problems that proved unsolvable.
Several cell-lines and mixed cultures enriched for "Orf3-expressing" cells were
developed on the basis of resistance to G-418, provided by the vector plasmid. Mixed
cultures enriched for G-418 resistant cells, and cell-lines developed from resistant
clones, were tested by Western blotting analysis and IF microscopy for the presence
of0rf3.
A mixed culture was developed which successfully expressed 0rf3 in a high
percentage of cells. However, this failed to persist in culture beyond 5-6 weeks
(approximately 10 passages), and frozen stocks could not successfully be maintained
after thawing. One possible explanation for this phenomenon could be that the cells
were exposed to bacterial or fungal contamination. Contamination of the 0rf3
expressing mixed culture would explain why these cells failed to plate down and why
frozen stocks could not be successfully resurrected. However, contaminants could not
be visualised under microscopy, and the addition of penicillin and streptomycin to the
media had no effect. This would argue that contamination was not the cause of the
problem.
At early stages in the assay, 0rf3 could be detected by IF microscopy, and to a lesser
extent by Western blotting, in certain of the cell-lines derived from single clones.
Over time and numerous passages however, any expression of 0rf3 appears to have
been lost from these lines. Western blotting analysis of the PML isofonns present in
these cells revealed no discernible difference in comparison with "normal" HEp-2
cells. Nevertheless, the cells were resistant to the effects of G-418, apparently
indefinitely. This suggests that resistance to this toxin had been incorporated from the
vector plasmid into the HEp-2 genome. The fact that 0rf3 was not also expressed in
these cells is revealing. Insertion events have a random quality, and foreign DNA may
incorporate into the cellular genome at various locations, and to differing extents.
Therefore all insertions are not equivalent, and different sections of foreign DNA may
be incorporated. It could be that the gene conferring G-418 resistance simply
incorporated more successfully into the HEp-2 genome, whether due to some intrinsic
qualities of this stretch of DNA, or simply bad luck. Perhaps repetition of these
experiments would produce viable cell-lines permanently expressing Orf3. A more
likely explanation, would be that 0rf3 has a deleterious effect on cell survival. This
would explain the preferential survival of cells with resistance to G-418, but not
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expressing OrB. This too would explain how, in a clone of "identical" cells,
expression of E4orf3 was lost over time. Cells carrying incorporated DNA have a
tendency to expel this DNA from their genome over time. The continual application
of selection (in this case 0-418), is designed to limit this, by putting these cells at a
selective disadvantage in comparison with cells maintaining the insert. Despite this
pressure, expression from OrfI was lost. In this case, it appears that selection
favoured cells maintaining certain portions of the foreign DNA, but rejecting Orf.3.If
this is the case, it will not be possible to generate cell lines from HEp-2 cells, to
permanently express E40rf3. It is, however, possible that other cell types will prove
resistant to the effects of the viral protein, and can be used to develop cell-lines
permanently expressing Orf3.
This conjecture leads one to consider how the Orf.3protein could cause such effects in
eukaryotic cells, and whether these effects are linked to the function of the protein
during infection. For example, it has been demonstrated in this thesis and elsewhere,
that transient expression of E4orf3 alone in eukaryotic cells reorganises endogenous
PML from the spherical PODs into track-like structures. As previously mentioned,
PML and the PODs have been implicated in several cellular processes, including cell-
cycle regulation and apoptosis (see 1.2.3.). The reorganisation of the PODs by 0rf3
may have an important role in the deregulation of the cell cycle, helping to provide an
environment suitable for viral replication. Perhaps those cells permanently expressing
0rf3 cannot, ultimately, sustain themselves in culture without the normal, discrete
PODs. If this was effected through a deregulation of cell cycle control, we might
expect the accumulation of high levels of pS3 in the nucleus, as occurs consequent to
expression of Ad EIA proteins (McMahon et al., 1998; Fuchs et al., 2001; Rikitake
and Moran, 1992; Barbeau et al., 1994; Shenk, 1996). These high levels of pS3 can
then induce apoptosis. Perhaps 0rf3 has a less-severe, but similar effect on cells over
time. If this were the case, we would expect to see evidence of a deregulated cell-
cycle. In effect, the cells might be expected to multiply in an uncoordinated fashion
and not as a monolayer. In the only culture to express high levels of Orf3 in a large
percentage of cells (the mixed culture, see fig.S.2), cells did indeed appear to be
growing on top of each other, rather than as a well-defined monolayer. It was not
possible to maintain this enriched culture for study, but these results are intriguing,
suggesting that 0rf3 may indeed act to transform cells if expressed strongly enough,
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before ultimately causing apoptosis, through the deregulation of PML and POD
function and cell cycle regulation.
Of note, is the work of Nevels et al. (1999), in which cell lines were developed which
permanently expressed E40rf3. While the successful development of these cell lines
would appear to be at variance with the observations made above, there were several
key differences in experimental approach, and the results presented in this thesis
perhaps go some way to help elucidate their observations. Of primary importance, the
transformed lines developed by Nevels et al., were designed to express not only
E40rf3, but also various combinations of the adenovirus EIA, EIB and E40rf6
products. The EIAlEIB products alone were found to be sufficient for cell
transformation, and it was within this environment that 0rf3 was expressed. Indeed,
in support of the observations made in this thesis, Nevels et al. observed that high
levels of E40rf3 were deleterious to cell survival, and concluded that the activities of
this protein may be modulated in the presence of other viral products, particularly
those of the EIB gene. Cell lines expressing EIA, EIB and E40rf3 gene products
exhibited higher growth rates and saturation densities, and induced tumours more
frequently than transformed cells expressing EIA and EIB only. Under these
conditions therefore, it would appear that E40rf3 has growth-promoting activities.
However, the presence of E40rf3 did not appear to have any effect on the steady-state
levels of pS3 in cel1lines expressing the EIA, EIB and E40rf3 gene products, in
comparison with cel1lines expressing the EIA and EIB gene products only. Thus it
would appear that any effects on cell survival and growth rates consequent to high
levels of E40rf3 expression, are not due to modification of pS3. Nevertheless, the
levels of this tumour suppressor protein have not been observed in cells expressing
only E40rf3. Nevels et al. demonstrated that unlike E40rf6, the 0rf3 gene product was
not capable of reducing steady-state levels of pS3, but did not convincingly
demonstrate that 0rf3 did not increase the levels of pS3 when expressed alone. The
EIA product greatly increased the steady-state levels of pS3, and in cells expressing
both this protein and Orf3, it may have been the case that an Orf3-induced pS3
increase went unnoticed. This is certainly worth investigation, although once again,
the deleterious effects of 0rf3 on cell-survival would make any such investigation
problematic.
Recent work by Stracker et al. (2002), has demonstrated that the E40rf3 protein is
responsible for the redistribution and inactivation of the cellular Mrell-RadSO-NBSI
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DNA repair complex. This multiprotein complex is important in double-strand break
repair, meiotic recombination and telomere maintenance in mammalian cells, but was
also shown by Stracker et al. (2002) to be required for the formation of the adenovirus
DNA concatomers seen upon infection with virus mutants lacking either functional
OrO or Or6/SSK complexes (see section I.I.S.S.). In uninfected cells, Mrell, RadSO
and NBS1were shown to be present throughout the nucleoplasm, but concentrated at
sites of replication and at the PODs. During a wild-type infection, the complex was
redistributed into speckles, followed by a decrease in abundance of the constituent
proteins. Upon infection with an E4 deleted virus, Mre11, RadSO and NBS1 were
shown to locate to viral replication centres, with the consequent generation of
concatemeric adenoviral DNA. Through the use of virus mutants, and the expression
of individual E4 proteins in eukaryotic cells, Stracker et al. demonstrated that the
E40rf6/SSK complex was responsible for the degradation of Mrel l and RadSO,but
that OrO was responsible for the redistribution of the proteins to the cytoplasm and to
nuclear speckles partially overlapping with the PML tracks of the redistributed PODs.
This redistribution was sufficient for the inactivation of the Mrell-RadSO-NBSI
complex in the formation of concatemeric viral DNA, and reflects a requirement for
the inactivation of this complex for viral reproduction. In addition however, these
results provide a mechanism by which OrO could affect the long term survival of
cells expressing the protein. The Mrell-RadSO-NBSI complex has been implicated as
an important regulator of genome stability, preventing normal cells from becoming
malignant. If expression of OrO alone is sufficient to disrupt the normal functioning
of the complex, it is likely that host cells would not persist in the long term, as such
DNA repair mechanisms are crucial to cell survival.
7.5. Construction of whole virus
Given the problems encountered during attempts to express 0rf3 in a large enough
percentage of cells to enable the study of any alterations in the Western blot banding
pattern for PML, it was decided to generate whole, infectious virus, substituting
mutant E40rB for wild-type 0rf3 in the virus genome. Initially, it was decided to
generate two mutants, expressing Orf3deI96-100 and Orf3T96A. These would have
enabled investigation of the effects of the altered pattern of OrB localisation upon the
PML banding pattern. A virus with aberrant localisation of 0rf3 would help to
address the question as to whether the typical 0rf3 nuclear localisation pattern was
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linked to PML biochemical modification, and important to 0rf3 function in infection.
Of course, the deletion mutant may have represented a non-functional 0rf3 protein, as
alluded to above, in which circumstance infection with Ad5de196-100would not tell
us more about 0rf3 function than existant mutants lacking orO entirely.
Nevertheless, using whole virus expressing these mutants, it would be possible to
determine whether other known 0rf3 interactions, such as with the viral protein, El B-
55K were also affected.
55K has a diffuse, cytoplasmic distribution in the absence of other viral proteins, but
during co-transfection experiments, complexes with 0rf3 to colocalise at the PODs.
This process is mirrored early in infection, until 55K apparently preferentially
complexes with E40rf6 to localise at the periphery of the viral replication centres
(OmeUes et al., 1991). Localisation mutations of0rf3 might still complex with 55K,
assuming that protein structure is not disrupted in the protein region required for this
activity. If this were the case, it would be of interest to observe any subsequent
alterations in 55K localisation and/or function.
Attempts to generate the desired mutant viruses were not completed. Nevertheless, the
plasmids necessary to in vivo recombination were successfully constructed,
facilitating any future attempts to generate infectious viruses expressing these E40rf3
mutations.
7.6. Concluding remarks
Using plasmid vectors to express the adenovirus protein, E40rO, in eukaryotic cells,
these studies have demonstrated that this protein is necessary and sufficient to
reorganise the PODs from discrete, spherical structures, into track-like structures
colocalising 0rf3 and PML, similar to those observed during infection. By generating
point mutations and deletion mutations in the OrO gene, and expressing the proteins
in eukaryotic cells, it has been possible to eliminate several conserved regions of the
gene as necessary for the interaction between 0rf3 and PML, and nuclear track
formation, However, one deletion mutant, OrOdeI96-100, was identified which
resulted in an unusual, diffuse cytoplasmic 0rf3 localisation when expressed in
eukaryotic cells and observed by IF microscopy. It was possible that the disruption in
0rf3 localisation caused by this, relatively large, deletion (5 residues), was caused by
a gross confonnational change of the protein, and not through modification of an
active site involved in track formation, Further point mutations of the residues in this
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region were generated, but none of the expressed proteins demonstrated a similar
protein distribution to the deletion. These results would appear to support the idea that
deletion of residues 96-100 simply disrupts the Orf3 protein, while leaving the
antibody-binding site intact. Nevertheless, one point mutation within this region
(0rf3T96A), did seem under IF microscopy, to have an extranuclear component, as
well as forming the "normal" nuclear tracks. While this observation was consistent, it
was not convincing, due to the inherent variability in levels of protein expression
using transient transfection. This method can result in wildly varying expression
levels from one cell to the next, and high expression of 0rf3 from any plasmid,
usually resulted in some extranuclear protein. While an extranuclear component was
usually, rather than occasionally, present in cells expressing Orf3T96A, the
observation was too vague and inconsistent to be considered ''true''.
It was also attempted to try and ascertain any link between the Orf3-inducible PML
''tracks'', and the PML biochemical alteration observed during infection. Once again,
transient transfection proved to be an unsuitable method for these studies, as the
transfection efficiency in two cell types, was simply too low to allow the reliable
interpretation of results.
Accordingly, other methods were used to attempt to elucidate the phenotype of the
two mutants and to determine whether 0rf3 alone was responsible for the PML
biochemical alteration, by generating stable cell lines or whole, mutant virus.
Unfortunately, it was not possible to generate cell lines permanently expressing
E40rfl, and the construction of mutant virus was not completed. Interestingly, it was
not possible to generate cell lines permanently expressing E40rf3deI96-100,
suggesting that either the method used to generate these cell-lines was faulty and 0rf3
may not, as earlier suggested, be deleterious to cell survival, or that to some extent
Orf3deI96-100 was still functional and selected against in culture.
It would be of interest to generate further point mutations in the 0rf3 gene, covering
other conserved residues that have not, so far, been investigated. Namely, these are
V9, BIO, GIl, A12, E38, N39, Y40 and L4t. Using the same methods, these could
initially be screened by transient transfection and IF analysis in eukaryotic cells, for
any abnormalities in interaction with PML and the PODs, and nuclear track
formation. Such studies may identify a single residue necessary for these interactions,
which could help to characterise the nature of the interaction between 0rf3 and PML.
For example, are nuclear localisation to the PODs and track formation two, separable
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processes, or two aspects of a single interaction? It is also possible that no single
residue is crucial to track formation, in which case, the deletion of residues 96-100
may yet point towards a crucial site. It would be of interest to express a protein with
an additional point mutation, adjacent to T96A, perhaps 097 A, and determine
whether this would result in an altered Orf.3 distribution, without resorting to deletions
or mutations that we might expect to result in gross, conformational changes.
The nature of the interaction between 0rf.3 and El b-55kDa is also of interest, and the
plasmids already constructed could be used in future investigations to explore the
importance of these conserved regions to this, second interaction. The regions
represented in the panel of 0rf.3 expressing plasmids are conserved across adenovirus
serotypes, suggesting some functional significance. If, as suggested by these studies,
they are not implicated in POD redistribution and track formation, they might be
expected to be important in other functions of the protein, such as the formation of a
complex with 55K. It would be a relatively simple matter to screen these Orf.3
proteins for 55K colocalisation mutants, by co-transfecting the two proteins into
eukaryotic cells. Previous work has demonstrated the utility of this approach, showing
that when co-expressed in HEp-2 cells with Orf.3, the El b-55kDa protein is
reorganised from a diffuse, cytoplasmic stain, to colocalise at the nuclear tracks (data
not shown). This simple procedure could be utilised to identify any 0rf3 mutations
that did not reorganise 55K.
It is becoming increasingly clear that the PODs and PML are integral to many cellular
processes and therefore have implications for many fields of interest. By gaining
greater insights into the function of these structures we will better understand complex
cellular processes such as apoptosis, transcriptional regulation and the antiviral
response. This will inevitably have an impact on research into and the successful
treatment of conditions involving inappropriate cell growth and survival such as APL
and other malignancies, and may impact on treatment strategies for degenerative
disorders involving inappropriate cell death such as Alzheimer's disease and
Parkinson's disease. By studying the interactions of virus and host in this manner, it
may become possible to harness viruses as tools for the treatment of disease by gene
delivery, and through the measured control of the processes of cell death, to treat or
prevent those illnesses brought about from within consequent to the deregulation of
our own, cellular processes.
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Appendices
Appendix I: Table of primer pairings, and expected 10 reaction product size.
For primer sequences, see section 2.1.6.1.
Desired product (AdS Outside primer Mutational Expected
genomic positions) primer product size (bp)
pcDNA3.1 as
template
G42A (5'-3') JD1 JD4 870
G42A (3'-5') JD2 JD3 319
R100A (5'-3') JD1 JD6 1040
R100A (3'-5') JD2 JD5 144
R68A (5'-3') JD1 JD8 946
R68A (3'-5') JD2 JD7 240
de196-100(5'-3') JD1 JD12 1020
de196-100(3'-5') JD2 JDll 146
de138-42(5'-3') JD1 JD14 850
de138-42(3'-5') JD2 JD13 317
de19-13(5'-3') JD1 JD16 774
de19-13(3'-5') J02 J015 423
T96A (5'-3') JOI JD18 1019
T96A (3'-5') J02 J017 163
G97A (5'-3') JOI J020 1024
G97A (3'-5') J02 J019 153
G98A (5'-3') JOI J022 1040
G98A (3'-5') J02 JD21 151
E99A (5'-3') JOI J023 1039
E99A (3'-5') J02 J024 124
AdS genome as
template
deI96-100 (3'-5') JC027 mu 718
deI96-100 (5'-3') JC028 J012 878
T96A (3' -5') JCD27 JD17 735
T96A (5' -3') JC028 J018 877
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Appendix II: equencing cbromatogram ofpcDNA3.1I0rf3wt
om gene po .73-423.
70 eo 90 100 110 121
). T C CAT G ). T T C GC T GC T T GAG G C T G A A G G T G GAG G GC GC T C T G GAG C A GAT T
~
!O 130 140 150 160 170
• TT TA C A AT G GC C G G AC TT A A TAT T C G G GAT TT GC TT A GAG A TAT AT T GAG A
WVfft if&M
230 240 250 260 270
ATAGAGGAGATTCACCCTGAAGGGTTTAGCCTTTACGTCCACTTGGACGTGA
aso 290 300 310 320
GGGCCGTTTGCCTTTTGGAAGCCATTGTGCAACATCTTACAAATGCCATTAT
330 340 350 360 370
CTGTTCTTTGGCTGTAGA GTTTGAC CAeGC CAe C GGAGGGGAGC GC GTTCACT
80 390 400 410 420 430
T A A TAG A TC T TC A T TT T GAG G TT TT G GAT A A T C TT TT G GA A T A A A A A A A A A A
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Appendix Ill: Sequencing chromatogram of pcDNA3.1I0rOG42A
o-n gene pos.73-443. Altered sites underlined in red
90 100 110 lZO 130 14C
,TCCATGATTCGCTGCTTGAGGCTGAAGGTGGAGGGCGCTCTGGAGCAGATT
~
I 150 160 170 180 190
TTTACAATGGC CGGACTTAATATTCGGGATTTGCTTAGAGATATATTGAGAAG
~1[r~~'1!i
ZOO Z10 ZZO Z30 Z40
C; T G GC GAG AT GAG A A T TAT TT c] G.uA T G c T T G A A C; G T GeT G C; A AT C; TT TAT A G A C;
~
250 260 Z70 280 290 300
GAGATTCACCCTGAAGGGTTTAGCCTTTACGTCCACTTGGACGTGAGGGCCGTTTGCC
310 no 330 340 350 360
T TT T G G AA G C CAT T G T G C A A CAT CT TA C A A A T G C CAT TAT C T G TT C T TT G GC T G TA GAG T TT
viEU
370 380 390 400 410 420 430
GAC CACGC CAC CGGAGGGGAGCGC GTTCACTTAATAGATCTTCATT TGAGGTT TGGATAATCTTTT
~
440
GGAATAAA
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Appendix IV: Sequencing chromatogram of pcDNA3.1I0rt3R68A
orO gene pos.73-423. Altered sites underlined in red
70 80 90 100 110 120
T C C AT GAT T C GC T GC TT GAG GC T G A A G G T G GAG G GC GC T c r G GAG C A GAT T T T
I A ~
~ t ~r! 1~IMI
I w'"' ~ f\" ~ f'. ~130 140 150 160 170
TACAATGGC CGGACTTAATATTCGGGATTTGCTTAGAGATATATTGAGAAGG
1\ fI
J 1~rf\P"
n
~ ~"~A~ ~ ~ ~ ~ A
A
u lA " I!:--I~ ~ .\ J j180 190 200 210 220
TGGCGAGATGAGAATTATTTGGGCATGGTTGAAGGTGCTGGAATGTTTATAG
~~
230 240 250 260 270
AG GAGATTCAC C C TGAAG G GTTTA GC CTTTAC GTC CAC TTGGAC
C GTTTGC CTTTTGGAA GC CATTGTGCAACATCTTACAAATGC CATTATCT GTT
340 350 360 370 380
CTTTGGCTGTAGAGTTTGACCACGCCACCGGA(;G(;GAGCGCGTTCACTTAATA
GAT C T T CAT TT T GAG G T T TT G G A TA A T C TT T T G G A A TA A
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Appendix V: Sequencing chromatogram of pcDNA3.1I0rf3T96A
OrO gene pos.99-449. Altered site underlined in red
100 110 120 130 140 15
T CA T GAT T C GeT GeT T GAG GeT G A A G G T G GAG G GC GeT c r G GAG CA GAT TT T TA
~
o 160 170 180 190 200
C A A T G s c c G G ACT TA A TAT T eGG GAT TT G C T TAG A GAT A TAT T GAG A A G G T G GC G
210 220 230 240 250 260
AGATGAGAATTATTTGGGCATGGTTGAAGGTGCTGGAATGTTTATAGAGGAGATTCAC
270 280 290 300 310 320
C C T GA A Ii G e r TT A GC C T T TA C G T C CA C T T G G A C GT GA G G c c c GT T T GC C T T TT G GAA G C CA'
330 340 350 360 370 380 390
r T GT G CA A CAT C TTA C AA AT GC CA T TA T C T GTT C TTTG GC T GTA GA GTTT GAe c AC G C C,:"C C GG AGG
400 410 420 430 440 4
G GA GC GC GTTCAC TTA ATA G ATC T~C A TTTTGAG GT'ITT GGAT AA TCTTTTGG AA TAA
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Appendix VI: Sequencing chromatogram ofpcDNA3.1I0rf3G97A
orO gene pos.74-424. Altered sites underlined in red
70 80 90 100 110 120
ATC CATGATTCGCTGCTTGAGGC TGAAGGTGGAGGGC GC TCTGG1o.GCA GAT
o 130 140 150 160 170
TTTTACAATGGCCGGACTTAATATTCGGGATTTGCTTAGAGATATATTGA
180 190 200 210 220
G A A G G T G GC GAG AT GAG A AT TAT TT G G G CAT G G T T G A A G G T G C T G G A A T G'
) 230 240 250 260 27(
TTTATAGAGGAGATTCACCCTGAAGGGTTTAGCCTTTACGTCCACTTGGA
) 280 290 300 310 32C
C GTGAGGGC C GTTTGC CTTTTGGAAGC CATTGTGCAACATCTTACAAATG
~
o 330 340 350 360 371
. C CAT TAT C T G TT C T T T G GeT G TAG A G T TT G A C CA C G C CAe C G.... G G G GAG
o 380 390 400 410 420
C GC G TT CA C T TA A TA GAT C T TC AT TT T GAG G T TT T G G A TA A T C TT TT G GA A TA A
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Appendix VII: Sequencing chromatogram of pcDNA3.1I0rf3G98A
Orf3 gene pos.1l2462. Altered sites underlined in red
110 120 130 140 150 16
~
I 170 180 190 200 210
TTACAATGGC C GGAC TTAATATTCGGGATTTGCTTAGAGATATATTGAGAAG
~
220 230 240 250 260
GTG GC GA GATGA GA ATTATTTGGGCATGGTTGAAGGTGC TGGAATGTTTAT,
270 Z80 290 300 310
ATA GAGGAGATTCAC CCTGAAGGGTTTAGC CTTTAC GTCCACTTGGAC GTGA
320 330 340 350 360
GGGC CGTTTGCCTTTTGGAAGC CATTGTGCAACATCTTACAAATGCCATTA
J
370 380 390 400 410
TCTGTTCTTTGGCTGTA GA GTTTGAC CAG GC GAC CGGAGUGAGG GC GTTG
420 430 440 450 460
AGTTAATAGATCTTCATTTTGAGGTTTTGGATAATCTTTTGGAATAAA
]76
Appendix VIII: Sequencing chromatogram of pcDNA3.1I0rf3E99A
OrO gene pos.96-446. Altered site underlined in red
150 160 170 180 190 200
AATGGC CGGACTTAATATTCGGGATTTGCTTAGAGATATATTGAGAAGGTGGC
240
GAGATGAGAATTATTTGGGCATGGTTGAAGGTGCTGGAATGTTTATAGAGGAG
~~
260 270 280 290 300
A TT CAe C C T GA A G G GTT TAG C C T T TA. C GTe C ACT T G G A C GT GAG G c c c GTT T GC
310 320 330 340 350 360
CTTTTGGAA GC CATTGTGCAACATCTTACAAATGC CATTATCTGTTCTTTGGC
370 380 390 400 410
T G TAG A G T T T 17Ace A C 17C C Ace G GAG G G GC,. C G C 17T TeA C T T A A TAG A T C T T
~ ~
420 430 440
CATTTT GAG GTTTTG GATA ATC TTTTGGAATAA A
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Appendix IX: Sequencing chromatogram ofpcDNA3.1I0rf3RlOOA
OrO gene pos.73-423. Altered sites underlined in red
70 60 90 100 110 lZ0
TCCATGATTCGCTGCTTGAGGCTGAAGGTGGAGGGCGCTCTGGAGCAGATT
r: f1 r r t
~f r~~1A
(w \1 '" 1\ J'\...-,j 1\.
130 140 150 160 17(
TTTACAATGGCCGGACTTAATATTCGGGATTTGCTTAGAGATATATTGAG
\ ~
o 160 ZOO Z10 ZZO
·AAGGTGGCGAGATGAGAATTATTTGGGCATGGTTGAAGGTGCTGGAATGT·
TT A TAG A G GAG A T T C A C C C T G A A G G GT T TA GC C TT TA C GTe CAe TT G G A C
260 290 300 310 320
G T GAG G GC C GT T T GC C TT TT G G A A GCe AT T GT GC A A CAT c r TA C A A A T G C
o 330 340 350 360 37
CATTATCT GTTCTTTGGCT GTA GA GTTTGAC CAe GC CAC C GGAGG GGAG~
--'--
o 360 390 400 410 420
CCGTTCACTTAATAGATCTTCATTTTGAGGTTTTGGATAATCTTTTGGAATAAA
_
:
178
Appendix X: Sequencing chromatogram of pcDNA3.1I0rf3deI9-13
Orf3 gene pos.72-407. 'Y = site of deletion
70 BO 90 Y 100 110
~CCATGATTCGCTGCTTGAGGCTGAAGGAGCAGATTTTTACAATGGCCGGAC
12(
) 130 140 150 160 170
TTAATATTCGGGATTTGCTTAGAGATATATTGAGAAGGTGGC GAGATGAGA
~~
160 190 200 210 220
230 240 250 260 270
CTGAAGGGTTTAGCCTTTACGTCCACTTGGACGTGAGGGCCGTTTGCCTTTT
280 290 300 310 320
G GA AGe CAT T GT GC A A CAT CTTA C A A A T G C CAT TAT C C GT T C TT T G GC T G TA
330 340 350 360 370
GA GTTTGAC CAC GC CAC C GGAGG GGAGC GC GTTCAC TTAATA GATC TTCATT·
360 390 400 410
TT GAG GTTTTGGATAATCTTTTGGAATAAAAA~
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Appendix XI: Sequencing chromatogram of pcDNA3.1I0rOdeI38-42
o-e gene pos.73-408 ~ = site of deletion
70 110 12080 90 100
~:Ni!
130 140 150 160 170
'TTACAATGGCCGGACTTAATATTCGGGATTTGCTTAGAGATATATTGAGAAGI
~.
180 ". 190 200 210 220
:TTGGC GAGATATGGTTGAAGGTGCTGGAATGTTTATA GAGGAGATTCACe eTG
~
230 240 250 260 270
,AAG G GTTTA GC CTTTAC GTe CAC TTG GAC GT GA G G GC C GTTTGC C TTTTG GAA
280 290 300 310 320 330
GC CATTGTGCAACATCTTACAAATGC CATTATCTGTTCTTTGGCT GTA GA GTT
340 350 360 370 380
'TGACCACGCCACCGGAGGGGAGCGCGTTCACTTAATAGATCTTCATTTTGAGG
390 400 410 420 43(
TT TT G GAT A AT C TT TT G GA A TA A A A A A A A A A CAT G GT T c r T C CA G
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Appendix XII: Sequencing chromatogram ofpcDNA3.1I0rf3deI96-100
Orf3 gene po .70-405 T = site of deletion
70 80 90 100 110 120
ATGATTCGCTGCTTGAGGCTGAAGGTGGAGGGCGCTCTGGAGCAGATTTTTA(
~'NI~
170
190
GCGAGATGAGAATTATTTGGGCATGGTTGAAGGTGCTGGAATGTTTATAGAG
~I:i~
230 240 zso 260 270
GAG" TT C" C C C T G " A G G G TT TAG C C TT TA C GTe C ACT T G G A C GT GAG G o c c G
280 290 300 310 320 33
TTTGCCTTTTGGAAGCCATTGTGCAACATCTTACAAATGCCATTATCTGTTCT
) 340 350 360 370 380
TTGGCTGTAGAGTTTGAC CAC GC C GTTCACTTAAT" GATCTTCATTTTGAGGT
3~ 400 CC
TT T G GAT A ... T c r TT T G G A A TA A A A A A A
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